https://www.欧洲杯微信买球astrazeneca.com/ 2021 - 06 - 17 t15:58:54.740z https://www.欧洲杯微信买球astrazeneca.com/covid - 19. - html 2021 - 06 - 15 - t06:21:00.528z https://www.欧洲杯微信买球astrazeneca.com/covid-19/frequently-asked-questions.html 2021 - 03 - 22 - t07:11:53.999z https://www.欧洲杯微信买球astrazeneca.com/asn -肾周- 2020 reimagined.html 2020 - 10 - 21 - t18:55:14.375z https://www.欧洲杯微信买球astrazeneca.com/publication.html 2021 - 01 - 08 - t10:28:36.368z https://www.欧洲杯微信买球astrazeneca.com/publication/04082020.html 2020 - 09 - 12 - t20:25:25.417z https://www.欧洲杯微信买球astrazeneca.com/publication/14082020.html 2020 - 09 - 15 - t13:08:30.448z https://www.欧洲杯微信买球astrazeneca.com/publication/01062020.html 2020 - 09 - 02 - t07:29:27.126z https://www.欧洲杯微信买球astrazeneca.com/publication/01062020 - 2. - html 2020 - 09 - 02 - t07:31:00.325z https://www.欧洲杯微信买球astrazeneca.com/publication/29052020.html 2020 - 09 - 15 - t13:09:16.308z https://www.欧洲杯微信买球astrazeneca.com/publication/27052020.html 2020 - 09 - 14 - t11:24:22.102z https://www.欧洲杯微信买球astrazeneca.com/publication/21052020.html 2020 - 09 - 14 - t16:24:12.192z https://www.欧洲杯微信买球astrazeneca.com/publication/20052020.html 2020 - 09 - 15 - t13:59:49.604z https://www.欧洲杯微信买球astrazeneca.com/publication/18052020.html 2020 - 09 - 12 - t20:36:11.815z https://www.欧洲杯微信买球astrazeneca.com/publication/02052020.html 2020 - 09 - 02 - t07:38:47.973z https://www.欧洲杯微信买球astrazeneca.com/publication/14042020.html 2020 - 09 - 14 - t15:09:10.883z https://www.欧洲杯微信买球astrazeneca.com/publication/07042020.html 2020 - 09 - 06 - t19:16:39.700z https://www.欧洲杯微信买球astrazeneca.com/publication/24032020.html 2020 - 09 - 02 - t07:43:06.868z https://www.欧洲杯微信买球astrazeneca.com/publication/16032020.html 2020 - 09 - 14 - t12:17:42.894z https://www.欧洲杯微信买球astrazeneca.com/publication/11032020.html 2020 - 09 - 12 - t20:38:04.968z https://www.欧洲杯微信买球astrazeneca.com/publication/11022020.html 2020 - 09 - 12 - t20:38:47.683z https://www.欧洲杯微信买球astrazeneca.com/publication/27012020.html 2020 - 09 - 14 - t16:24:12.169z https://www.欧洲杯微信买球astrazeneca.com/publication/20012020.html 2020 - 09 - 14 - t12:18:10.387z https://www.欧洲杯微信买球astrazeneca.com/publication/09012020.html 2020 - 09 - 02 - t07:50:31.579z https://www.欧洲杯微信买球astrazeneca.com/publication/01012020.html 2020 - 09 - 02 - t07:51:31.879z https://www.欧洲杯微信买球astrazeneca.com/publication/29112019.html 2020 - 09 - 02 - t07:54:11.510z https://www.欧洲杯微信买球astrazeneca.com/publication/19112019.html 2020 - 09 - 14 - t16:53:04.339z https://www.欧洲杯微信买球astrazeneca.com/publication/06112019.html 2020 - 09 - 14 - t16:24:12.243z https://www.欧洲杯微信买球astrazeneca.com/publication/28102019.html 2020 - 09 - 02 - t07:57:51.275z https://www.欧洲杯微信买球astrazeneca.com/publication/25102019.html 2020 - 09 - 02 - t07:58:41.622z https://www.欧洲杯微信买球astrazeneca.com/publication/21102019.html 2020 - 09 - 02 - t07:59:41.284z https://www.欧洲杯微信买球astrazeneca.com/publication/11102019.html 2020 - 09 - 14 - t12:18:24.408z https://www.欧洲杯微信买球astrazeneca.com/publication/24092019.html 2020 - 09 - 14 - t16:24:12.250z https://www.欧洲杯微信买球astrazeneca.com/publication/28082019.html 2020 - 09 - 14 - t12:17:00.783z https://www.欧洲杯微信买球astrazeneca.com/publication/31072019.html 2020 - 09 - 14 - t12:18:40.906z https://www.欧洲杯微信买球astrazeneca.com/publication/29072019.html 2020 - 09 - 14 - t12:18:55.292z https://www.欧洲杯微信买球astrazeneca.com/publication/17072019.html 2020 - 09 - 14 - t12:19:08.542z https://www.欧洲杯微信买球astrazeneca.com/publication/10072019.html 2020 - 09 - 14 - t12:19:24.591z https://www.欧洲杯微信买球astrazeneca.com/publication/110072019 - 2. - html 2020 - 09 - 14 - t12:19:37.859z https://www.欧洲杯微信买球astrazeneca.com/publication/01072019.html 2020 - 09 - 14 - t12:19:51.978z https://www.欧洲杯微信买球astrazeneca.com/publication/17062019.html 2020 - 09 - 14 - t12:20:05.192z https://www.欧洲杯微信买球astrazeneca.com/publication/13062019.html 2020 - 09 - 14 - t15:07:25.017z https://www.欧洲杯微信买球astrazeneca.com/publication/10062019.html 2020 - 09 - 15 - t13:12:41.727z https://www.欧洲杯微信买球astrazeneca.com/publication/02062019.html 2020 - 09 - 14 - t12:20:38.281z https://www.欧洲杯微信买球astrazeneca.com/publication/02052019.html 2020 - 09 - 14 - t12:20:48.720z https://www.欧洲杯微信买球astrazeneca.com/publication/25042019.html 2020 - 09 - 14 - t12:21:06.076z https://www.欧洲杯微信买球astrazeneca.com/publication/22042019.html 2020 - 09 - 14 - t16:24:12.254z https://www.欧洲杯微信买球astrazeneca.com/publication/19042019.html 2020 - 09 - 15 - t13:14:34.031z https://www.欧洲杯微信买球astrazeneca.com/publication/28032019.html 2020 - 09 - 15 - t13:15:06.049z https://www.欧洲杯微信买球astrazeneca.com/publication/14032019.html 2020 - 09 - 14 - t12:22:00.561z https://www.欧洲杯微信买球astrazeneca.com/publication/07032019.html 2020 - 09 - 14 - t12:22:13.064z https://www.欧洲杯微信买球astrazeneca.com/publication/28022019.html 2020 - 09 - 14 - t12:22:23.355z https://www.欧洲杯微信买球astrazeneca.com/publication/25022019.html 2020 - 09 - 14 - t15:06:59.852z https://www.欧洲杯微信买球astrazeneca.com/publication/20022019.html 2020 - 09 - 14 - t16:24:12.248z https://www.欧洲杯微信买球astrazeneca.com/publication/18022019.html 2020 - 09 - 14 - t12:23:04.266z https://www.欧洲杯微信买球astrazeneca.com/publication/04022019.html 2020 - 09 - 14 - t12:23:15.781z https://www.欧洲杯微信买球astrazeneca.com/publication/30012019.html 2020 - 09 - 14 - t12:28:32.210z https://www.欧洲杯微信买球astrazeneca.com/publication/29012019.html 2020 - 09 - 14 - t12:15:59.986z https://www.欧洲杯微信买球astrazeneca.com/publication/08012019.html 2020 - 09 - 14 - t12:28:58.041z https://www.欧洲杯微信买球astrazeneca.com/publication/02012019.html 2020 - 09 - 14 - t12:29:13.652z https://www.欧洲杯微信买球astrazeneca.com/publication/26122018.html 2020 - 09 - 14 - t16:24:12.208z https://www.欧洲杯微信买球astrazeneca.com/publication/18122018.html 2020 - 09 - 14 - t16:24:12.216z https://www.欧洲杯微信买球astrazeneca.com/publication/17122018.html 2020 - 09 - 14 - t12:29:51.801z https://www.欧洲杯微信买球astrazeneca.com/publication/10122018.html 2020 - 09 - 14 - t12:30:03.509z https://www.欧洲杯微信买球astrazeneca.com/publication/03122018.html 2020 - 09 - 14 - t12:30:17.347z https://www.欧洲杯微信买球astrazeneca.com/publication/22102018.html 2020 - 09 - 14 - t12:30:28.164z https://www.欧洲杯微信买球astrazeneca.com/publication/18102018.html 2020 - 09 - 14 - t12:30:46.223z https://www.欧洲杯微信买球astrazeneca.com/publication/17102018.html 2020 - 09 - 14 - t16:24:12.236z https://www.欧洲杯微信买球astrazeneca.com/publication/12102018.html 2020 - 09 - 14 - t12:31:09.337z https://www.欧洲杯微信买球astrazeneca.com/publication/04102018.html 2020 - 09 - 14 - t16:50:44.398z https://www.欧洲杯微信买球astrazeneca.com/publication/12092018.html 2020 - 09 - 14 - t12:31:29.071z https://www.欧洲杯微信买球astrazeneca.com/publication/12092018 - 2. - html 2020 - 09 - 14 - t15:05:30.889z https://www.欧洲杯微信买球astrazeneca.com/publication/02092020.html 2020 - 09 - 12 - t20:24:27.098z https://www.欧洲杯微信买球astrazeneca.com/publication/02072020.html 2020 - 09 - 14 - t15:10:02.409z https://www.欧洲杯微信买球astrazeneca.com/publication/11102019 - 2. - html 2020 - 09 - 14 - t12:32:17.278z https://www.欧洲杯微信买球astrazeneca.com/publication/15072020.html 2020 - 09 - 25 - t17:41:32.431z https://www.欧洲杯微信买球astrazeneca.com/publication/05082020.html 2020 - 09 - 25 - t18:00:01.884z https://www.欧洲杯微信买球astrazeneca.com/publication/15072020 - 2. - html 2020 - 09 - 25 - t18:05:06.158z https://www.欧洲杯微信买球astrazeneca.com/publication/17082020.html 2020 - 09 - 25 - t18:18:17.007z https://www.欧洲杯微信买球astrazeneca.com/publication/12102020.html 2020 - 10 - 30 - t13:30:53.627z https://www.欧洲杯微信买球astrazeneca.com/publication/19102020.html 2020 - 10 - 30 - t14:52:43.630z https://www.欧洲杯微信买球astrazeneca.com/publication/21092020.html 2020 - 10 - 30 - t13:30:43.111z https://www.欧洲杯微信买球astrazeneca.com/publication/29092020.html 2020 - 10 - 30 - t14:53:41.680z https://www.欧洲杯微信买球astrazeneca.com/publication/28092020.html 2020 - 10 - 30 - t14:48:58.607z https://www.欧洲杯微信买球astrazeneca.com/publication/09102020.html 2020 - 10 - 30 - t13:32:24.560z https://www.欧洲杯微信买球astrazeneca.com/publication/07012021.html 2021 - 01 - 08 - t11:58:45.151z https://www.欧洲杯微信买球astrazeneca.com/publication/21122020.html 2021 - 01 - 08 - t13:05:26.151z https://www.欧洲杯微信买球astrazeneca.com/publication/070120211.html 2021 - 01 - 11 t10:21:18.994z https://www.欧洲杯微信买球astrazeneca.com/publication/02122020.html 2021 - 01 - 25 - t07:38:47.187z https://www.欧洲杯微信买球astrazeneca.com/publication/16122020.html 2021 - 01 - 25 - t07:40:14.290z https://www.欧洲杯微信买球astrazeneca.com/publication/161220201.html 2021 - 01 - 25 - t07:41:29.933z https://www.欧洲杯微信买球astrazeneca.com/publication/21012021.html 2021 - 04 - 07 - t13:42:27.003z https://www.欧洲杯微信买球astrazeneca.com/publication/210120211.html 2021 - 01 - 25 - t07:53:14.362z https://www.欧洲杯微信买球astrazeneca.com/publication/25012021.html 2021 - 02 - 04 - t10:11:31.946z https://www.欧洲杯微信买球astrazeneca.com/publication/26022021.html 2021 - 04 - 07 - t13:43:47.204z https://www.欧洲杯微信买球astrazeneca.com/publication/16032021.html 2021 - 04 - 07 - t05:53:54.199z https://www.欧洲杯微信买球astrazeneca.com/publication/08032021.html 2021 - 04 - 07 - t13:36:39.715z https://www.欧洲杯微信买球astrazeneca.com/publication/05032021.html 2021 - 04 - 07 - t05:55:50.259z https://www.欧洲杯微信买球astrazeneca.com/publication/23032021.html 2021 - 04 - 06 - t15:54:17.079z https://www.欧洲杯微信买球astrazeneca.com/r-d.html 2021 - 04 - 20 - t13:13:02.888z https://www.欧洲杯微信买球astrazeneca.com/r-d/our-approach.html 2020 - 11 - 10 - t17:57:07.873z https://www.欧洲杯微信买球astrazeneca.com/r-d/our-approach/stem-at-astrazeneca.html 2021 - 05 - 10 - t11:57:45.375z https://www.欧洲杯微信买球astrazeneca.com/r-d/our-technologies.html 2020 - 11 - 12 - t17:12:41.674z https://www.欧洲杯微信买球astrazeneca.com/r-d/our-technologies/acoustic-tube-sample-management.html 2020 - 11 - 16 - t13:55:17.992z https://www.欧洲杯微信买球astrazeneca.com/r-d/our-technologies/advanced-molecular-imaging.html 2021 - 01 - 08 - t08:20:00.355z https://www.欧洲杯微信买球astrazeneca.com/r-d/our-technologies/cryo-em.html 2020 - 11 - 12 - t10:57:55.885z https://www.欧洲杯微信买球astrazeneca.com/r-d/our-technologies/functional-genomics.html 2020 - 09 - 16 - t06:38:00.595z https://www.欧洲杯微信买球astrazeneca.com/r-d/our-technologies/multi-omics.html 2020 - 09 - 16 - t06:38:17.202z https://www.欧洲杯微信买球astrazeneca.com/r-d/our-technologies/ilab.html 2020 - 09 - 16 - t07:00:14.499z https://www.欧洲杯微信买球astrazeneca.com/r-d/next-generation-therapeutics.html 2021 - 02年- 15 - t11:39:30.279z https://www.欧洲杯微信买球astrazeneca.com/r-d/next-generation-therapeutics/oligonucleotide-conjugates.html 2020 - 09 - 21 - t10:30:03.285z https://www.欧洲杯微信买球astrazeneca.com/r-d/next-generation-therapeutics/antisense-oligonucleotides.html 2020 - 09 - 21 - t10:29:30.023z https://www.欧洲杯微信买球astrazeneca.com/r-d/next-generation-therapeutics/small-molecule.html 2020 - 09 - 21 - t10:27:02.500z https://www.欧洲杯微信买球astrazeneca.com/r-d/next-generation-therapeutics/protacs.html 2020 - 09 - 21 - t10:26:36.804z https://www.欧洲杯微信买球astrazeneca.com/r-d/next-generation-therapeutics/mrna.html 2020 - 09 - 21 - t10:26:10.473z https://www.欧洲杯微信买球astrazeneca.com/r-d/next-generation-therapeutics/cell-therapies.html 2021 - 06 - 09 - t07:16:19.528z https://www.欧洲杯微信买球astrazeneca.com/r-d/next-generation-therapeutics/in-vivo-expressed-biologics.html 2020 - 09 - 16 - t06:41:17.111z https://www.欧洲杯微信买球astrazeneca.com/r-d/next-generation-therapeutics/sodium-zirconium-cyclosilicate.html 2020 - 09 - 16 - t06:42:52.787z https://www.欧洲杯微信买球astrazeneca.com/r-d/next-generation-therapeutics/therapeutic-gene-editing.html 2020 - 09 - 16 - t06:43:12.625z https://www.欧洲杯微信买球astrazeneca.com/r-d/next-generation-therapeutics/small-interfering-rna.html 2020 - 09 - 16 - t06:46:02.673z https://www.欧洲杯微信买球astrazeneca.com/r-d/next-generation-therapeutics/monoclonal-antibodies.html 2020 - 09 - 16 - t06:46:19.321z https://www.欧洲杯微信买球astrazeneca.com/r-d/next-generation-therapeutics/antibody-drug-conjugate.html 2020 - 09 - 16 - t07:01:43.380z https://www.欧洲杯微信买球astrazeneca.com/r-d/next-generation-therapeutics/bispecific-antibody.html 2020 - 09 - 16 - t06:46:45.646z https://www.欧洲杯微信买球astrazeneca.com/r-d/next-generation-therapeutics/fragment-antibody.html 2020 - 09 - 16 - t06:46:57.369z https://www.欧洲杯微信买球astrazeneca.com/r-d/next-generation-therapeutics/therapeutic-proteins.html 2020 - 09 - 21 - t10:29:02.442z https://www.欧洲杯微信买球astrazeneca.com/r-d/next-generation-therapeutics/bicyclic-peptides.html 2020 - 09 - 21 - t10:27:40.276z https://www.欧洲杯微信买球astrazeneca.com/r-d/next-generation-therapeutics/anticalin-proteins.html 2020 - 09 - 21 - t10:31:31.561z https://www.欧洲杯微信买球astrazeneca.com/r-d/transformative-science.html 2020 - 09 - 16 - t09:36:25.708z https://www.欧洲杯微信买球astrazeneca.com/r-d/our-strategic-r-d-centres.html 2020 - 09 - 16 - t09:58:39.062z https://www.欧洲杯微信买球astrazeneca.com/r-d/data-science-and-ai.html 2021 - 06 - 07 - t11:05:12.320z https://www.欧洲杯微信买球astrazeneca.com/r-d/digital-health-revolutionising-healthcare-for-patients.html 2021 - 06 - 16 - t11:40:47.362z https://www.欧洲杯微信买球astrazeneca.com/AstraZeneca-presents-new-data-at-ERA-EDTA-HFA-Discoveries-and-ADA.html 2020 - 11 - 02 - t11:46:03.783z https://www.欧洲杯微信买球astrazeneca.com/our-therapy-areas.html 2021 - 04 - 29 - t20:43:39.187z https://www.欧洲杯微信买球astrazeneca.com/our-therapy-areas/oncology.html 2021 - 06 - 07 - t12:30:10.709z https://www.欧洲杯微信买球astrazeneca.com/our-therapy-areas/oncology/clinical-strategy.html 2021 - 06 - 09 - t05:46:59.846z https://www.欧洲杯微信买球astrazeneca.com/our-therapy-areas/oncology/medicines-portfolio-and-pipeline.html 2021 - 06 - 06 - t12:37:09.654z https://www.欧洲杯微信买球astrazeneca.com/our-therapy-areas/oncology/patient-experience.html 2021 - 06 - 07 - t07:40:19.291z https://www.欧洲杯微信买球astrazeneca.com/our-therapy-areas/oncology/our-people-and-culture.html 2021 - 06 - 07 - t07:36:22.910z https://www.欧洲杯微信买球astrazeneca.com/our-therapy-areas/oncology/haematology.html 2021 - 06 - 04 - t09:30:37.694z https://www.欧洲杯微信买球astrazeneca.com/our-therapy-areas/oncology/cervical-cancer.html 2021 - 02年- 23 - t11:09:29.435z https://www.欧洲杯微信买球astrazeneca.com/our-therapy-areas/oncology/immuno-oncology.html 2021 - 05 - 27 - t10:56:14.080z https://www.欧洲杯微信买球astrazeneca.com/our-therapy-areas/oncology/dna-damage-response.html 2021 - 04 - 15 - t11:01:55.221z https://www.欧洲杯微信买球astrazeneca.com/our-therapy-areas/oncology/antibody-drug-conjugates.html 2021 - 01 - 21 t17:57:16.141z https://www.欧洲杯微信买球astrazeneca.com/our-therapy-areas/oncology/Tumour-drivers-and-resistance.html 2019 - 05 - 30 - t18:31:34.573z https://www.欧洲杯微信买球astrazeneca.com/our-therapy-areas/oncology/at-the-forefront-of-lung-cancer-treatment.html 2021 - 06 - 08 - t14:46:57.309z https://www.欧洲杯微信买球astrazeneca.com/our-therapy-areas/oncology/prostate-cancer.html 2020 - 06 - 19 t17:59:34.141z https://www.欧洲杯微信买球astrazeneca.com/our-therapy-areas/oncology/leading-the-revolution-in-pancreatic-cancer.html 2020 - 06 - 19 t18:04:06.648z https://www.欧洲杯微信买球astrazeneca.com/our-therapy-areas/oncology/breast-cancer.html 2020 - 06 - 19 t18:03:22.675z https://www.欧洲杯微信买球astrazeneca.com/our-therapy-areas/oncology/ovarian-cancer.html 2020 - 06 - 22 - t09:54:39.610z https://www.欧洲杯微信买球astrazeneca.com/our-therapy-areas/oncology/Liver-cancer.html 2021 - 04 - 16 - t16:23:59.209z https://www.欧洲杯微信买球astrazeneca.com/our-therapy-areas/oncology/new-normal-same-cancer.html 2021 - 06 - 09 - t05:45:08.074z https://www.欧洲杯微信买球astrazeneca.com/our-therapy-areas/biopharmaceuticals.html 2021 - 05 - 10 - t16:26:50.933z https://www.欧洲杯微信买球astrazeneca.com/our-therapy-areas/cardiovascular-renal-and-metabolism.html 2021 - 04 - 29 - t20:40:08.681z https://www.欧洲杯微信买球astrazeneca.com/our-therapy-areas/cardiovascular-renal-and-metabolism/heart-failure.html 2020 - 10 - 12 - t13:26:11.146z https://www.欧洲杯微信买球astrazeneca.com/our-therapy-areas/cardiovascular-renal-and-metabolism/chronic-kidney-disease.html 2021 - 03 - 16 - t13:38:07.698z https://www.欧洲杯微信买球astrazeneca.com/our-therapy-areas/cardiovascular-renal-and-metabolism/metabolism.html 2020 - 10 - 12 - t13:25:15.514z https://www.欧洲杯微信买球astrazeneca.com/our-therapy-areas/cardiovascular-renal-and-metabolism/cardiovascular-disease.html 2021 - 01 - 15 - t18:05:00.855z https://www.欧洲杯微信买球astrazeneca.com/our-therapy-areas/respiratory-and-immunology.html 2021 - 05 - 17 - t15:22:31.892z https://www.欧洲杯微信买球astrazeneca.com/our-therapy-areas/respiratory-and-immunology/lupus.html 2021 - 05 - 12 - t15:39:06.576z https://www.欧洲杯微信买球astrazeneca.com/our-therapy-areas/infection-and-vaccines.html 2020 - 10 - 15 - t13:10:23.101z https://www.欧洲杯微信买球astrazeneca.com/our-therapy-areas/neuroscience.html 2020 - 10 - 15 - t13:10:50.661z https://www.欧洲杯微信买球astrazeneca.com/our-therapy-areas/other-disease-areas.html 2021 - 04 - 30 - t13:53:06.020z https://www.欧洲杯微信买球astrazeneca.com/our-therapy-areas/pipeline.html 2021 - 04 - 29 - t20:37:39.123z https://www.欧洲杯微信买球astrazeneca.com/our-therapy-areas/medicines.html 2020 - 10 - 15 - t13:12:51.444z https://www.欧洲杯微信买球astrazeneca.com/our-therapy-areas/eosinophilic-immune-dysfunction.html 2021 - 05 - 04 - t10:27:34.532z https://www.欧洲杯微信买球astrazeneca.com/government-contract-t-cs.html 2020 - 09 - 06 - t12:05:26.555z https://www.欧洲杯微信买球astrazeneca.com/az-suppliers.html 2021 - 03 - 30 - t13:17:05.861z https://www.欧洲杯微信买球astrazeneca.com/az-suppliers/supplier-contact-information.html 2021 - 05 - 17 - t15:36:42.598z https://www.欧洲杯微信买球astrazeneca.com/az-suppliers/healthcheck.html 2018 - 09 - 13 - t23:10:42.884z https://www.欧洲杯微信买球astrazeneca.com/az-suppliers/az-coupa-supplier.html 2021 - 04 - 21 - t07:28:52.638z https://www.欧洲杯微信买球astrazeneca.com/az-suppliers/az-coupa-supplier/faq.html 2020 - 08 - 13 - t12:37:35.161z https://www.欧洲杯微信买球astrazeneca.com/az-suppliers/az-coupa-supplier/latest-update.html 2021 - 05 - 28 - t12:41:57.384z https://www.欧洲杯微信买球astrazeneca.com/az-suppliers/az-coupa-supplier/information.html 2021 - 02年- 15 - t07:21:37.222z https://www.欧洲杯微信买球astrazeneca.com/patient-reported-outcomes.html 2018 - 09 - 13 - t23:13:37.089z https://www.欧洲杯微信买球astrazeneca.com/patient-reported-outcomes/gastrointestinal.html 2021 - 03 - 30 - t11:39:43.856z https://www.欧洲杯微信买球astrazeneca.com/patient-reported-outcomes/cardiovascular.html 2018 - 02年- 21 - t11:04:33.833z https://www.欧洲杯微信买球astrazeneca.com/patient-reported-outcomes/respiratory.html 2021 - 03 - 31 - t02:38:53.490z https://www.欧洲杯微信买球astrazeneca.com/patient-reported-outcomes/order-instrument.html 2017 - 07 - 06 - t12:51:55.943z https://www.欧洲杯微信买球astrazeneca.com/patient-reported-outcomes/faqs.html 2020 - 10 - 08 - t11:32:53.092z https://www.欧洲杯微信买球astrazeneca.com/patient-reported-outcomes/contact-us.html 2017 - 07 - 06 - t13:59:29.634z https://www.欧洲杯微信买球astrazeneca.com/patient-reported-outcomes/confirmation.html 2016 - 10 - 03 - t10:40:27.637z https://www.欧洲杯微信买球astrazeneca.com/astrazeneca-exchange.html 2020 - 10 - 08 - t14:39:06.659z https://www.欧洲杯微信买球astrazeneca.com/unpublished/test -释放- 4 - 1 - 0. - html 2021 - 04 - 19 - t14:14:30.897z https://www.欧洲杯微信买球astrazeneca.com/media-centre.html 2021 - 04 - 30 - t13:01:09.352z https://www.欧洲杯微信买球astrazeneca.com/media-centre/press-releases.html 2021 - 03 - 21 - t13:52:15.097z https://www.欧洲杯微信买球astrazeneca.com/media-centre/press-releases/2021/us-clearance-of-proposed-acquisition-of-alexion.html 2021 - 05 - 12 - t15:15:28.067z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2021/atacand撤资- -在- 70国家completed.html 2021 - 01 - 03 - t10:54:27.629z https://www.欧洲杯微信买球astrazeneca.com/media-centre/press-releases/2021/farxiga-granted-us-priority-review-for-ckd.html 2021 - 01 - 06 - t00:10:03.126z https://www.欧洲杯微信买球astrazeneca.com/media-centre/press-releases/2021/serum-institute-of-india-obtains-emergency-use-authorisation-in-india-for-astrazenecas-covid-19-vaccine.html 2021 - 01 - 06 - t14:11:46.752z https://www.欧洲杯微信买球astrazeneca.com/media-centre/press-releases/2021/astrazeneca-to-showcase-transformative-data-across-diverse-pipeline-at-world-conference-on-lung-cancer.html 2021 - 01 - 15 - t10:49:56.337z https://www.欧洲杯微信买球astrazeneca.com/media-centre/press-releases/2021/imfinzi-new-dosing-approved-in-eu.html 2021 - 01 - 14 t22:44:12.806z https://www.欧洲杯微信买球astrazeneca.com/media-centre/press-releases/2021/enhertu-approved-in-the-us-for-gastric-cancer.html 2021 - 01 - 17 t20:16:24.353z https://www.欧洲杯微信买球astrazeneca.com/media-centre/press-releases/2021/enhertu-approved-in-the-eu-for-breast-cancer.html 2021 - 01 - 19 t22:52:00.697z https://www.欧洲杯微信买球astrazeneca.com/media-centre/press-releases/2021/calquence-approved-in-japan-for-cll.html 2021 - 01 - 24 t20:42:07.886z https://www.欧洲杯微信买球astrazeneca.com/media-centre/press-releases/2021/calquence-met-primary-endpoint-against-ibrutinib.html 2021 - 01 - 25 - t07:16:56.155z https://www.欧洲杯微信买球astrazeneca.com/media-centre/press-releases/2021/symbicort-approved-in-china-for-mild-asthma.html 2021 - 01 - 25 - t16:02:45.291z https://www.欧洲杯微信买球astrazeneca.com/media-centre/press-releases/2021/datopotamab-deruxtecan-and-enhertu-show-promising-early-clinical-activity-in-patients-with-advanced-non-small-cell-lung-cancer.html 2021 - 01 - 28 - t23:43:17.532z https://www.欧洲杯微信买球astrazeneca.com/media-centre/press-releases/2021/tagrisso-extended-disease-free-survival-regardless-of-prior-adjuvant-chemotherapy-in-early-stage-egfr-mutated-lung-cancer.html 2021 - 01 - 29 t00:14:38.411z https://www.欧洲杯微信买球astrazeneca.com/media-centre/press-releases/2021/covid-19-vaccine-astrazeneca-recommended-for-use-in-the-eu.html 2021 - 01 - 29 t15:56:02.335z https://www.欧洲杯微信买球astrazeneca.com/media-centre/press-releases/2021/covid-19-vaccine-authorised-for-use-in-the-eu.html 2021 - 01 - 29 t21:08:03.660z https://www.欧洲杯微信买球astrazeneca.com/media-centre/press-releases/2021/astrazeneca-agrees-to-divest-viela-shareholding.html 2021 - 02 - 01 - t11:32:23.966z https://www.欧洲杯微信买球astrazeneca.com/media-centre/press-releases/2021/covid-19-vaccine-astrazeneca-confirms-protection-against-severe-disease-hospitalisation-and-death-in-the-primary-analysis-of-phase-iii-trials.html 2021 - 02 - 03 - t07:10:14.335z https://www.欧洲杯微信买球astrazeneca.com/media-centre/press-releases/2021/forxiga-approved-in-china-for-heart-failure.html 2021 - 02 - 04 - t07:26:58.995z https://www.欧洲杯微信买球astrazeneca.com/media-centre/press-releases/2021/update-on-kestrel-phase-iii-trial-for-imfinzi.html 2021 - 02 - 04 - t22:48:50.370z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2021/full -年- 2020 results.html 2021 - 02 - 11 - t07:58:14.610z https://www.欧洲杯微信买球astrazeneca.com/media-centre/press-releases/2021/divestment-of-crestor-in-europe-completed.html 2021 - 02 - 10 - t07:28:56.684z https://www.欧洲杯微信买球astrazeneca.com/media-centre/press-releases/2021/astrazeneca-and-idt-biologika-sign-letter-of-intent-to-increase-covid-19-vaccine-manufacturing-in-europe-and-secure-long-term-supply-capacity.html 2021 - 02 - 10 - t12:12:16.642z https://www.欧洲杯微信买球astrazeneca.com/media-centre/press-releases/2021/olympia-trial-of-lynparza-idmc-recommend-early-analysis.html 2021 - 02年- 17 - t07:09:11.448z https://www.欧洲杯微信买球astrazeneca.com/media-centre/press-releases/2021/astrazeneca-covid-19-vaccine-authorised-for-emergency-use-by-the-world-health-organization.html 2021 - 02年- 22 - t16:01:18.201z https://www.欧洲杯微信买球astrazeneca.com/media-centre/press-releases/2021/voluntary-withdrawal-imfinzi-us-bladder-indication.html 2021 - 02年- 21 - t14:25:08.122z https://www.欧洲杯微信买球astrazeneca.com/media-centre/press-releases/2021/tezepelumab-is-the-first-biologic-to-consistently-and-significantly-reduce-exacerbations-in-broad-population-of-severe-asthma-patients.html 2021 - 02年- 26 - t14:12:24.429z https://www.欧洲杯微信买球astrazeneca.com/media-centre/press-releases/2021/further-update-on-us-regulatory-review-of-roxadustat-in-anaemia-of-chronic-kidney-disease.html 2021 - 03 - 02 - t11:37:01.653z https://www.欧洲杯微信买球astrazeneca.com/media-centre/press-releases/2021/astrazeneca-advances-mass-global-rollout-of-covid-19-vaccine-through-covax.html 2021 - 03 - 02 - t12:53:59.746z https://www.欧洲杯微信买球astrazeneca.com/media-centre/press-releases/2021/us-court-decision-favours-symbicort-patents.html 2021 - 03 - 03 - t07:41:34.095z https://www.欧洲杯微信买球astrazeneca.com/media-centre/press-releases/2021/update-on-the-safety-of-covid-19-vaccine-astrazeneca.html 2021 - 03 - 14 - t18:35:37.216z https://www.欧洲杯微信买球astrazeneca.com/media-centre/press-releases/2021/divestment-of-viela-shareholding-completed.html 2021 - 03 - 15 - t22:11:23.856z https://www.欧洲杯微信买球astrazeneca.com/media-centre/press-releases/2021/us-supply-agreement-for-additional-azd7442-doses.html 2021 - 03 - 15 - t23:40:03.103z https://www.欧洲杯微信买球astrazeneca.com/media-centre/press-releases/2021/uk-and-eu-regulatory-agencies-confirm-covid-19-vaccine-astrazeneca-is-safe-and-effective.html 2021 - 03 - 19 - t08:50:05.586z https://www.欧洲杯微信买球astrazeneca.com/media-centre/press-releases/2021/statement-on-the-passing-of-jose-baselga.html 2021 - 03 - 21 - t19:08:31.453z https://www.欧洲杯微信买球astrazeneca.com/media-centre/press-releases/2021/astrazeneca-us-vaccine-trial-met-primary-endpoint.html 2021 - 03 - 22 - t07:47:31.779z https://www.欧洲杯微信买球astrazeneca.com/media-centre/press-releases/2021/update-following-statement-by-niaid-on-azd1222-us-phase-iii-trial-data.html 2021 - 04 - 15 - t15:05:33.140z https://www.欧洲杯微信买球astrazeneca.com/media-centre/press-releases/2021/statement-on-covid-19-vaccine-supply-at-anagni-plant-in-italy.html 2021 - 04 - 15 - t15:05:18.766z https://www.欧洲杯微信买球astrazeneca.com/media-centre/press-releases/2021/azd1222-us-phase-iii-primary-analysis-confirms-safety-and-efficacy.html 2021 - 03 - 29 - t11:54:01.716z https://www.欧洲杯微信买球astrazeneca.com/media-centre/press-releases/2021/astrazeneca-accelerates-early-oncology-pipeline-across-key-strategic-scientific-platforms-at-aacr.html 2021 - 04 - 09 - t06:00:30.076z https://www.欧洲杯微信买球astrazeneca.com/media-centre/press-releases/2021/update-on-farxiga-covid-19-dare-19-phase-iii-trial.html 2021 - 04 - 12 - t15:52:56.566z https://www.欧洲杯微信买球astrazeneca.com/media-centre/press-releases/2021/tagrisso-approved-in-china-in-early-lung-cancer.html 2021 - 04 - 20 - t08:02:35.578z https://www.欧洲杯微信买球astrazeneca.com/media-centre/press-releases/2021/tagrisso-adjuvant-receives-positive-chmp-opinion.html 2021 - 04 - 26 - t06:02:16.794z https://www.欧洲杯微信买球astrazeneca.com/media-centre/press-releases/2021/selumetinib-recommended-for-eu-approval-in-nf1.html 2021 - 04 - 25 - t20:16:51.813z https://www.欧洲杯微信买球astrazeneca.com/media-centre/press-releases/2021/nirsevimab-phase-iii-trial-met-primary-endpoint.html 2021 - 04 - 25 - t20:24:33.500z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2021/q1 - 2021 results.html 2021 - 04 - 30 - t06:08:58.954z https://www.欧洲杯微信买球astrazeneca.com/media-centre/press-releases/2021/farxiga-approved-in-the-us-for-ckd.html 2021 - 04 - 30 - t20:50:53.150z https://www.欧洲杯微信买球astrazeneca.com/media-centre/press-releases/2021/imfinzi-and-tremelimumab-showed-survival-in-poseidon.html 2021 - 05 - 07 - t05:15:41.922z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2021/results - - -一般年会举行5月- 11 - 2021. - html 2021 - 05 - 11 - t13:56:43.342z https://www.欧洲杯微信买球astrazeneca.com/media-centre/press-releases/2021/approval-recognises-acquisitions-advancement-of-the-companys-strategic-and-financial-development.html 2021 - 05 - 12 - t15:12:31.961z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2021/astrazeneca asco - 2021 -数据-支持-野心- -彻底改变癌症- - -治疗前和结果转换——experience.html——耐心 2021 - 05 - 19 - t20:06:25.736z https://www.欧洲杯微信买球astrazeneca.com/media-centre/press-releases/2021/astrazeneca-covid-19-vaccine-vaxzevria-authorised-for-emergency-use-in-japan.html 2021 - 05 - 21 - t05:56:13.177z https://www.欧洲杯微信买球astrazeneca.com/media-centre/press-releases/2021/tagrisso-approved-in-eu-in-early-lung-cancer.html 2021 - 05 - 27 - t22:01:52.930z https://www.欧洲杯微信买球astrazeneca.com/media-centre/press-releases/2021/anifrolumab-showed-benefit-across-different-measures-of-skin-and-joint-disease-activity-in-patients-with-systemic-lupus-erythematosus.html 2021 - 06 - 02 - t05:46:24.689z https://www.欧洲杯微信买球astrazeneca.com/media-centre/press-releases/2021/lynparza-reduced-the-risk-of-cancer-recurrence-by-42-in-the-adjuvant-treatment-of-patients-with-germline-brca-mutated-high-risk-early-breast-cancer-in-olympia-phase-iii-trial.html 2021 - 06 - 03 - t20:05:52.243z https://www.欧洲杯微信买球astrazeneca.com/media centre/press releases/2021/imfinzi -展示了前所未有的生存- - - - - - -不可切除的阶段- iii -肺癌症- - 43%的患者存活years.html——5 2021 - 06 - 03 - t21:42:02.571z https://www.欧洲杯微信买球astrazeneca.com/media-centre/press-releases/2021/astrazeneca-appoints-aradhana-sarin-as-new-chief-financial-officer.html 2021 - 06 - 04 - t05:52:01.641z https://www.欧洲杯微信买球astrazeneca.com/media-centre/press-releases/2021/calquence-head-to-head-results-versus-ibrutinib.html 2021 - 06 - 07 - t05:54:29.945z https://www.欧洲杯微信买球astrazeneca.com/media-centre/press-releases/2021/covid-19-vaccine-astrazeneca-effective-against-delta-indian-variant.html 2021 - 06 - 17 t09:14:07.314z https://www.欧洲杯微信买球astrazeneca.com/media-centre/press-releases/2021/update-on-azd7442-storm-chaser-trial.html 2021 - 06 - 15 - t05:35:31.418z https://www.欧洲杯微信买球astrazeneca.com/media-centre/press-releases/2020/farxiga-granted-fast-track-designation-in-the-us-for-heart-failure-following-acute-myocardial-infarction-leveraging-an-innovative-registry-based-trial-design.html 2020 - 07 - 16 - t12:01:51.322z https://www.欧洲杯微信买球astrazeneca.com/media-centre/press-releases/2020/covid-19-vaccine-azd1222-showed-robust-immune-responses-in-all-participants-in-phase-i-ii-trial.html 2020 - 11 - 19 - t16:48:33.573z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2020/h1 - 2020 results.html 2020 - 07 - 30 - t07:12:57.063z https://www.欧洲杯微信买球astrazeneca.com/media-centre/press-releases/2020/breztri-aerosphere-approved-in-the-us-for-copd.html 2020 - 07 - 23 - t20:51:37.697z https://www.欧洲杯微信买球astrazeneca.com/media-centre/press-releases/2020/astrazeneca-and-daiichi-sankyo-enter-collaboration-to-develop-and-commercialise-new-antibody-drug-conjugate.html 2020 - 07 - 27 - t06:38:35.930z https://www.欧洲杯微信买球astrazeneca.com/media-centre/press-releases/2020/imfinzi-recommended-for-approval-in-the-eu-by-chmp-for-extensive-stage-small-cell-lung-cancer.html 2020 - 07 - 27 - t06:05:52.108z https://www.欧洲杯微信买球astrazeneca.com/media-centre/press-releases/2020/calquence-recommended-for-approval-in-the-eu-by-chmp-for-chronic-lymphocytic-leukaemia.html 2020 - 07 - 27 - t06:11:04.189z https://www.欧洲杯微信买球astrazeneca.com/media-centre/press-releases/2020/farxiga-met-all-primary-and-secondary-endpoints-in-groundbreaking-phase-iii-dapa-ckd-trial-for-the-treatment-of-patients-with-chronic-kidney-disease.html 2020 - 07 - 28 - t06:38:27.174z https://www.欧洲杯微信买球astrazeneca.com/media-centre/press-releases/2020/tagrisso-us-btd-for-egfrm-adjuvant-lung-cancer.html 2020 - 07 - 29 - t22:17:00.737z https://www.欧洲杯微信买球astrazeneca.com/media-centre/press-releases/2020/nirsevimab-reduced-respiratory-syncytial-virus-infections-and-hospitalisations-in-preterm-infants-in-phase-iib-trial.html 2020 - 07 - 29 - t22:25:10.461z https://www.欧洲杯微信买球astrazeneca.com/media-centre/press-releases/2020/brilinta-significantly-reduced-the-rate-of-the-composite-of-stroke-and-death-in-patients.html 2020 - 07 - 16 - t06:11:24.445z https://www.欧洲杯微信买球astrazeneca.com/media-centre/press-releases/2020/brilinta-granted-fda-priority-review-for-the-reduction-of-subsequent-stroke-in-patients-who-had-an-acute-ischemic-stroke-or-transient-ischemic-attack.html 2020 - 07 - 09 - t06:14:36.372z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2020/lokelma批准- -中国- - -治疗的成年患者- - - - - - -高钾血症- 06012020. - html 2020 - 01 - 06 - t06:53:57.714z https://www.欧洲杯微信买球astrazeneca.com/media centre/press releases/2020/farxiga -获得fda -优先审查- -患者- - - - - - -心-失败- - -射血分数降低06012020. - html 2020 - 01 - 06 - t07:19:29.822z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2020/update - -相- iii -强度-试验- - epanova的混合- dyslipidaemia - 13012020. - html 2020 - 01 - 13 t06:50:56.529z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2020/lynparza -管理-提交授予优先——审查——————————1 -线-维护- - -贝伐单抗治疗-高级-卵巢癌症- 13012020. - html 2020 - 01 - 13 t06:57:13.920z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2020/lynparza -管理-提交授予优先——审查——————————嗯——抗突变-转移-阉割- -前列腺癌症- 20012020. - html 2020 - 01 - 19 t22:46:03.237z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2020/imfinzi -和- tremelimumab授予孤儿-药物-设计- - - - -我们- -肝癌症- 20012020. - html 2020 - 01 - 20 - t06:52:56.919z https://www.欧洲杯微信买球astrazeneca.com/media-centre/press-releases/2020/astrazeneca-young-health-programme-to-partner-with-unicef-to-prevent-non-communicable-diseases-among-young-people.html 2021 - 06 - 08 - t15:22:48.779z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2020/astrazenecas野心——零碳-战略- -消除排放- - 2025和-是-碳- - - - - - - - - -整个价值链条——- 2030 - 22012020. - html 2020 - 01 - 21 t21:39:54.092z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2020/astrazeneca剥离权利- -建立高血压药物- 27012020. - html 2020 - 01 - 26 t22:01:45.546z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2020/brilinta - -主-端点在阶段- iii -泰利斯-试验-在-中风- 27012020. - html 2020 - 01 - 27 t06:47:16.612z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2020/astrazeneca - -恢复- -全球权利- - brazikumab medi2070 -从-爱力根- 27012020. - html 2020 - 01 - 27 t06:35:23.909z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2020/phase - ii -命运gastric01 -试验- - enhertu和化疗-满足主要端点- 27012020. - html 2020 - 01 - 27 t06:41:13.661z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2020/full年和第四季度- 2019 results.html 2020 - 02 - 14 - t14:41:09.545z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2020/astrazeneca剥离-全球权利- movantik - 25022020. - html 2020 - 02 - 25 - t07:04:07.313z https://www.欧洲杯微信买球astrazeneca.com/media-centre/press-releases/2020/astrazeneca-completes-divestment-agreement-with-atnahs-pharma-for-established-hypertension-medicines.html 2020 - 03 - 02 - t07:30:45.702z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2020/update - -相- iii -多瑙河-试验- - imfinzi和tremelimumab - -不可切除的阶段- iv -膀胱癌症- 06032020. - html 2020 - 03 - 06 - t06:57:54.729z https://www.欧洲杯微信买球astrazeneca.com/media-centre/press-releases/2020/update-on-phase-iii-gy004-trial-for-cediranib-added-to-lynparza-in-platinum-sensitive-relapsed-ovarian-cancer.html 2020 - 03 - 12 - t06:54:01.898z https://www.欧洲杯微信买球astrazeneca.com/media-centre/press-releases/2020/imfinzi-confirmed-a-sustained-overall-survival-benefit-in-final-analysis-of-the-phase-iii-caspian-trial-in-1st-line-extensive-stage-small-cell-lung-cancer.html 2020 - 03 - 17 - t06:48:11.510z https://www.欧洲杯微信买球astrazeneca.com/media-centre/press-releases/2020/lynparza-granted-orphan-drug-designation-in-japan-for-brca-mutated-metastatic-pancreatic-cancer.html 2020 - 03 - 19 - t06:59:04.918z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2020/astrazeneca捐赠- 900万面面具- -支持医疗工作者——世界各地————————————打击covid - 19. - html 2020 - 11 - 19 - t16:45:46.590z https://www.欧洲杯微信买球astrazeneca.com/media-centre/press-releases/2020/astrazeneca-to-discover-and-develop-sirna-therapeutics-for-cardiovascular-renal-metabolic-and-respiratory-diseases-in-new-collaboration.html 2020 - 03 - 25 - t07:12:32.098z https://www.欧洲杯微信买球astrazeneca.com/media-centre/press-releases/2020/lokelma-approved-in-japan-for-the-treatment-of-hyperkalaemia.html 2020 - 03 - 26 - t07:21:24.283z https://www.欧洲杯微信买球astrazeneca.com/media-centre/press-releases/2020/farxiga-reduced-the-incidence-of-heart-failure-worsening-or-cardiovascular-death-in-a-sub-analysis-from-landmark-phase-iii-dapa-hf-trial.html 2020 - 03 - 28 - t13:48:44.309z https://www.欧洲杯微信买球astrazeneca.com/media-centre/press-releases/2020/farxiga-phase-iii-dapa-ckd-trial-will-be-stopped-early-after-overwhelming-efficacy-in-patients-with-chronic-kidney-disease.html 2020 - 03 - 30 - t05:55:49.275z https://www.欧洲杯微信买球astrazeneca.com/media-centre/press-releases/2020/imfinzi-approved-in-the-us-for-extensive-stage-small-cell-lung-cancer.html 2020 - 03 - 30 - t05:57:45.992z https://www.欧洲杯微信买球astrazeneca.com/media-centre/press-releases/2020/brilinta-reduced-bleeding-vs-dual-therapy-in-high-risk-coronary-patients-in-sub-analyses-from-phase-iv-twilight-trial.html 2020 - 03 - 30 - t13:33:59.822z https://www.欧洲杯微信买球astrazeneca.com/media-centre/press-releases/2020/lokelma-recommended-for-approval-in-eu-for-patients-with-hyperkalaemia-on-stable-haemodialysis.html 2020 - 03 - 30 - t20:00:18.008z https://www.欧洲杯微信买球astrazeneca.com/media-centre/press-releases/2020/astrazeneca-divestment-of-movantik-to-redhill-biopharma-completed.html 2020 - 04 - 01 - t19:17:50.947z https://www.欧洲杯微信买球astrazeneca.com/media-centre/press-releases/2020/tagrisso-phase-iii-adaura-trial-will-be-unblinded-early-after-overwhelming-efficacy-in-the-adjuvant-treatment-of-patients-with-egfr-mutated-lung-cancer.html 2020 - 04 - 11 - t13:29:27.172z https://www.欧洲杯微信买球astrazeneca.com/media-centre/press-releases/2020/koselugo-selumetinib-approved-in-us-for-paediatric-patients-with-neurofibromatosis-type-1-plexiform-neurofibromas.html 2020 - 04 - 13 - t06:33:55.071z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2020/astrazeneca发起calavi -临床试验- - calquence反对covid - 19. - html 2020 - 11 - 19 - t16:44:51.745z https://www.欧洲杯微信买球astrazeneca.com/media-centre/press-releases/2020/astrazeneca-and-saint-lukes-mid-america-heart-institute-initiate-phase-iii-dare-19-trial-with-farxiga-in-covid-19-patients.html 2020 - 11 - 19 - t16:43:58.166z https://www.欧洲杯微信买球astrazeneca.com/media-centre/press-releases/2020/lynparza-shows-overall-survival-in-prostate-cancer.html 2020 - 04 - 24 - t05:56:28.973z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2020/q1 - 2020 results.html 2020 - 04 - 29 - t06:58:13.718z https://www.欧洲杯微信买球astrazeneca.com/media-centre/press-releases/2020/astrazeneca-and-oxford-university-announce-landmark-agreement-for-covid-19-vaccine.html 2020 - 11 - 19 - t16:41:58.947z https://www.欧洲杯微信买球astrazeneca.com/media-centre/press-releases/2020/farxiga-approved-in-the-us-for-the-treatment-of-heart-failure-in-patients-with-heart-failure-with-reduced-ejection-fraction.html 2020 - 05 - 06 - t05:56:31.985z https://www.欧洲杯微信买球astrazeneca.com/media-centre/press-releases/2020/tlynparza-approved-in-the-us-as-1st-line-maintenance-treatment-with-bevacizumab-for-hrd-positive-advanced-ovarian-cancer.html 2020 - 05 - 11 - t05:55:21.768z https://www.欧洲杯微信买球astrazeneca.com/media-centre/press-releases/2020/astrazeneca-recovery-of-global-rights-to-brazikumab-medi2070-from-allergan-completed.html 2020 - 05 - 11 - t06:05:51.643z https://www.欧洲杯微信买球astrazeneca.com/media-centre/press-releases/2020/enhertu-granted-breakthrough-therapy-designation-in-the-us-for-her2-positive-metastatic-gastric-cancer.html 2020 - 05 - 11 - t06:13:40.250z https://www.欧洲杯微信买球astrazeneca.com/media-centre/press-releases/2020/astrazeneca-advances-the-science-of-cancer-medicine-with-practice-changing-data-at-the-asco20-virtual-scientific-program.html 2020 - 05 - 13 - t21:14:00.112z https://www.欧洲杯微信买球astrazeneca.com/media-centre/press-releases/2020/bevespi-aerosphere-approved-in-china-for-patients-with-copd.html 2020 - 05 - 18 - t06:34:26.813z https://www.欧洲杯微信买球astrazeneca.com/media-centre/press-releases/2020/enhertu-granted-breakthrough-therapy-designation-in-the-us-for-her2-mutant-metastatic-non-small-cell-lung-cancer.html 2020 - 05 - 18 - t06:11:37.265z https://www.欧洲杯微信买球astrazeneca.com/media-centre/press-releases/2020/lynparza-approved-in-the-us-for-hrr-gene-mutated-metastatic-castration-resistant-prostate-cancer.html 2020 - 05 - 19 - t22:39:15.669z https://www.欧洲杯微信买球astrazeneca.com/media-centre/press-releases/2020/astrazeneca-advances-response-to-global-covid-19-challenge-as-it-receives-first-commitments-for-oxfords-potential-new-vaccine.html 2020 - 10 - 29 - t12:33:45.684z https://www.欧洲杯微信买球astrazeneca.com/media-centre/press-releases/2020/enhertu-granted-orphan-drug-designation-in-the-us-for-gastric-cancer.html 2020 - 05 - 22 - t06:10:56.698z https://www.欧洲杯微信买球astrazeneca.com/media-centre/press-releases/2020/astrazeneca-collaborates-with-archerdx-to-use-personalised-cancer-assays-to-detect-minimal-residual-disease-in-lung-cancer-trials.html 2020 - 05 - 26 - t14:16:57.819z https://www.欧洲杯微信买球astrazeneca.com/media-centre/press-releases/2020/tagrisso-demonstrated-unprecedented-disease-free-survival-in-the-adjuvant-treatment-of-stage-ib-iiia-patients-with-egfr-mutated-lung-cancer.html 2020 - 05 - 28 - t20:02:24.324z https://www.欧洲杯微信买球astrazeneca.com/media-centre/press-releases/2020/enhertu-achieved-a-tumour-response-rate-of-45p-in-patients-with-her2-positive-metastatic-colorectal-cancer-in-phase-ii-destiny-crc01-trial.html 2020 - 05 - 29 - t12:49:39.959z https://www.欧洲杯微信买球astrazeneca.com/media-centre/press-releases/2020/enhertu-demonstrated-meaningful-clinical-activity-in-patients-with-her2-mutant-non-small-cell-lung-cancer.html 2020 - 05 - 29 - t12:49:18.830z https://www.欧洲杯微信买球astrazeneca.com/media-centre/press-releases/2020/enhertu-significantly-improved-tumour-response-rate-and-overall-survival-in-her2-positive-metastatic-gastric-cancer.html 2020 - 05 - 29 - t12:54:30.916z https://www.欧洲杯微信买球astrazeneca.com/media-centre/press-releases/2020/imfinzi-showed-a-sustained-overall-survival-benefit-in-1st-line-extensive-stage-small-cell-lung-cancer-in-the-phase-iii-caspian-trial.html 2020 - 05 - 29 - t13:29:00.805z https://www.欧洲杯微信买球astrazeneca.com/media-centre/press-releases/2020/imfinzi-plus-tremelimumab-demonstrated-promising-clinical-activity-and-tolerability-in-patients-with-advanced-liver-cancer.html 2020 - 05 - 29 - t13:29:42.149z https://www.欧洲杯微信买球astrazeneca.com/media-centre/press-releases/2020/brilinta-approved-in-the-us-to-reduce-the-risk-of-a-first-heart-attack-or-stroke-in-high-risk-patients-with-coronary-artery-disease.html 2020 - 06 - 01 - t05:49:26.783z https://www.欧洲杯微信买球astrazeneca.com/media-centre/press-releases/2020/lynparza-recommended-for-approval-in-eu-by-chmp-for-brca-mutated-metastatic-pancreatic-cancer.html 2020 - 06 - 01 - t06:10:26.354z https://www.欧洲杯微信买球astrazeneca.com/media-centre/press-releases/2020/astrazeneca-to-discover-and-develop-novel-therapies-targeting-rna-modifying-proteins-in-oncology-collaboration-with-accent-therapeutics.html 2020 - 06 - 03 - t17:25:29.955z https://www.欧洲杯微信买球astrazeneca.com/media-centre/press-releases/2020/astrazeneca-takes-next-steps-towards-broad-and-equitable-access-to-oxford-universitys-covid-19-vaccine.html 2020 - 11 - 19 - t16:40:51.215z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2020/astrazeneca -呈现-新-数据-在-连续- -保健——从其广泛-肾-投资组合- - - edta - 2020虚拟congress.html时代 2020 - 10 - 29 - t12:32:12.565z https://www.欧洲杯微信买球astrazeneca.com/media-centre/press-releases/2020/calquence-showed-promising-clinical-improvement-in-majority-of-19-hospitalised-covid-19-patients.html 2020 - 11 - 19 - t16:40:14.294z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2020/astrazeneca - -展示领导- - - - - - - - - 2型糖尿病治疗和- cardiorenal并发症- -艾达- 2020. - html 2020 - 06 - 11 - t06:36:00.102z https://www.欧洲杯微信买球astrazeneca.com/media-centre/press-releases/2020/calquence-showed-long-term-efficacy-and-tolerability-for-patients-with-chronic-lymphocytic-leukaemia-in-two-trials.html 2020 - 06 - 12 - t06:55:33.334z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2020/astrazeneca - - -欧洲-提供- - - 4亿- - -牛津大学疫苗剂量在profit.html——没有 2020 - 11 - 19 - t16:39:31.499z https://www.欧洲杯微信买球astrazeneca.com/media-centre/press-releases/2020/breztri-aerosphere-significantly-reduced-rate-of-moderate-or-severe-copd-exacerbations-in-phase-iii-ethos-trial.html 2020 - 06 - 24 t18:52:11.752z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2020/selumetinib授予-孤儿药物——指定-日本- -神经纤维瘤类型- 1. - html 2020 - 06 - 30 - t06:03:56.476z https://www.欧洲杯微信买球astrazeneca.com/media-centre/press-releases/2020/lynparza-approved-in-the-eu-for-brca-mutated-metastatic-pancreatic-cancer.html 2020 - 07 - 08 - t06:05:24.214z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2020/astrazeneca -总结-协议- - -欧洲委员会的-的-供应- - 4亿剂量的- azd1222 covid vaccine.html——19 2020 - 11 - 19 - t16:37:17.294z https://www.欧洲杯微信买球astrazeneca.com/media-centre/press-releases/2020/imfinzi-granted-fda-priority-review-for-less-frequent-fixed-dose-use.html 2020 - 08 - 18 - t06:12:16.799z https://www.欧洲杯微信买球astrazeneca.com/media-centre/press-releases/2020/imfinzi-approved-in-japan-for-sclc.html 2020 - 08 - 21 - t06:11:59.112z https://www.欧洲杯微信买球astrazeneca.com/media centre/press releases/2020/phase - 1 -临床试验启动- -单克隆抗体的结合- - -预防和治疗- 19. - covid html 2020 - 10 - 28 - t15:18:32.734z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2020/farxiga采办局-相- iii - - ckd -试验-模式-转移-数据- - -在esc - 2020. - html 2020 - 08 - 27 - t06:01:01.385z https://www.欧洲杯微信买球astrazeneca.com/media-centre/press-releases/2020/farxiga-demonstrated-reduction-in-the-risk-of-kidney-failure-and-cardiovascular-or-renal-death-in-patients-with-ckd-in-the-phase-iii-dapa-ckd-trial.html 2020 - 08 - 30 - t15:56:38.793z https://www.欧洲杯微信买球astrazeneca.com/media-centre/press-releases/2020/astrazenecas-scientific-and-social-commitment-for-covid-19-vaccine.html 2020 - 10 - 28 - t15:17:53.539z https://www.欧洲杯微信买球astrazeneca.com/media-centre/press-releases/2020/imfinzi-approved-in-EU-for-small-cell-lung-cancer.html 2020 - 09 - 01 - t06:06:45.157z https://www.欧洲杯微信买球astrazeneca.com/media-centre/press-releases/2020/development-of-covid-19-vaccine-azd1222-expands-into-us-phase-iii-clinical-trial-across-all-adult-age-groups.html 2020 - 10 - 28 - t15:17:20.378z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2020/new -分析-从- breztri大气层阶段iii -精神-试验- - -呈现在- -欧洲呼吸协会国际-国会- 2020. - html 2020 - 09 - 07 - t21:08:30.835z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2020/astrazeneca -目标- -变换-癌症治疗,促进临床-实践-与-数据-呈现- 2020. - esmo html 2020 - 09 - 07 - t21:03:38.998z https://www.欧洲杯微信买球astrazeneca.com/media-centre/press-releases/2020/biopharma-leaders-unite-to-stand-with-science.html 2020 - 09 - 08 - t08:21:53.498z https://www.欧洲杯微信买球astrazeneca.com/media-centre/press-releases/2020/statement-on-astrazeneca-oxford-sars-cov-2-vaccine-azd1222-covid-19-vaccine-trials-temporary-pause.html 2020 - 10 - 28 - t15:16:47.684z https://www.欧洲杯微信买球astrazeneca.com/media-centre/press-releases/2020/fasenra-met-both-co-primary-endpoints-of-reduced-nasal-polyp-size-and-blockage-in-the-ostro-phase-iii-trial.html 2020 - 09 - 10 - t06:09:40.817z https://www.欧洲杯微信买球astrazeneca.com/media-centre/press-releases/2020/astrazeneca-to-list-us-adr-equity-and-all-us-debt-securities-on-nasdaq.html 2020 - 09 - 10 - t07:04:18.607z https://www.欧洲杯微信买球astrazeneca.com/media-centre/press-releases/2020/tagrisso-reduces-brain-recurrence-in-early-lung.html 2020 - 10 - 01 - t22:44:00.641z https://www.欧洲杯微信买球astrazeneca.com/media-centre/press-releases/2020/imfinzi-demonstrated-unprecedented-survival-in-unresectable-stage-III-nsclc.html 2020 - 09 - 17 - t21:23:48.294z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2020/lynparza - - - -的死亡风险降低31% - - - brca -或- atm mcrpc profound.html——在 2020 - 09 - 20 - t17:09:46.666z https://www.欧洲杯微信买球astrazeneca.com/media-centre/press-releases/2020/covid-19-vaccine-azd1222-clinical-trials-resumed-in-the-uk.html 2020 - 10 - 28 - t15:05:58.466z https://www.欧洲杯微信买球astrazeneca.com/media-centre/press-releases/2020/astrazeneca-acquires-oral-pcsk9-inhibitor-programme-from-dogma-therapeutics.html 2020 - 09 - 17 - t06:19:24.583z https://www.欧洲杯微信买球astrazeneca.com/media-centre/press-releases/2020/lynparza-improved-median-time-patients-lived-without-disease-progression-to-over-four-and-half-years-in-BRCA-mutated-advanced-ovarian-cancer.html 2020 - 09 - 18 - t07:29:53.691z https://www.欧洲杯微信买球astrazeneca.com/media-centre/press-releases/2020/lynparza-eu-recommendation-in-prostate-cancer.html 2020 - 09 - 21 - t06:20:41.571z https://www.欧洲杯微信买球astrazeneca.com/media-centre/press-releases/2020/lynparza-eu-recommendation-in-ovarian-cancer.html 2020 - 09 - 21 - t06:21:08.250z https://www.欧洲杯微信买球astrazeneca.com/media-centre/press-releases/2020/farxiga-granted-breakthrough-therapy-designation-in-us-for-chronic-kidney-disease.html 2020 - 10 - 02 - t06:10:07.312z https://www.欧洲杯微信买球astrazeneca.com/media-centre/press-releases/2020/covid-19-vaccine-azd1222-clinical-trial-resumed-in-japan-follows-restart-of-trials-in-the-uk-brazil-south-africa-and-india.html 2020 - 10 - 28 - t15:05:01.649z https://www.欧洲杯微信买球astrazeneca.com/media-centre/press-releases/2020/covid-19-long-acting-antibody-laab-combination-azd7442-rapidly-advances-into-phase-iii-clinical-trials.html 2020 - 10 - 28 - t15:04:24.336z https://www.欧洲杯微信买球astrazeneca.com/media-centre/press-releases/2020/trixeo-aerosphere-recommended-for-approval-in-the-eu-by-chmp-for-the-maintenance-treatment-of-copd.html 2020 - 10 - 19 - t06:07:05.248z https://www.欧洲杯微信买球astrazeneca.com/media-centre/press-releases/2020/forxiga-recommended-for-approval-in-the-eu-by-chmp-for-heart-failure.html 2020 - 10 - 19 - t06:10:18.671z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2020/astrazeneca -发展-领导- -肾疾病- - -比- 80 -抽象asn -肾周- 2020 reimagined.html 2020 - 10 - 20 - t06:14:28.466z https://www.欧洲杯微信买球astrazeneca.com/media-centre/press-releases/2020/tagrisso-adjuvant-lung-cancer-us-priority-review.html 2020 - 10 - 20 - t06:08:00.870z https://www.欧洲杯微信买球astrazeneca.com/media-centre/press-releases/2020/farxiga-dapa-ckd-phase-iii-trial-reduced-worsening-of-kidney-function-risk-of-cardiovascular-or-renal-death-in-patients-with-chronic-kidney-disease.html 2020 - 10 - 23 - t14:50:27.799z https://www.欧洲杯微信买球astrazeneca.com/media-centre/press-releases/2020/fda-authorises-restart-of-the-covid-19-azd1222-vaccine-us-phase-iii-trial.html 2020 - 10 - 28 - t15:02:31.148z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2020/year - -日期-和- q3 - 2020 results.html 2020 - 11 - 05 - t08:14:58.086z https://www.欧洲杯微信买球astrazeneca.com/media-centre/press-releases/2020/enhertu-us-priority-review-in-gastric-cancer.html 2020 - 10 - 28 - t07:08:56.676z https://www.欧洲杯微信买球astrazeneca.com/media-centre/press-releases/2020/forxiga-cv-outcomes-benefit-approved-in-china.html 2020 - 10 - 28 - t07:08:03.205z https://www.欧洲杯微信买球astrazeneca.com/media-centre/press-releases/2020/fasenra-eliminated-oral-corticosteroid-use-in-a-majority-of-ocs-dependent-patients-with-asthma-in-ponente-phase-iiib-trial.html 2020 - 10 - 29 - t07:05:50.036z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2020/atacand - -被转让股权- - cheplapharm -在-更多- 70 countries.html 2020 - 10 - 30 - t07:07:51.856z https://www.欧洲杯微信买球astrazeneca.com/media-centre/press-releases/2020/lynparza-approved-in-the-eu-for-prostate-cancer.html 2020 - 11 - 04 - t18:43:47.409z https://www.欧洲杯微信买球astrazeneca.com/media-centre/press-releases/2020/lynparza-approved-in-the-eu-for-wider-ovarian-use.html 2020 - 11 - 04 - t18:37:27.755z https://www.欧洲杯微信买球astrazeneca.com/media-centre/press-releases/2020/forxiga-approved-in-the-eu-for-heart-failure.html 2020 - 11 - 05 - t07:31:54.790z https://www.欧洲杯微信买球astrazeneca.com/media-centre/press-releases/2020/calquence-approved-in-the-eu-for-cll.html 2020 - 11 - 09 - t07:13:02.639z https://www.欧洲杯微信买球astrazeneca.com/media-centre/press-releases/2020/brilinta-approved-in-the-us-in-stroke.html 2020 - 11 - 05 - t21:35:17.409z https://www.欧洲杯微信买球astrazeneca.com/media-centre/press-releases/2020/tezepelumab-navigator-phase-iii-trial-met-primary-endpoint.html 2020 - 11 - 10 - t07:16:36.497z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2020/update -上- calavi - - ii期试验- - calquence在病人住院- -呼吸道症状的covid - 19. - html 2020 - 11 - 12 - t07:00:57.593z https://www.欧洲杯微信买球astrazeneca.com/media centre/press releases/2020/astrazeneca -展示优势- -血液学和健壮的数据-在-灰- 2020. - html 2020 - 11 - 18 - t23:06:29.758z https://www.欧洲杯微信买球astrazeneca.com/media-centre/press-releases/2020/imfinzi-new-dosing-approved-in-the-us.html 2020 - 11 - 20 - t07:06:00.221z https://www.欧洲杯微信买球astrazeneca.com/media-centre/press-releases/2020/azd1222hlr.html 2020 - 12 - 21 - t16:29:43.171z https://www.欧洲杯微信买球astrazeneca.com/media-centre/press-releases/2020/forxiga-approved-in-japan-for-heart-failure.html 2020 - 11 - 30 - t07:09:02.047z https://www.欧洲杯微信买球astrazeneca.com/media-centre/press-releases/2020/crestor-to-be-divested-to-grunenthal-in-europe.html 2020 - 12 - 01 - t07:07:15.357z https://www.欧洲杯微信买球astrazeneca.com/media-centre/press-releases/2020/astrazeneca-demonstrates-growing-leadership-in-breast-cancer-at-sabcs.html 2020 - 12 - 02 - t23:15:37.200z https://www.欧洲杯微信买球astrazeneca.com/media-centre/press-releases/2020/calquence-shows-long-term-efficacy-and-tolerability-at-three-years-for-patients-with-relapsed-or-refractory-mantle-cell-lymphoma.html 2020 - 12 - 07 - t16:05:49.841z https://www.欧洲杯微信买球astrazeneca.com/media-centre/press-releases/2020/calquence-data-across-four-trials-reinforces-cardiovascular-safety-profile-in-patients-with-chronic-lymphocytic-leukaemia.html 2020 - 12 - 07 - t14:50:57.296z https://www.欧洲杯微信买球astrazeneca.com/media-centre/press-releases/2020/azd1222-oxford-phase-iii-trials-interim-analysis-results-published-in-the-lancet.html 2020 - 12 - 08 - t19:00:26.742z https://www.欧洲杯微信买球astrazeneca.com/media-centre/press-releases/2020/enhertu-continues-to-demonstrate-durable-responses-with-new-data-from-destiny-breast01-in-her2-positive-metastatic-breast-cancer.html 2020 - 12 - 10 - t11:00:47.660z https://www.欧洲杯微信买球astrazeneca.com/media-centre/press-releases/2020/astrazeneca-to-acquire-alexion.html 2021 - 05 - 12 - t15:14:14.055z https://www.欧洲杯微信买球astrazeneca.com/media-centre/press-releases/2020/trixeo-aerosphere-approved-in-the-eu-for-copd.html 2020 - 12 - 13 - t20:59:29.347z https://www.欧洲杯微信买球astrazeneca.com/media-centre/press-releases/2020/trastuzumab-deruxtecan-positive-chmp.html 2020 - 12 - 13 - t21:04:46.727z https://www.欧洲杯微信买球astrazeneca.com/media-centre/press-releases/2020/imfinzi-new-dose-receives-positive-eu-chmp-opinion.html 2020 - 12 - 14 - t21:17:13.432z https://www.欧洲杯微信买球astrazeneca.com/media-centre/press-releases/2020/update-on-us-regulatory-review-of-roxadustat-in-anaemia-of-chronic-kidney-disease.html 2020 - 12 - 18 - t22:56:04.942z https://www.欧洲杯微信买球astrazeneca.com/media-centre/press-releases/2020/tagrisso-approved-in-the-us-for-early-lung-cancer.html 2020 - 12 - 20 - t18:40:53.452z https://www.欧洲杯微信买球astrazeneca.com/media-centre/press-releases/2020/update-on-source-phase-iii-trial-for-tezepelumab-in-patients-with-severe-oral-corticosteroid-dependent-asthma.html 2020 - 12 - 22 - t07:37:02.256z https://www.欧洲杯微信买球astrazeneca.com/media-centre/press-releases/2020/lynparza-approved-in-japan-for-three-cancers.html 2020 - 12 - 27 - t23:35:26.836z https://www.欧洲杯微信买球astrazeneca.com/media-centre/press-releases/2020/astrazenecas-covid-19-vaccine-authorised-in-uk.html 2020 - 12 - 30 - t07:11:56.019z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2019/lynparza -收到积极的欧盟- chmp意见- -使用-在生殖系- brca突变her2 - - -先进的乳腺癌症- 01032019. - html 2019 - 03 - 01 - t13:31:42.019z https://www.欧洲杯微信买球astrazeneca.com/media-centre/press-releases/2019/astrazeneca-announces-organisational-changes.html 2019 - 01 - 14 t17:38:14.225z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2019/linzess linaclotide -批准在中国- - - - - - - - -肠激惹综合征的治疗便秘- 18012019. html 2019 - 01 - 18 - t06:21:14.778z https://www.欧洲杯微信买球astrazeneca.com/media-centre/press-releases/2019/forxiga-receives-positive-eu-chmp-opinion-for-the-treatment-of-adults-with-type-1-diabetes.html 2019 - 02 - 01 - t13:44:25.287z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2019/ema授予- ' -资格- -潜在的下一代rsv -医学medi8897 - 05022019. - html 2019 - 02 - 04 - t22:41:47.313z https://www.欧洲杯微信买球astrazeneca.com/media-centre/press-releases/2019/us-fda-grants-breakthrough-therapy-designation-for-potential-next-generation-rsv-medicine-medi8897.html 2019 - 02 - 04 - t22:41:54.101z https://www.欧洲杯微信买球astrazeneca.com/media-centre/press-releases/2019/us-fda-grants-fasenra-orphan-drug-designation-for-hypereosinophilic-syndrome.html 2019 - 02 - 06 - t06:10:52.816z https://www.欧洲杯微信买球astrazeneca.com/media centre/press - releases/2019/lynparza显著延迟疾病-发展- 1号线-维修-治疗生殖系- brca突变-转移-胰腺癌症- 26022019. - html 2019 - 02年- 26 - t00:37:16.786z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2019/astrazeneca - -现在-新-心血管数据——farxiga - - 2型糖尿病在acc - 2019 - 11032019. - html 2019 - 03 - 08 - t17:58:50.796z https://www.欧洲杯微信买球astrazeneca.com/media centre/press releases/2019/us - fda拨款- saracatinib孤儿药物-设计-特发性肺纤维化- 18032019. - html 2019 - 03 - 17 - t21:46:13.459z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2019/brilintas阶段- iii -法律-试验- -主-端点在患者- - - - - - -建立-冠状动脉-病-和- 2型糖尿病- 25022019. - html 2019 - 02年- 26 - t09:18:04.170z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2019/full -年- 2018 - 14022019. - html结果 2019 - 02 - 14 - t09:07:20.011z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2019/first -子-分析- - -报关- timi - 58 -试验-进一步支持- -心血管效应——farxiga - - 2型糖尿病- 18032019. - html 2019 - 03 - 18 - t10:09:20.114z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2019/forxiga批准了-在-日本- - - 1型糖尿病- 27032019. - html 2019 - 03 - 26 - t19:50:51.362z https://www.欧洲杯微信买球astrazeneca.com/media-centre/press-releases/2019/forxiga-approved-in-europe-for-type-1-diabetes22032019.html 2019 - 03 - 22 - t16:41:39.722z https://www.欧洲杯微信买球astrazeneca.com/media-centre/press-releases/2019/astraZeneca-showcases-next-generation-oncology-pipeline-addressing-unmet-patient-needs-at-aacr-annual-meeting.html 2019 - 03 - 13 - t20:48:50.283z https://www.欧洲杯微信买球astrazeneca.com/media-centre/press-releases/2019/proposed-placing-of-new-ordinary-shares.html 2019 - 04 - 03 - t10:00:18.391z https://www.欧洲杯微信买球astrazeneca.com/media-centre/press-releases/2019/astrazeneca-and-daiichi-sankyo-enter-collaboration-for-novel-her-2-targeting-antibody-drug-conjugate.html 2019 - 03 - 28 - t23:37:41.557z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2019/positive结果——从fasenra - - ii期临床试验在- hypereosinophilic综合症- -发表在新英格兰医学杂志-的- 04042019. - html 2019 - 04 - 03 - t15:33:15.829z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2019/lynparza - - -欧盟的批准的治疗- -生殖系- brca突变- her2 - - -高级-乳腺癌癌症- 10042019. - html 2019 - 04 - 10 - t05:29:31.432z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2019/selumetinib授予-我们-突破-治疗-设计- -神经纤维瘤类型1 - 01042019. - html 2019 - 04 - 01 - t05:21:17.854z https://www.欧洲杯微信买球astrazeneca.com/media centre/press releases/2019/lynparza -接收积极-欧盟- chmp意见- 1 -线-维护- - - brca突变-先进的治疗卵巢癌症- 26042019. html 2019 - 04 - 29 - t05:17:26.868z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2019/astrazeneca -开始-人工智能-合作- -加速药物发现- 30042019. - html 2019 - 04 - 30 - t05:38:47.908z https://www.欧洲杯微信买球astrazeneca.com/media centre/press - releases/2019/qternmet - xr -批准————————————- 2型糖尿病治疗- - - 03052019. - html 2019 - 05 - 03 - t05:20:46.986z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2019/calquence - - iii -提升阶段试验-遇见-主-端点是在临时-分析- -复发或难治性-慢性淋巴细胞白血病早期-和-将停止- 07052019. - html 2019 - 05 - 07 - t06:13:31.214z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2019/trastuzumab deruxtecan演示-临床意义——反应患者- - - - - - -耐火her2 -积极的转移性乳腺癌癌症-人口- -高-未满足的需要08052019. - html 2019 - 05 - 08 - t06:33:52.883z https://www.欧洲杯微信买球astrazeneca.com/media-centre/press-releases/2019/pooled-analyses-of-the-roxadustat-global-phase-3-programme-confirmed-cardiovascular-safety.html 2019 - 05 - 10 - t06:16:10.717z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2019/new -数据-在- symbicort - -一个潜在的抗-炎症-释放- -轻度哮喘- - -呈现- at - at - 2019 - 16052019. - html 2019 - 05 - 16 - t05:55:25.816z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2019/astrazeneca持续- -定义-癌症治疗——- 2019 asco年度会议- 16052019. html 2019 - 05 - 16 - t05:54:27.545z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2019/new -数据-显示- symbicort -减少-攻击-在-轻度哮喘- - -作为一个抗炎症-释放- 20052019. - html 2019 - 05 - 20 - t06:08:04.945z https://www.欧洲杯微信买球astrazeneca.com/media-centre/press-releases/2019/lynparza-nearly-doubled-the-time-patients-lived-without-disease-progression-from-germline-brca-mutated-metastatic-pancreatic-cancer02062019.html 2019 - 06 - 02 - t12:36:49.533z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2019/q1 - 2019 results.html 2019 - 04 - 26 - t22:04:05.225z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2019/lynparza几乎翻了一番————————住——没有疾病的患者——发展——从生殖系- brca突变-转移性胰腺癌cancer02062019 - 2. - html 2019 - 06 - 02 - t20:38:57.345z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2019/lynparza - - - 72 -目标-实现响应率- -患者的复发-生殖系brca突变-高级-卵巢癌症- 03062019. - html 2019 - 06 - 03 - t20:47:19.616z https://www.欧洲杯微信买球astrazeneca.com/media-centre/press-releases/2019/calquence-phase-iii-elevate-tn-trial-met-primary-endpoint-at-interim-analysis-in-previously-untreated-chronic-lymphocytic-leukaemia06062019.html 2019 - 09 - 02 - t16:30:06.203z https://www.欧洲杯微信买球astrazeneca.com/media-centre/press-releases/2019/lokelma-demonstrated-efficacy-in-treating-hyperkalaemia-in-patients-with-end-stage-renal-disease-on-haemodialysis14062019.html 2019 - 09 - 02 - t16:29:20.373z https://www.欧洲杯微信买球astrazeneca.com/media-centre/press-releases/2019/imfinzi-is-the-only-immunotherapy-to-demonstrate-overall-survival-at-three-years-in-unresectable-stage-iii-non-small-cell-lung-cancer02062019.html 2019 - 09 - 02 - t16:28:31.210z https://www.欧洲杯微信买球astrazeneca.com/media-centre/press-releases/2019/calquence-significantly-prolonged-the-time-patients-lived-without-disease-progression-in-relapsed-or-refractory-chronic-lymphocytic-leukaemia15062019.html 2019 - 06 - 17 t06:54:01.325z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2019/lynparza批准- - -欧盟- 1号线-维护- - - brca突变-先进的治疗卵巢癌症- 18062019. html 2019 - 06 - 18岁t06:46:05.532z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2019/bevespi大气层————通过-日本-省- -健康-劳动和福利- -病人与慢性阻塞性-肺疾病- 19062019. - html 2019 - 09 - 02 - t16:26:26.455z https://www.欧洲杯微信买球astrazeneca.com/media centre/press releases/2019/breztri -大气层pt010批准- -日本的病人- -慢性阻塞性肺疾病- 19062019. - html 2019 - 09 - 02 - t16:25:31.228z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2019/lynparza批准- -日本- 1号线-维护-治疗- brca突变-高级-卵巢癌症- 19062019. - html 2019 - 09 - 02 - t16:24:30.669z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2019/imfinzi -改进-整体生存——过渡——分析——————- iii -里海-阶段试验-在- 1 -线-广泛的阶段-小细胞肺癌-癌症- 27062019. - html 2019 - 06 - 27 - t12:57:02.671z https://www.欧洲杯微信买球astrazeneca.com/media centre/press releases/2019/fasenra -接收积极-欧盟- chmp意见————自我管理和-新- fasenra笔pre -填充-单-使用-汽车-喷射器- 01072019. - html 2019 - 07 - 01 - t06:25:11.196z https://www.欧洲杯微信买球astrazeneca.com/media centre/press releases/2019/forxiga -接收积极-欧盟- chmp意见声明- timi - 58 -心血管-结果-数据- 01072019. - html 2019 - 07 - 01 - t06:26:31.239z https://www.欧洲杯微信买球astrazeneca.com/media-centre/press-releases/2019/imfinzi-granted-us-orphan-drug-designation-for-small-cell-lung-cancer12072019.html 2019 - 09 - 02 - t16:22:53.807z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2019/update -对-我们-监管的决定——farxiga - - 1型糖尿病- 15072019. - html 2019 - 09 - 02 - t16:22:05.119z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2019/h1 - 2019 results.html 2019 - 07 - 25 - t06:57:11.231z https://www.欧洲杯微信买球astrazeneca.com/media-centre/press-releases/2019/forxiga-label-updated-in-the-eu-in-type-2-diabetes.html 2019 - 08 - 05 - t06:30:24.056z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2019/lynparza阶段- iii -深刻-试验-嗯-突变-选择-转移-阉割——抗前列腺癌-满足主要端点- 07082019. - html 2019 - 08 - 21 - t06:15:21.319z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2019/tagrisso -显著提高整体-生存- - - - - - iii - flaura阶段试验- - 1号线- egfr突变-非小细胞肺-癌症- 09082019. - html 2019 - 08 - 21 - t06:14:47.025z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2019/calquence授予-我们-突破-治疗-设计-慢性淋巴细胞白血病- 14082019. - html 2019 - 08 - 19 - t16:37:34.364z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2019/lynparza - - iii - paola - 1期临床试验满足-初级-端点1 -线-维护- - -贝伐单抗治疗-高级-卵巢癌症- 14082019. - html 2019 - 08 - 19 - t16:36:08.176z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2019/farxiga - -主-端点在采办局地标-相- iii - - hf -试验- - -治疗的患者——-心-失败- 20082019. - html 2019 - 08 - 20 - t06:35:00.737z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2019/update - - - - - - iii -海王星阶段试验- - imfinzi + tremelimumab -在第四阶段——-非小细胞肺-癌症- 21082019. - html 2019 - 08 - 21 - t06:22:51.132z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2019/astrazeneca同意-购买-美国fda -优先评审券-从艺人- 22082019. - html 2019 - 08 - 22 - t06:29:09.514z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2019/roxadustat批准————中国——————贫血的治疗——-非透析依赖与-慢性肾脏疾病患者——- 22082019. - html 2019 - 09 - 02 - t16:17:37.503z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2019/fda授予-快速跟踪指定- - farxiga -慢性肾脏疾病- 27082019. - html 2019 - 08 - 26 - t21:25:59.647z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2019/breztri -大气层阶段- iii -精神-试验- -其主要终点相遇-在-慢性阻塞性肺疾病- 28082019. - html 2019 - 09 - 02 - t16:01:48.930z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2019/fasenra授予-美国-孤儿药物名称- -嗜酸性食管炎- 28082019. - html 2019 - 09 - 02 - t16:03:09.903z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2019/anifrolumab - - iii期临床试验——满足主要-端点-系统性红斑狼疮- 29082019. - html 2019 - 08 - 29 - t06:38:50.030z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2019/astrazeneca -现在-数据-在esc -国会- 2019 -可能重新定义- -心-失败-的-治疗29082019. - html 2019 - 09 - 02 - t16:16:16.215z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2019/detailed结果——从采办局-相- iii - - hf -试验-显示- farxiga显著降低发病率————————————————心血管死亡的恶化- -心-失败- 01092019.的html 2019 - 09 - 01 - t13:05:06.560z https://www.欧洲杯微信买球astrazeneca.com/media centre/press releases/2019/brilinta -减少-心血管事件的风险- - -患者的冠状动脉疾病-和- 2型糖尿病——忒弥斯-相- iii - -试验- 01092018. - html 2019 - 09 - 02 - t16:15:08.557z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2019/tagrisso批准————中国————- 1号线-治疗- - - - - - - egfr突变-非小细胞肺-癌症- 04092019. - html 2019 - 09 - 04 - t06:50:00.757z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2019/imfinzi - -第一次免疫疗法- - -两个明显的生存-效益-和-改进-耐用-反应- -广泛的舞台-小-细胞-肺癌症- 10092019. - html 2019 - 11 - 07 - t13:54:51.264z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2019/astrazeneca重新定义-癌症治疗- -实践-改变-数据- 2019. - esmo html 2019 - 09 - 16 - t06:32:08.179z https://www.欧洲杯微信买球astrazeneca.com/media-centre/press-releases/2019/fda-grants-fast-track-designation-for-farxiga-in-heart-failure.html 2019 - 09 - 16 - t06:50:15.572z https://www.欧洲杯微信买球astrazeneca.com/media-centre/press-releases/2019/astrazeneca-amends-collaboration-with-ironwood-for-linzess-in-china.html 2019 - 09 - 18 - t06:31:29.932z https://www.欧洲杯微信买球astrazeneca.com/media centre/press - releases/2019/qtrilmet -推荐- - - - - - - - -欧盟的批准chmp - - - - - -的- 2型糖尿病治疗- 23092019. - html 2019 - 09 - 23 - t06:33:07.432z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2019/astrazeneca - -现在-未来-波-科学- -呼吸道疾病-人-国际大会- 25092019. - html 2019 - 09 - 25 - t06:32:28.892z https://www.欧洲杯微信买球astrazeneca.com/media-centre/press-releases/2019/tagrisso-is-the-only-1st-line-treatment-for-egfr-mutated-non-small-cell-lung-cancer-to-deliver-a-median-overall-survival-of-more-than-three-years.html 2019 - 09 - 30 - t08:02:32.854z https://www.欧洲杯微信买球astrazeneca.com/media-centre/press-releases/2019/lynparza-improved-the-time-women-lived-without-disease-progression-to-22-months-in-the-broad-population-and-to-37-months-in-hrd-positive-patients.html 2019 - 09 - 30 - t08:03:35.174z https://www.欧洲杯微信买球astrazeneca.com/media centre/press releases/2019/lynparza - -比翻了一番- -时间-没有疾病进展- -患者的乳腺癌易感基因1 - 2 atm -突变-转移-阉割-抗前列腺癌- 30092019. - html 2019 - 09 - 30 - t15:58:53.541z https://www.欧洲杯微信买球astrazeneca.com/media centre/press releases/2019/update - -我们监管审查- - pt010的慢性阻塞性肺病- 01102019. - html 2019 - 10 - 01 - t06:28:19.501z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2019/astrazeneca -剥离权利- - -拥有cheplapharm - 01102019. - html 2019 - 10 - 01 - t06:33:39.320z https://www.欧洲杯微信买球astrazeneca.com/media centre/press - releases/2019/fasenra批准- - -我们的自我-政府-在-一个新的pre -填充-汽车-喷射器fasenra笔- 04102019. - html 2019 - 10 - 04 - t06:29:35.368z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2019/trastuzumab deruxtecan -获得fda -优先审查- -治疗的患者- - - - - - - her2阳性-转移性乳腺癌癌症- 17102019. - html 2019 - 10 - 17 - t06:26:22.322z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2019/year - -日期-和- q3 - 2019 results.html 2019 - 10 - 24 - t06:44:13.001z https://www.欧洲杯微信买球astrazeneca.com/media centre/press - releases/2019/farxiga批准- - -我们-减少- - - - - - - - -住院的风险——心脏——失败————————- 2型糖尿病患者- 21102019. - html 2019 - 10 - 21 - t06:25:30.574z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2019/astrazeneca -承诺- 35 - m - -帮助年轻-人-解决- - -非传染性疾病的威胁——- 22102019. - html 2019 - 10 - 21 - t15:32:42.809z https://www.欧洲杯微信买球astrazeneca.com/media-centre/press-releases/2019/imfinzi-and-imfinzi-plus-tremelimumab-delayed-disease-progression-in-phase-iii-poseidon-trial-for-1st-line-treatment-of-stage-iv-non-small-cell-lung-cancer.html 2019 - 10 - 28 - t15:56:44.488z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2019/astrazeneca -剥离权利-思瑞康-和-思瑞康- xr - -欧洲-和-俄罗斯- 30102019. - html 2019 - 10 - 30 - t07:25:34.227z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2019/astrazeneca -现在-关键roxadustat阶段- iii -数据- - -美国-社会- -肾脏学-肾周- 2019 - 30102019. - html 2019 - 10 - 30 - t07:34:27.377z https://www.欧洲杯微信买球astrazeneca.com/media centre/press - releases/2019/astrazeneca宣布三-大-规模-行动-中国-发展-全球——医学研究和发展- 061120119. - html 2019 - 11 - 07 - t08:46:25.395z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2019/calquence -数据-显示-改进-发展-免费-生存阶段- iii -前-线-慢性淋巴细胞白血病-试验-灰- 2019年度meeting.html 2019 - 11 - 06 - t14:54:45.017z https://www.欧洲杯微信买球astrazeneca.com/media-centre/press-releases/2019/roxadustat-significantly-increased-haemoglobin-levels-for-chronic-kidney-disease-patients-with-anaemia-in-phase-iii-olympus-and-rockies-trials.html 2019 - 11 - 07 - t21:47:24.480z https://www.欧洲杯微信买球astrazeneca.com/media-centre/press-releases/2019/roxadustat-phase-iii-programme-pooled-analyses-showed-positive-efficacy-and-no-increased-cv-risk-in-patients-with-anaemia-from-chronic-kidney-disease.html 2019 - 11 - 08 - t19:18:12.343z https://www.欧洲杯微信买球astrazeneca.com/media-centre/press-releases/2019/anifrolumab-demonstrated-superiority-across-multiple-efficacy-endpoints-in-patients-with-systemic-lupus-erythematosus-in-phase-iii-tulip-2-trial.html 2019 - 11 - 12 - t16:26:13.200z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2019/us - fda接受监管-提交selumetinib - -神经纤维瘤类型1 -和-赠款优先审查- 14112019. - html 2019 - 11 - 14 - t07:15:39.640z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2019/qtrilmet批准欧盟————————————————- 2型糖尿病治疗- 15112019. - html 2019 - 11 - 15 - t06:54:17.592z https://www.欧洲杯微信买球astrazeneca.com/media centre/press - releases/2019/calquence批准- - -我们的成人患者- - - - - - -慢性淋巴细胞白血病- 21112019. html 2019 - 11 - 21 - t20:59:00.171z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2019/harvard -业务-审核-名字-帕斯卡- soriot最好- - - - - - -执行-高级- 100 -首席执行官- - -世界- 2019. - html 2019 - 11 - 22 - t13:56:12z https://www.欧洲杯微信买球astrazeneca.com/media-centre/press-releases/2019/imfinzi-granted-fda-priority-review-for-the-treatment-of-patients-with-extensive-stage-small-cell-lung-cancer.html 2019 - 11 - 29 - t07:21:58.683z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2019/astrazeneca -剥离权利-思瑞康-和-思瑞康- xr - - -美国和加拿大- 03122019. - html 2019 - 12 - 02 - t16:58:21.107z https://www.欧洲杯微信买球astrazeneca.com/media-centre/press-releases/2019/lynparza-approved-in-china-as-a-1st-line-maintenance-therapy-in-brca-mutated-advanced-ovarian-cancer.html 2019 - 12 - 05 - t07:44:38.161z https://www.欧洲杯微信买球astrazeneca.com/media-centre/press-releases/2019/calquence-significantly-prolonged-the-time-patients-lived-without-disease-progression-or-death-in-previously-untreated-chronic-lymphocytic-leukaemia.html 2019 - 12 - 09 - t10:32:30.070z https://www.欧洲杯微信买球astrazeneca.com/media centre/press - releases/2019/trastuzumab deruxtecan - - -肿瘤反应率实现- - - 60的关键阶段- ii - her2阳性-转移性乳腺癌癌症-试验- 11122019. - html 2019 - 12 - 11 - t13:27:11.405z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2019/imfinzi -批准在中国- - - - - - -的-治疗不可切除的阶段- iii -非小细胞肺癌症- - - - - - -基于-相- iii -太平洋-试验- 12122019. - html 2019 - 12 - 12 - t07:06:05.507z https://www.欧洲杯微信买球astrazeneca.com/media centre/press releases/2019/agreement -与- cheplapharm权利-思瑞康-和-思瑞康- xr -欧洲- - - -俄罗斯-完成- 16122019. - html 2019 - 12 - 16 - t07:53:38.701z https://www.欧洲杯微信买球astrazeneca.com/media-centre/press-releases/2019/lynparza-recommended-by-fda-advisory-committee-for-1st-line-maintenance-treatment-of-germline-brca-mutated-metastatic-pancreatic-cancer.html 2019 - 12 - 18 - t09:17:05.780z https://www.欧洲杯微信买球astrazeneca.com/media centre/press releases/2019/astrazeneca -剥离权利-瑞宁德-和- casodex -欧洲-和-某些额外的国家- 20122019. - html 2019 - 12 - 20 - t07:00:53.310z https://www.欧洲杯微信买球astrazeneca.com/media-centre/press-releases/2019/enhertu-trastuzumab-deruxtecan-approved-in-the-us-for-her2-positive-unresectable-or-metastatic-breast-cancer-following-2-or-more-prior-anti-her2-based-regimens.html 2019 - 12 - 23 - t11:35:52.429z https://www.欧洲杯微信买球astrazeneca.com/media centre/press releases/2019/astrazenecas -三重组合疗法-批准在中国- - - - - - -患者,慢性阻塞性肺病- 23122019. - html 2019 - 12 - 23 - t12:31:29.098z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2019/astrazenecas弥尼-潘加洛斯授予骑士- - -新的一年2020 -荣誉- - 28122019. - html列表 2019 - 12 - 27 - t22:53:06.009z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2019/lynparza批准————————————1日线-维护-治疗生殖系- brca突变-转移-胰腺癌症- 30122019. - html 2019 - 12 - 30 - t07:10:42.592z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2018/lokelma——欧盟批准了——————————- - -成人的治疗高钾血症- 22032018. - html 2018 - 04 - 02 - t22:04:18.205z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2018/astrazeneca -接收-欧盟-审批-的- fasenra - -严重嗜酸性哮喘- 10012018. - html 2018 - 01 - 10 - t15:07:51.640z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2018/lynparza批准- -美国fda在生殖系- brca突变-转移性乳腺癌癌症- 12012018. - html 2018 - 01 - 15 - t13:38:48.402z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2018/fasenra接待-审批- -日本- 19012018. - html 2018 - 01 - 18 - t22:11:19.282z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2018/lynparza接收-审批- -日本- - - - - -高级-卵巢癌症的治疗- - 19012018. - html 2018 - 01 - 18 - t22:05:43.626z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2018/astrazeneca上市——————————世界- - 100最可持续的公司-和-认识- - -三倍增加——可再生能源-使用- 23012018. - html 2018 - 01 - 23 t07:52:37.266z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2018/astrazeneca报告-前-线- - iii -二氧化钛-阶段试验结果- - - - - - - pt010三-组合疗法-在-慢性阻塞性肺疾病- 26102018. - html 2018 - 01 - 26 t18:31:56.609z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2018/full -年- 2017 results.html 2018 - 02年- 02 - t08:08:45.295z https://www.欧洲杯微信买球astrazeneca.com/media centre/press - releases/2018/brilinta显著降低- cv -事件-和-冠状动脉-死亡- -一年的心-攻击-幸存者- -多-船-疾病- 07022018. - html 2018 - 02 - 07 - t07:08:35.088z https://www.欧洲杯微信买球astrazeneca.com/media centre/press releases/2018/selumetinib -授予孤儿-药物-设计- - -美国fda的神经纤维瘤-类型1 - 15022018. - html 2018 - 02年- 15 - t06:53:14.414z https://www.欧洲杯微信买球astrazeneca.com/media centre/press releases/2018/us - fda批准- imfinzi - -不可切除的阶段- iii -非小细胞肺-癌症- 180202018. - html 2018 - 02年- 23 - t06:48:59.242z https://www.欧洲杯微信买球astrazeneca.com/media centre/press releases/2018/lynparza -接收积极-欧盟- chmp意见-铂敏感复发-卵巢癌症- 23022018. - html 2018 - 02年- 23 - t12:25:13.406z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2018/medimmune独自-创造-站- -公司- - -阶段早期炎症和自身免疫-生物制剂28022018. - html 2018 - 02 - 28 - t06:28:49.957z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2018/the -欧洲-药物-机构-接受监管提交- - forxiga的成人- - - 1型糖尿病患者05032018. - html 2018 - 03 - 05 - t06:27:47.333z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2018/astrazeneca -目标- - -临床实践的cv -风险-管理- - - - - - -新-数据- acc - 2018 - 05032018. - html 2018 - 03 - 05 - t06:25:25.526z https://www.欧洲杯微信买球astrazeneca.com/media centre/press releases/2018/astrazeneca -提供-更新神秘-试验-时间- 12032018. - html 2018 - 03 - 12 - t08:11:11.943z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2018/new -数据-从地标- cvd的——研究——- - - - 2型糖尿病患者证实- cv -利益关联——sglt - 2抑制剂- 12032018. - html 2018 - 03 - 12 - t07:00:40.061z https://www.欧洲杯微信买球astrazeneca.com/media centre/press releases/2018/us - fda接受-生物制品许可-应用程序- moxetumomab pasudotox - -毛细胞白血病- 03042018. - html 2018 - 04 - 03 - t05:48:00.427z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2018/the -欧洲-药物-机构-接受监管提交- - lynparza的brca突变her2 - - -转移性乳腺癌癌症- 03042018. - html 2018 - 04 - 03 - t05:45:00.103z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2018/astrazenecas - - -后期阶段早期肿瘤-组合aacr -年度会议上展示了- - - - - - - - - -得- 04042018. - html 2018 - 04 - 06 - t17:21:10.245z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2018/1st -线- tagrisso演示-持续受益后进展- -病人的表皮生长因子受体突变-非小细胞肺-癌症- 13042018. - html 2018 - 04 - 13 - t13:52:55.714z https://www.欧洲杯微信买球astrazeneca.com/media centre/press releases/2018/updated -整体生存-数据- - - - - - - lynparza - - brca突变her2 - - -转移性乳腺癌癌症-呈现- aacr - 16042018. - html 2018 - 04 - 16 - t10:51:08.349z https://www.欧洲杯微信买球astrazeneca.com/media-centre/press-releases/2018/us-fda-approves-tagrisso-as-1st-line-treatment-for-EGFR-mutated-non-small-cell-lung-cancer.html 2018 - 04 - 19 - t15:41:53.280z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2018/astrazeneca报道——结果——从北极-试验-第三行-非小细胞肺-癌症- 24042018. - html 2018 - 04 - 24 - t05:22:23.881z https://www.欧洲杯微信买球astrazeneca.com/media-centre/press-releases/2018/tagrisso-receives-positive-eu-chmp-opinion-for-1st-line-treatment-of-egfr-mutated-non-small-cell-lung-cancer27042018.html 2018 - 04 - 27 - t14:03:20.591z https://www.欧洲杯微信买球astrazeneca.com/media-centre/press-releases/2018/lynparza-tablets-receive-eu-approval-for-the-treatment-of-platinum-sensitive-relapsed-ovarian-cancer08052018.html 2018 - 05 - 08 - t10:17:45.404z https://www.欧洲杯微信买球astrazeneca.com/media-centre/press-releases/2018/astrazeneca-and-luye-pharma-group-enter-agreement-for-rights-to-seroquel-and-seroquel-xr-in-the-uk-china-and-other-international-markets.html 2018 - 05 - 07 - t13:14:40.181z https://www.欧洲杯微信买球astrazeneca.com/media centre/press releases/2018/astrazeneca -提供-更新galathea - - iii期临床试验——fasenra -在-慢性阻塞性肺疾病- 11052018. - html 2018 - 05 - 11 - t06:06:22.118z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2018/astrazeneca - -推进临床-实践- -呼吸医学-与-新-数据- - -美国-胸-社会- 2018 -国际congress.html 2018 - 05 - 16 - t05:46:23.318z https://www.欧洲杯微信买球astrazeneca.com/media-centre/press-releases/2018/new-england-journal-of-medicine-publishes-two-trials-for-symbicort-as-an-anti-inflammatory-reliever-therapy-as-needed-in-mild-asthma16052018.html 2018 - 05 - 17 - t13:37:29.771z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2018/q1 - 2018 results.html 2018 - 05 - 18 - t06:21:48.563z https://www.欧洲杯微信买球astrazeneca.com/media centre/press - releases/2018/regulatory提交- -日本- - - - - - - forxiga -中- - 1型糖尿病- 21052018. - html 2018 - 06 - 05 - t08:57:09.815z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2018/lokelma批准——————————- - -成人的治疗高钾血症- 21052018. - html 2018 - 06 - 04 - t16:02:06.989z https://www.欧洲杯微信买球astrazeneca.com/media centre/press releases/2018/astrazeneca -头- 2018 asco -年度会议————其多元化-肿瘤学组合——pipeline24052018.html——下一代 2018 - 05 - 24 - t21:37:17.047z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2018/imfinzi -显著提高整体生存-在-相- iii -太平洋-试验- -不可切除的阶段- iii -非小细胞肺-癌症- 25052018. - html 2018 - 05 - 24 - t23:55:11.430z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2018/update——•艾伯特- - iii期临床试验——fasenra -在-慢性阻塞性肺疾病- 30052018. - html 2018 - 05 - 30 - t04:54:50.340z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2018/moxetumomab pasudotox -关键数据——治疗的患者- - - - - - -以前毛-细胞白血病——了————- 2018 asco会议上- 04062018. - html 2018 - 06 - 04 - t13:12:10.299z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2018/lynparza阿比特龙————组合————-延迟疾病-发展- -转移-阉割——抗前列腺癌- 04062018. - html 2018 - 06 - 04 - t21:02:58.634z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2018/the -欧盟批准tagrisso - -第一线治疗的- egfr突变-非小细胞肺-癌症- 08062018. - html 2018 - 06 - 11 - t13:00:30.120z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2018/update - - - iii期临床试验————lanabecestat - -老年痴呆症病- 12062018. - html 2018 - 06 - 12 - t05:22:15.675z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2018/astrazeneca - -分享-最新数据-从一个行业领先——投资组合——-目标-推进临床-理解- -糖尿病和cv -风险-管理- - - - - - -艾达- 2018 - 19062018. - html 2018 - 06 - 19 t05:52:04.974z https://www.欧洲杯微信买球astrazeneca.com/media-centre/press-releases/2018/lynparza-significantly-delays-disease-progression-in-phase-iii-1st-line-solo-1-trial-for-ovarian-cancer.html 2018 - 06 - 27 - t06:42:44.767z https://www.欧洲杯微信买球astrazeneca.com/media centre/press releases/2018/bydureon -接收积极-欧盟- chmp意见-新- bcise -设备- - - - - - - - - - 2型糖尿病患者29062018. - html 2018 - 06 - 29 t12:45:18.345z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2018/lynparza批准-在-日本- brca突变-转移性乳腺癌癌症- 02072018. - html 2018 - 06 - 29 t16:18:53.866z https://www.欧洲杯微信买球astrazeneca.com/media centre/press - releases/2018/imfinzi批准- -日本- - - -不可切除的阶段- iii -非小细胞肺-癌症- 02072018. - html 2018 - 06 - 29 t16:32:21.097z https://www.欧洲杯微信买球astrazeneca.com/media-centre/press-releases/2018/Atacand-to-be-divested-to-Cheplapharm-in-Europe24072018.html 2018 - 07 - 24 - t06:10:06.129z https://www.欧洲杯微信买球astrazeneca.com/media centre/press releases/2018/h1 - 2018 - 25072018. - html结果 2018 - 07 - 26 - t10:05:57.248z https://www.欧洲杯微信买球astrazeneca.com/media centre/press releases/2018/imfinzi -接收积极-欧盟- chmp意见-本地-高级-不可切除的非小细胞肺-癌症27072018. - html 2018 - 07 - 27 - t12:56:20.900z https://www.欧洲杯微信买球astrazeneca.com/media centre/press releases/2018/selumetinib -授予孤儿——指定-欧洲- -神经纤维瘤类型1 - 03082018. - html 2018 - 08 - 03 - t05:51:47.544z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2018/astrazeneca - -发展-理解- -心肺肾代谢——互连- -新证据在esc - 2018 - 20082018. - html 2018 - 08 - 17 - t14:47:46.834z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2018/tagrisso批准————日本——治疗- 1号线- - - egfr突变的非小细胞-肺癌症- 21082018. - html 2018 - 08 - 21 - t05:57:45.099z https://www.欧洲杯微信买球astrazeneca.com/media-centre/press-releases/2018/european-commission-approves-new-easy-to-use-once-weekly-bydureon-bcise-device-for-patients-with-type-2-diabetes30082018.html 2018 - 08 - 30 - t05:51:20.252z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2018/update - -郁金香- 1——- iii期临床试验————anifrolumab -系统性红斑狼疮- 31082018. - html 2018 - 08 - 30 - t21:48:28.209z https://www.欧洲杯微信买球astrazeneca.com/media-centre/press-releases/2018/astrazeneca-provides-update-on-aeristo-phase-iiib-trial-for-bevespi-aerosphere-in-chronic-obstructive-pulmonary-disease23082018.html 2018 - 08 - 23 - t05:37:09.413z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2018/tezepelumab授予-突破-治疗名称- 07092018. -美国fda - html 2018 - 09 - 11 - t16:47:39.320z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2018/astrazeneca - -现在- fasenra长期-安全性-和有效性-数据- -欧洲呼吸协会——国际——国会- 2018 - 13092018. - html 2018 - 09 - 12 - t15:05:42.520z https://www.欧洲杯微信买球astrazeneca.com/media centre/press - releases/2018/new -数据- - - - - - - - -获得耐药性的机制在- 1号线- tagrisso nsclc -支持-起始果园——试验———探索—post -发展-处理-选项- 19102018. - html 2018 - 10 - 19 - t13:53:30.394z https://www.欧洲杯微信买球astrazeneca.com/media-centre/press-releases/2018/us-fda-approves-lumoxiti-moxetumomab-pasudotox-tdfk-for-certain-patients-with-relapsed-or-refractory-hairy-cell-leukaemia.html 2018 - 09 - 14 - t06:24:41.549z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2018/the柳叶刀-呼吸医学-发布第一个- - iii期临床试验——pt010 -三重组合疗法- -温和的很严重-慢性阻塞性肺疾病- 16092018. html 2018 - 09 - 16 - t18:01:20.742z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2018/fasenra -显示-一致的安全- - - -持续有效性- -长期阶段- iii -拉博拉-试验- -严重嗜酸性哮喘- 18092018. - html 2018 - 09 - 18 - t05:13:15.220z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2018/astrazeneca礼物-进一步-数据-显示- - -心血管和肾脏之间的互连,-风险-在-糖尿病- 2 - 2018 - 20092018. - html 2018 - 09 - 20 - t05:40:40.741z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2018/bydureon -收到积极的欧盟- chmp意见- - exscel心血管-结果-数据- 25092018. - html 2018 - 09 - 25 - t05:16:11.862z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2018/european委员会批准- imfinzi -本地先进-不可切除的非小细胞肺癌- 24092018. - html 2018 - 10 - 11 - t18:25:24.114z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2018/farxiga - - -积极的结果在实现阶段- iii声明- timi 58 -试验- -大-心血管-结果-试验- - 17000 - 2型糖尿病病人————- 24092018. - html 2018 - 09 - 24 - t05:38:23.196z https://www.欧洲杯微信买球astrazeneca.com/media-centre/press-releases/2018/imfinzi-is-the-first-immunotherapy-to-demonstrate-significant-overall-survival-benefit-in-unresectable-stage-iii-lung-cancer25092018.html 2018 - 10 - 11 - t18:27:20.982z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2018/astrazeneca礼物-发展- -改善治疗-选项- -卵巢和肺癌症患者——- esmo - 2018 - 09102018. - html 2018 - 10 - 10 - t07:10:04.137z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2018/us - fda拨款lynparza -孤儿药物名称- -胰腺癌症- 16102018. - html 2018 - 10 - 16 - t06:01:25.174z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2018/chmp -问题- -积极意见- bevespi大气层治疗- - - - - - - - -慢性阻塞性肺疾病- 19102018. - html 2018 - 10 - 19 - t12:22:12.467z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2018/astrazeneca - -现在-新-数据-展示广度- -研究投资组合- -肾疾病- asn -肾周22102018. - html 2018 - 10 - 22 - t07:51:49.022z https://www.欧洲杯微信买球astrazeneca.com/media-centre/press-releases/2018/astrazeneca-strengthens-and-expands-oncology-development-and-commercialisation-collaboration-with-innate-pharma23102018.html 2018 - 10 - 24 - t09:09:48.268z https://www.欧洲杯微信买球astrazeneca.com/media centre/press releases/2018/agreement -与- grunenthal权利-埃索美拉唑- -欧洲和vimovo -世界- ex -我们- 30102018. - html 2018 - 10 - 30 - t06:08:53.913z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2018/us fda接受-管理-提交lynparza -维修-治疗新诊断- brca突变-高级-卵巢癌症-和-赠款优先审查- 12112018. - html 2018 - 11 - 12 - t06:58:42.217z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2018/year - -日期-和- q3 - 2018 - 08112018. - html结果 2018 - 11 - 08 - t07:27:30.053z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2018/the里程碑式的声明- timi 58 -心血管结果-试验-的- farxiga - - 2型糖尿病病人————————————01112018. -啊哈——html 2018 - 11 - 01 - t06:12:33.799z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2018/solo - 1 - - iii期临床试验——显示——lynparza -维护-治疗减少风险- -疾病进展或死亡——70%——————————新诊断的患者——高级- brca突变cancer.html——卵巢 2018 - 10 - 22 - t05:48:04.456z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2018/phase全球-试验- iii -协调- - lokelma证实功效————维持正常-钾水平-亚洲-患者高钾血症- 25102018. - html 2018 - 10 - 25 - t14:08:59.763z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2018/divestment - -权利——alvesco -德-和- zetonna covis丙制药- 06112018. - html 2018 - 11 - 06 - t15:34:06.482z https://www.欧洲杯微信买球astrazeneca.com/media-centre/press-releases/2018/farxiga-significantly-reduced-hospitalisation-for-heart-failure-or-cv-death-in-a-broad-patient-population-with-type-2-diabetes-in-the-landmark-declare-timi-58-trial.html 2018 - 11 - 11 - t10:30:39.626z https://www.欧洲杯微信买球astrazeneca.com/media-centre/press-releases/2018/astrazeneca-to-divest-us-synagis-rights-to-sobi131120180.html 2018 - 11 - 13 - t06:54:29.185z https://www.欧洲杯微信买球astrazeneca.com/media-centre/press-releases/2018/astrazeneca-provides-update-on-the-phase-iii-mystic-trial-of-imfinzi-and-tremelimumab-in-stage-iv-non-small-cell-lung-cancer16112018.html 2018 - 11 - 16 - t06:24:12.888z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2018/update - - -相- iii -鹰-试验- imfinzi -和- tremelimumab -高级-头和颈部的癌症- 07122018. - html 2018 - 12 - 07 - t06:42:50.777z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2018/astrazeneca -和-英国癌症研究- -发射-功能-基因组学中心- -加速-的-发现-新-药物- 10122018. - html 2018 - 12 - 07 - t16:25:57.327z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2018/us fda授予- fasenra孤儿药物-设计-嗜酸性肉芽肿病- 26112018. - polyangiitis html 2018 - 11 - 25 - t19:56:39.893z https://www.欧洲杯微信买球astrazeneca.com/media-centre/press-releases/2018/phase-iii-olympus-and-rockies-trials-for-roxadustat-met-their-primary-endpoints-in-chronic-kidney-disease-patients-with-anaemia20122018.html 2018 - 12 - 20 - t07:12:10.540z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2018/astrazeneca礼物-临床研究进展- -血液癌症病人- - 2018 -美国-社会- -血液学年度会议- 27112018. - html 2018 - 11 - 27 - t06:48:29.535z https://www.欧洲杯微信买球astrazeneca.com/media-centre/press-releases/2018/roxadustat-approved-in-china-for-the-treatment-of-anaemia-in-chronic-kidney-disease-patients-on-dialysis18122018.html 2018 - 12 - 18 - t10:13:58.453z https://www.欧洲杯微信买球astrazeneca.com/media-centre/press-releases/2018/lynparza-meets-primary-endpoint-in-phase-iii-solo-3-trial-for-the-treatment-of-relapsed-brca-mutated-advanced-ovarian-cancer20122018.html 2018 - 12 - 20 - t06:48:23.185z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2018/new长期-数据- - calquence呈现在灰- 2018 - 03122018. - html 2018 - 12 - 03 - t18:47:41.560z https://www.欧洲杯微信买球astrazeneca.com/media-centre/press-releases/2018/lynparza-approved-by-us-fda-for-1st-line-maintenance-therapy-in-brca-mutated-advanced-ovarian-cancer19122018.html 2018 - 12 - 19 - t18:57:05.974z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2018/bevespi大气层——批准- - -欧盟-慢性阻塞性肺疾病- 20122018. html 2018 - 12 - 20 - t13:58:36.293z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2017/astrazeneca -和-地区-药物- - -开发和商业化协作anticalin -基础-吸入疗法- -呼吸道疾病- 03052017. - html 2017 - 05 - 03 - t05:31:31.251z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2017/astrazeneca -膨胀- 1号线-肺癌症免疫-肿瘤-计划- - 17012017. - html的机会 2017 - 01 - 26 t14:47:40.196z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2017/symbicort授予-儿科排他性- - -我们- 26012017. - html 2017 - 01 - 26 t10:12:39.603z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2017/full年和第四季度- 2016 - 02022017. - html结果 2018 - 07 - 05 - t13:09:10.856z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2017/siliq - brodalumab批准- - -美国fda的-成人患者- - - - - - -中度-重度斑块牛皮癣- 160220170. - html 2017 - 02 - 16 - t12:06:07.300z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2017/lynparza满足-主-端点- - - iii期临床试验中- brca突变-转移性乳腺癌癌症- 17022017. - html 2017 - 02年- 17 - t06:53:58.246z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2017/updated durvalumab单一疗法-数据-确认结果在移行细胞-膀胱癌症- 17022017. - html 2017 - 02年- 17 - t17:23:06.562z https://www.欧洲杯微信买球astrazeneca.com/media centre/press releases/2017/astrazeneca -进入协议-与- tersera疗法- zoladex - - -美国和加拿大- 20022017. - html 2017 - 03 - 21 - t10:34:17.144z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2017/zs - 9 -钠-锆环硅酸盐-接收积极- chmp意见- - -治疗的高钾血症- 24022017. - html 2017 - 02 - 24 t12:50:26.828z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2017/fda批准-一旦每日qtern dapagliflozin -和- saxagliptin平板电脑——成年人————- 2型糖尿病- 240217. - html 2017 - 02 - 28 - t06:40:45.511z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2017/medimmune -和-赛诺菲-巴斯德-形式——联盟- -开发和商业化潜力——下一代-呼吸道合胞病毒抗体- medi8897 030317. - html 2017 - 03 - 03 - t06:57:12.544z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2017/lynparza阶段- iii -个人- 2 -数据-展示-发展-免费-生存受益- - brca突变-卵巢癌症- -维护-治疗- 14032017. - html 2017 - 03 - 14 - t18:10:09.196z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2017/astrazeneca收到信-完成-反应- - -美国食品及药物管理局的z -钠-锆环硅酸盐-高钾血症- 17032017. - html 2017 - 03 - 17 - t07:08:09.857z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2017/astrazeneca -和-切尔克西亚-输入-战略-合作-呼吸道疾病- 17032017. - html 2017 - 03 - 17 - t07:28:05.690z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2017/astrazeneca - s - cvd -真正的研究显示- sglt - 2抑制剂显著减少-死亡-和-住院治疗上心脏-失败-和-其他- - 2型糖尿病药物- 19032017. - html 2017 - 03 - 20 - t06:20:19.010z https://www.欧洲杯微信买球astrazeneca.com/media centre/press releases/2017/tagrisso -批准在中国- - - - - - -第一-类-处理- egfr - t790m -突变-正-转移-非小细胞肺-癌症- 27032017. - html 2017 - 03 - 27 - t05:49:39.829z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2017/astrazeneca - -分享-其健壮的早期科学-在-肿瘤-医学-社区- aacr - 28032017. - html 2017 - 03 - 28 - t05:21:24.217z https://www.欧洲杯微信买球astrazeneca.com/media centre/press releases/2017/astrazenecas -潜在-医学neuromyelitis -视-谱系障碍-接收孤儿——指定-欧洲- 29032017. - html 2017 - 03 - 31 - t05:14:50.251z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2017/tagrisso osimertinib -收到fda -全部-审批- 31032017. - html 2017 - 03 - 31 - t05:36:39.526z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2017/astrazeneca - - -关键里程碑——————一流的————-新-全球- r和d -中心- - - -总部- -剑桥大学英国- 25042017. - html 2017 - 04 - 25 - t12:46:29.260z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2017/tagrisso接收-全部-审批- - -欧盟- 25042017. - html 2017 - 04 - 25 - t12:36:16.314z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2017/q1 - 2017 results.html 2017 - 05 - 02 - t12:15:24.070z https://www.欧洲杯微信买球astrazeneca.com/media centre/press - releases/2017/astrazenecas imfinzi durvalumab -接收之前fda -加速-审批- - - - - - - -治疗患者- - - - - - -高级-膀胱癌症- 01052017. - html 2017 - 05 - 08 - t09:36:46.641z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2017/astrazeneca -提供-更新stratos 1 - - iii期临床试验——tralokinumab -严重的不受控制的哮喘- 100517. - html 2017 - 05 - 10 - t11:40:11.286z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2017/imfinzi显著-减少-风险-疾病恶化或死亡- - -阶段iii -太平洋-审判阶段- iii -不可切除的肺癌症- 12052017. - html 2017 - 08 - 17 - t09:46:09.430z https://www.欧洲杯微信买球astrazeneca.com/media centre/press releases/2017/astrazeneca - -现在科学进步——从增长——呼吸——投资组合————-美国-胸协会会议- 2017 - 18052017. - html 2017 - 05 - 18 - t07:15:49.656z https://www.欧洲杯微信买球astrazeneca.com/media centre/press releases/2017/brodalumab -接收积极- chmp意见- - -治疗的成人患者- - - - - - -中度-重度斑块牛皮癣- 19052017. - html 2017 - 05 - 19 - t12:57:23.937z https://www.欧洲杯微信买球astrazeneca.com/media centre/press releases/2017/astrazeneca -进入协议-与- recordati seloken - -欧洲- 22052017. - html 2017 - 05 - 22 - t06:36:49.962z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2017/phase - iii -北风-试验- - benralizumab -显示-能力-减少-口服类固醇- - -严重哮喘患者使用22052017. - html 2017 - 05 - 22 - t18:44:40.502z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2017/bydureon exscel -试验-与-主-安全-目标- - - 2型糖尿病病人- -宽距离——心血管风险- 23052017. - html 2017 - 05 - 23 - t06:05:03.053z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2017/astrazeneca -传递-新-数据-扩大投资组合- -癌症药物- 2017 -美国-社会- -临床肿瘤学学会年度会议——26052017. - html 2017 - 07 - 06 - t12:56:48.548z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2017/astrazeneca任命-教授nazneen -拉赫曼- -董事会-的-和-科学委员会- 31052017. - html 2017 - 05 - 31 - t05:29:38.254z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2017/lynparza显著-减少-风险-疾病恶化或死亡- -患者的brca突变-转移性乳腺癌癌症- 04062017. - html 2017 - 06 - 04 - t20:36:26.317z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2017/astrazeneca进入协议-与- grunenthal剥离-权利- -偏头痛治疗-佐米格- 07062017. - html 2017 - 06 - 07 - t12:03:13.932z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2017/astrazeneca - -现在科学的进步- -心血管和代谢疾病- - 2017 - ada -科学会议- 08062017. - html 2017 - 06 - 08 - t05:36:08.741z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2017/astrazeneca礼物-新-数据-基础-安全-概要和真正的世界- cv -结果- - farxiga -在- ada - 2017 - 12062017. - html 2017 - 06 - 12 - t05:29:08.925z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2017/faslodex fulvestrant -接收积极- chmp意见- -使用-在- 1 -行激素-受体阳性-高级-乳腺癌癌症- 23062017. - html 2017 - 06 - 23 - t12:18:52.189z https://www.欧洲杯微信买球astrazeneca.com/media centre/press - releases/2017/kyntheum批准- - -欧盟- - -治疗的成人——-中度-重度斑块牛皮癣- 20072017. - html 2017 - 07 - 20 - t16:08:05.358z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2017/faslodex -收到欧盟批准- -第一线疗法-高级-乳腺癌癌症- 26072017. - html 2017 - 07 - 26 - t16:43:28.704z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2017/h1 - 2017 results.html 2017 - 08 - 01 - t14:03:37.641z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2017/astrazeneca -和-默克公司建立战略-肿瘤-合作- 27072017. - html 2017 - 07 - 27 - t07:11:01.617z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2017/astrazeneca报告-初始结果——从正在进行的-神秘-试验- - - iv阶段肺癌症- 27072017. - html 2017 - 07 - 27 - t05:49:00.525z https://www.欧洲杯微信买球astrazeneca.com/media centre/press - releases/2017/tagrisso显著改善-发展-自由-生存——————- iii - flaura阶段试验- -肺癌症- 27072017. - html 2017 - 07 - 27 - t07:16:13.408z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2017/imfinzi -授予-突破-治疗-美国fda - -指定的患者- - - - - - -本地先进-不可切除的非小细胞肺——癌症- 31072017. - html 2017 - 08 - 02 - t13:01:10.221z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2017/acalabrutinib授予-突破-治疗-设计-由美国食品药品管理局- - -治疗的病人- -套细胞淋巴瘤- 01082017. - html 2017 - 08 - 01 - t06:02:24.592z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2017/us - fda接受监管-提交acalabrutinib -和-赠款优先审查- 02082017. - html 2017 - 08 - 02 - t06:04:22.752z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2017/lynparza收到额外的-和-广泛认可——————————卵巢癌症- 17082017. - html 2017 - 08 - 17 - t19:38:25.677z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2017/extended治疗——- brilinta -减少- - -心血管死亡的风险——29%——的患者- - - - - - -历史-心-攻击- 24082017. - html 2017 - 08 - 24 - t06:08:34.500z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2017/astrazeneca -和-武田建立协作- -开发和商业化medi1341 - -帕金森氏病疾病- 25082017. - html 2017 - 08 - 27 - t20:03:16.984z https://www.欧洲杯微信买球astrazeneca.com/media-centre/press-releases/2017/faslodex-receives-us-fda-approval-as-monotherapy-for-expanded-use-in-breast-cancer.html 2017 - 08 - 27 - t20:14:25.567z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2017/astrazeneca亮点-最新进展- -肺癌症在国会esmo - 2017 - 31082017. - html 2017 - 08 - 31 - t08:14:42.645z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2017/astrazeneca -现在-数据- -下一代的生物制剂- -欧洲呼吸协会国际-国会- 04092017. - html 2017 - 09 - 04 - t05:35:03.895z https://www.欧洲杯微信买球astrazeneca.com/media centre/press - releases/2017/tezepelumab显著减少-哮喘急性加重- -人口-广泛的患者- - - - - - -严重失控-哮喘- 06092017. - html 2017 - 09 - 06 - t20:46:07.674z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2017/duaklir -显著改善肺功能- -慢性阻塞性肺病患者07092017. - html 2017 - 09 - 07 - t05:54:56.617z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2017/celgene -和-阿斯利康-提供更新- - -融合-临床试验计划- 07092017. - html 2017 - 09 - 07 - t11:58:18.645z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2017/astrazeneca tagrisso -显示潜在的- - -新标准- 1号线- -保健的表皮生长因子受体突变-肺癌症——在国会esmo - 2017 - 08092017. - html 2017 - 09 - 08 - t21:45:09.126z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2017/astrazeneca礼物-高级-发展-免费-生存——imfinzi————-太平洋-试验- - - -本地先进不可切除的病人肺癌症-在国会esmo - 2017 - 08092017. - html 2017 - 09 - 09 - t14:45:23.444z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2017/astrazeneca礼物-新-结果-确定-严重哮喘患者-谁将从中受益——大多数- benralizumab - 11092017. - html 2017 - 09 - 11 - t05:46:34.971z https://www.欧洲杯微信买球astrazeneca.com/media-centre/press-releases/2017/astrazeneca-and-aspen-enter-agreement-for-remaining-rights-to-anaesthetics-medicines14092017.html 2017 - 09 - 14 - t05:13:15.761z https://www.欧洲杯微信买球astrazeneca.com/media-centre/press-releases/2017/bydureon-exscel-trial-demonstrates-favourable-cardiovascular-cv-safety-profile-and-fewer-cv-events-in-patients-with-type-2-diabetes-at-wide-range-of-cv-risk14092017.html 2017 - 09 - 14 - t16:27:16.660z https://www.欧洲杯微信买球astrazeneca.com/media centre/press releases/2017/bevespi -大气层演示-统计上显著的改进- -肺功能-与copd的患者- - - - - - - 25092017. - html 2017 - 09 - 25 - t06:00:53.117z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2017/the -欧洲-药物-机构-接受-营销-授权-应用程序- imfinzi - -本地先进不可切除的非小细胞-肺癌症- 09102017. - html 2017 - 10 - 09 - t05:20:06.911z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2017/tagrisso授予-突破-治疗-设计-由美国食品药品管理局- - - 1号线-治疗的患者- - - - - - - egfr突变阳性-非小细胞肺-癌症- 09102017. - html 2017 - 10 - 09 - t05:40:07.849z https://www.欧洲杯微信买球astrazeneca.com/media centre/press - releases/2017/astrazeneca -股票-方法-综合-科学- - - - - -世界会议上-肺癌症- 2017 - 16102017. - html 2017 - 10 - 16 - t05:53:58.209z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2017/us - fda接受补充-生物制品许可-应用程序- imfinzi - -本地先进不可切除的非小细胞-肺癌症- 171017. - html 2017 - 10 - 17 - t05:35:56.834z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2017/us fda -接受监管提交- - lynparza在转移性乳腺癌癌症-和-赠款优先审查- 18102017. - html 2017 - 10 - 18 - t05:56:14.471z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2017/us fda批准-新-容易使用——一旦-每周bydureon bcise -注射药物- - - - - 2型糖尿病患者231017. - html 2017 - 10 - 23 - t05:21:09.010z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2017/astrazeneca -和- - -迅速推进- lynparza -日本-与-第二个监管提交- 231017. - html 2017 - 10 - 23 - t06:10:33.578z https://www.欧洲杯微信买球astrazeneca.com/media centre/press releases/2017/us - fda批准-阿斯利康calquence acalabrutinib - -成人患者与先前- -地幔-细胞淋巴瘤治疗24102017. - html 2017 - 10 - 31 - t17:25:53.479z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2017/astrazeneca -和- incyte进入早期临床-试验-合作- - -肺癌症- 31102017. - html 2017 - 10 - 31 - t07:28:04.679z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2017/astrazeneca -提供-更新tralokinumab -相- iii -计划- - -不受控制的哮喘严重01112017. - html 2017 - 11 - 01 - t06:43:33.635z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2017/astrazeneca -股票-科学-更新——从其广泛的心血管-肾和-代谢疾病- cvmd投资组合——啊哈- 2017 - 08112017. - html 2017 - 11 - 07 - t19:50:30.563z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2017/year - -日期-和- q3 - 2017 results.html 2017 - 11 - 13 - t13:07:46.608z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2017/benralizumab -收到积极的欧盟- chmp意见- - -控制-嗜酸性哮喘严重10112017. - html 2018 - 04 - 30 - t08:42:21.740z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2017/fasenra benralizumab -收到fda审批- - - - - - -严重失控——嗜酸性哮喘- 14112017. - html 2017 - 11 - 14 - t23:14:46.133z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2017/faslodex接收-美国fda -审批- - - - - - - - - -高级-乳腺癌症的治疗与abemaciclib - 15112017. -结合html 2017 - 11 - 15 - t06:27:52.979z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2017/the -欧洲-药物-机构-接受监管-提交tagrisso -在- 1 -线- egfr突变-非小细胞肺-癌症- 24112017. - html 2017 - 11 - 28 - t06:06:50.359z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2017/astrazeneca -和-中国-未来产业投资基金-建立合资- -发展-新-药物-中国- 27112017. - html 2017 - 11 - 27 - t06:50:34.415z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2017/astrazeneca -让-管理-提交tagrisso -在- 1 -线- egfr突变-非小细胞肺——癌症-日本- 27112017. - html 2017 - 11 - 27 - t06:31:12.310z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2017/tudorza -减少急性加重和演示-心血管安全- -慢性阻塞性肺病患者- 041217. - html 2017 - 12 - 03 - t21:47:29.824z https://www.欧洲杯微信买球astrazeneca.com/media centre/press releases/2017/astrazeneca - -强调其承诺- -血液癌症在美国- 2017 -社会-血液学年度会议- 06122017. - html 2017 - 12 - 06 - t06:11:19.215z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2017/us fda接受-管理-提交tagrisso -在- 1 -线- egfr突变-非小细胞肺-癌症- 18122017. - html 2017 - 12 - 18 - t07:12:49.366z https://www.欧洲杯微信买球astrazeneca.com/media-centre/press-releases/2016.html 2016 - 11 - 22 - t17:01:57.829z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2016/astrazeneca -头-和-颈部癌症-试验- 27102016. - html 2017 - 01 - 13 t15:03:23.012z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2016/q3 - 2016 results.html 2018 - 07 - 05 - t11:50:11.958z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2016/fda接受- -评估-新-药物-应用程序- 18102016. -钠-锆- html 2017 - 01 - 13 t15:14:20.554z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2016/lynparza - - iii -个人- 2期试验显示-重大进展——自由——生存——- 261020161. - html中获益 2017 - 01 - 13 t15:14:36.328z https://www.欧洲杯微信买球astrazeneca.com/media-centre/press-releases/2016/astrazeneca-completes-acquisition-of-takedas-respiratory-business.html 2017 - 01 - 13 t15:14:49.529z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2016/astrazeneca -进入许可协议——-利奥制药- -皮肤疾病- 01072016. - html 2017 - 01 - 13 t15:15:02.939z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2016/tagrisso - -主-端点在阶段- iii - 2 -线-肺癌症-试验- 18072016. - html 2017 - 01 - 13 t15:15:16.287z https://www.欧洲杯微信买球astrazeneca.com/media-centre/press-releases/2016/AstraZeneca-receives-approval-in-the-EU-for-Qtern-saxagliptin-and-dapagliflozin-for-treatment-of-Type-2-diabetes.html 2017 - 01 - 13 t15:15:29.146z https://www.欧洲杯微信买球astrazeneca.com/media centre/press releases/2016/astrazenecas -抗生素zavicefta - -主-端点-在- iii期临床试验——-治疗医院-获得肺炎- 21072016. - html 2017 - 01 - 13 t15:15:44.953z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2016/astrazeneca -文件-第一个临床试验——应用程序——现代化-信使rna -合作- 26072016. - html 2017 - 01 - 13 t15:15:59.540z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2016/h1 - 2016 results.html 2018 - 07 - 05 - t11:55:12.058z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2016/astrazeneca -提供更新- - - iii期试验的selumetinib - -非小细胞肺-癌症09082016. - html 2017 - 01 - 13 t15:16:29.002z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2016/astrazeneca -和-莉莉收到fda -快速跟踪指定- - azd3293作为潜在的治疗- - -老年痴呆症早期疾病- 22082016. - html 2017 - 01 - 13 t15:16:44.473z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2016/astrazeneca - -销售-小分子-抗生素-业务- -辉瑞- 24082016. - html 2017 - 01 - 13 t15:17:01.801z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2016/astrazeneca - -现在-新-数据-强调其增长-呼吸组合-人- 30082016. - html 2017 - 01 - 13 t15:17:24.404z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2016/astrazeneca -完成-商业化协议-与-阿斯彭麻醉学组合- 01092016. - html 2017 - 01 - 13 t15:17:58.782z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2016/benralizumub - - iii期临床试验——显示——积极的结果——严重哮喘- 05092016. - html 2017 - 01 - 13 t15:18:13.339z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2016/pepfar -和-阿斯利康-发射-合作- -艾滋病毒和高血压-服务-在非洲- 080920161. - html 2017 - 01 - 13 t15:18:27.625z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2016/astrazeneca宣布-两个新阶段为——forxiga -希望-试验- - -慢性肾脏疾病和-慢性心脏衰竭- 120920161. - html 2017 - 01 - 13 t15:18:42.470z https://www.欧洲杯微信买球astrazeneca.com/media centre/press releases/2016/phase - iii -试验- - bydureon和组合forxiga -显示-重要的好处- - - - 2型糖尿病患者1609201611. - html 2017 - 01 - 13 t15:18:56.662z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2016/astrazeneca -提供更新- - cediranib -欧盟-营销-授权-应用程序- 21092016. - html 2017 - 01 - 13 t15:19:11.904z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2016/astrazeneca -呈现-新-数据- faslodex - -乳腺癌癌症和肿瘤-提供-免疫-更新在国会esmo - 2016 - 30092016. - html 2017 - 01 - 13 t15:19:30.729z https://www.欧洲杯微信买球astrazeneca.com/media centre/press releases/2016/medimmune - -许可证潜在医学- -炎症疾病-爱力根- 03102016. - html 2017 - 01 - 13 t15:19:54.093z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2016/astrazeneca报告-高级-线-结果- - - brilinta欧几里得——试验——————-周边动脉疾病的患者- 04102016. - html 2017 - 01 - 13 t15:20:17.191z https://www.欧洲杯微信买球astrazeneca.com/media centre/press releases/2016/astrazeneca -进入协议-与- aralez -β-阻滞剂医学- - -我们04102016. - html 2017 - 01 - 13 t15:20:38.108z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2016/astrazeneca -进入协议-与- cilag gmbh是一家国际- -剥离权利之外- rhinocort -水- - -我们- 071020161. - html 2017 - 01 - 13 t15:20:56.394z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2016/medimmune -完成- -许可协议-与-爱力根- medi2070 - 17112016. - html 2017 - 01 - 13 t15:21:12.026z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2016/astrazeneca -和-现代化疗法-宣布-新-合作- - co -发展-和- co -商业化免疫-肿瘤学信使rna治疗- 11012016. - html 2017 - 01 - 13 t15:21:28.239z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2016/astrazeneca -和- incyte宣布-新-肺癌症临床试验——合作——11012016. - html 2017 - 01 - 13 t15:22:36.102z https://www.欧洲杯微信买球astrazeneca.com/media-centre/press-releases/2016/AstraZeneca-partners-with-peers-and-academia-to-establish-translational-research-fund.html 2017 - 01 - 13 t15:22:52.687z https://www.欧洲杯微信买球astrazeneca.com/media centre/press - releases/2016/lynparza olaparib授予-突破-治疗-设计-由美国食品药品管理局- -治疗的乳腺癌易感基因1 - 2 -或- atm基因突变-转移-阉割抗前列腺癌- 28012016. - html 2017 - 01 - 13 t15:23:10.653z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2016/astrazeneca完成事务- - - - - - -多数股权-股权投资- - acerta制药- 01022016. - html 2017 - 01 - 13 t15:23:29.237z https://www.欧洲杯微信买球astrazeneca.com/media centre/press - releases/2016/tagrisso osimertinib - - -欧盟的批准第一——-类-治疗肺癌症- 03022016. - html 2017 - 01 - 13 t15:23:48.978z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2016/full年和第四季度- 2015 - 04022016. - html结果 2018 - 07 - 05 - t13:12:00.178z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2016/astrazeneca -和-美-输入-协会- -传递-新- - -慢性肾脏疾病治疗11022016. - html 2017 - 01 - 13 t15:24:26.184z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2016/durvalumab授予-突破-治疗-设计-由美国食品药品管理局- -治疗的患者- - - - - - - pd - l1 -积极移行细胞-膀胱癌症- 17022016. - html 2017 - 01 - 13 t15:24:43.419z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2016/zurampic - lesinurad批准- - -欧洲联盟的患者- - - - - - -痛风19022016. - html 2017 - 01 - 13 t15:25:03.001z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2016/brilique ticagrelor——批准欧盟- -延长治疗的患者- - - - - - -历史-心-攻击- 19022016. - html 2017 - 01 - 13 t15:25:18.277z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2016/acalabrutinib -推荐- -孤儿药物名称-在-欧洲-三-显示- 25022016. - html 2017 - 01 - 13 t15:25:35.697z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2016/astrazeneca -进入许可协议————中国——医学-系统-控股- -高血压药- 29022016. - html 2017 - 01 - 13 t15:25:51.337z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2016/astrazeneca报告-前-线- - - tremelimumab单一疗法的试验结果,间皮瘤- 29022016. - html 2017 - 01 - 13 t15:26:19.482z https://www.欧洲杯微信买球astrazeneca.com/media centre/press releases/2016/astrazeneca -进入到协议——- prostrakan的权利- - - - - - - moventig -欧洲- 03012016. - html 2017 - 01 - 13 t15:26:37.699z https://www.欧洲杯微信买球astrazeneca.com/media centre/press releases/2016/medimmune -接收快速-轨道-设计- - -我们的medi8852 - -治疗的患者,住院,流感- 07032016. - html 2017 - 01 - 13 t15:26:54.499z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2016/astrazenecas潜在-医学neuromyelitis -视-收到fda孤儿-药物-设计- 09032016. - html 2017 - 01 - 13 t15:27:11.189z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2016/astrazeneca报告-高级-线-结果- - - brilinta苏格拉底审判-在中风- 23032016. - html 2017 - 01 - 13 t15:27:38.302z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2016/tagrisso批准- -日本-患者与表皮生长因子受体- t790m突变-积极的转移性非小细胞-肺癌症- 29032016. - html 2017 - 01 - 13 t15:28:08.763z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2016/brilinta首选-对-氯吡格雷- -更新-美国大学的心脏病-和-美国心脏协会-指导-急性冠状动脉综合征- 31032016. - html 2017 - 01 - 13 t15:28:33.767z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2016/pandemic流感疫苗-接收积极- chmp意见- 01042016. - html 2017 - 01 - 13 t15:29:19.477z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2016/astrazeneca - -展示-临床和科学领导-在-肺癌症-得- 2016 - 06042016. - html 2017 - 01 - 13 t15:29:36.560z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2016/astrazeneca -和- eli lilly -和-公司宣布延续的关键-临床试验- -人- -早期老年痴呆症患者- 08042016. - html 2017 - 01 - 13 t15:29:54.788z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2016/astrazeneca展示广度- -肿瘤学组合- aacr - 2016年度会议上- 14042016. - html 2017 - 01 - 13 t15:30:14.856z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2016/astrazeneca -发射-整合基因组学方法-变换-药物-发现-和-发展- 22042016. - html 2017 - 01 - 13 t15:30:42.708z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2016/bevespi大气层——————-美国fda批准- -病人与慢性阻塞性肺病- 25042016. - html 2017 - 01 - 13 t15:30:58.344z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2016/astrazeneca进入- -我们-许可协议与铁木-制药- lesinurad - 26042016. - html 2017 - 01 - 13 t15:31:18.061z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2016/q1 - 2016 results.html 2017 - 01 - 13 t15:31:42.691z https://www.欧洲杯微信买球astrazeneca.com/media centre/press - releases/2016/positive chmp意见-的- caz avi -欧盟- - -严重的细菌感染29042016. - html 2017 - 01 - 13 t15:32:11.137z https://www.欧洲杯微信买球astrazeneca.com/media centre/press releases/2016/astrazeneca -完成-撤资imdur - -中国医疗系统-控股03052016. - html 2017 - 01 - 13 t15:32:31.586z https://www.欧洲杯微信买球astrazeneca.com/media centre/press releases/2016/selumetinib -授予孤儿-药物-设计- - - - -我们- -辅助治疗-分化甲状腺癌- 12052016. - html 2017 - 01 - 13 t15:33:06.526z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2016/astrazeneca - -突出——它的广度————呼吸-药物-在美国胸-社会- 2016国际会议- 12052016. - html 2017 - 01 - 13 t15:33:29.893z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2016/astrazeneca宣布——积极的结果——从- benralizumab阶段- iii -计划- -严重哮喘- 17052016. - html 2017 - 01 - 13 t15:34:36.280z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2016/astrazeneca -提供-高级-线-结果- lynparza -金-试验- -高级-胃癌症- 1805206. - html 2017 - 01 - 13 t15:34:52.384z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2016/astrazeneca亮点-持续进展- -肿瘤-管道的asco - 2016 - 19052016. - html 2017 - 01 - 13 t15:35:08.458z https://www.欧洲杯微信买球astrazeneca.com/media-centre/press-releases/2016/astrazenecas-faslodex-met-primary-endpoint-in-first-line-treatment-of-advanced-breast-cancer.html 2017 - 01 - 13 t15:35:26.436z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2016/astrazeneca收到信-完成-反应- - -美国食品及药物管理局的钠-锆环硅酸盐- z - 9 - -口服悬挂的治疗- 27052016. -高钾血症的html 2017 - 01 - 13 t15:35:44.564z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2016/positive chmp意见-在欧盟- - saxa采办局的成年人-与- 2型糖尿病- 27052016. - html 2017 - 01 - 13 t15:36:04.452z https://www.欧洲杯微信买球astrazeneca.com/media centre/press releases/2016/astrazeneca -许可证zurampic - - grunenthal gmbh是一家在欧洲-和-拉丁美洲- 02062016. - html 2017 - 01 - 13 t15:36:20.308z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2016/astrazeneca -完成-美国-许可协议与铁木-药物- 03062016. - lesinurad html 2017 - 01 - 13 t15:36:36.736z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2016/astrazeneca -和-基础-药物-输入-战略-合作- lynparza同伴-诊断-分析- 04062016. - html 2017 - 01 - 13 t15:37:00.298z https://www.欧洲杯微信买球astrazeneca.com/media centre/press releases/2016/astrazeneca -进入商业化——协议——阿斯彭- -麻醉药物组合- 08062016. - html 2017 - 01 - 13 t15:38:02.861z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2016/astrazeneca -提供更新- -喷雾剂四价的疫苗——————————- 2016 - 17 -流感季节- 23062016. - html 2017 - 01 - 13 t15:38:26.811z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2016/new抗生素- zavicefta批准- - -欧洲联盟的- - - - - - - -严重的细菌感染患者28062016. - html 2017 - 01 - 13 t15:38:43.365z https://www.欧洲杯微信买球astrazeneca.com/media centre/press - releases/2016/astrazeneca——头部和颈部癌症-试验-恢复-新-病人-报名- - fda -电梯部分临床- 22112016. - html 2017 - 01 - 13 t15:39:01.542z https://www.欧洲杯微信买球astrazeneca.com/media-centre/press-releases/2016/astrazeneca-takes-latest-scientific-advances-in-oncology-to-major-us-and-european-congresses29112016.html 2017 - 01 - 13 t15:39:36.952z https://www.欧洲杯微信买球astrazeneca.com/media centre/press - releases/2016/astrazeneca -完成- - - cilag gmbh是一家国际协议——权利-外- rhinocort -水- - -我们- 05122016. - html 2017 - 01 - 13 t15:39:57.631z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2016/tagrisso展示优势- -化疗的表皮生长因子受体- t790m突变-正-非小细胞肺-癌症- 06122016. - html 2017 - 07 - 06 - t12:56:48.480z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2016/astrazeneca -和-莉莉-开发-第二个潜在疾病-修改- - -老年痴呆症病治疗09122016. - html 2017 - 01 - 13 t15:40:35.984z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2016/us fda -接受第一个生物制品许可-应用程序-阿斯利康durvalumab - -膀胱癌症- 09122016. - html 2017 - 01 - 13 t15:40:58.617z https://www.欧洲杯微信买球astrazeneca.com/media-centre/press-releases/2015.html 2016 - 11 - 22 - t17:01:47.383z https://www.欧洲杯微信买球astrazeneca.com/media centre/press releases/2015/astrazeneca -考古挖掘-剑桥生物医学校园- 11062015. - html 2017 - 01 - 13 t09:05:39.037z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2015/astrazeneca - pam - cheng - -副总裁-操作- 16062015. - html 2017 - 01 - 13 t09:49:08.016z https://www.欧洲杯微信买球astrazeneca.com/media centre/press releases/2015/astrazeneca -肿瘤学研究-欧洲-癌症-国会- 2015 - 24092015. - html 2017 - 01 - 19 t10:43:01.994z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2015/real -世界-数据- saxagliptin sitagliptin -心-失败-风险- 08062015. - html 2017 - 01 - 19 t10:43:31.725z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2015/astrazeneca - - 2型糖尿病-三-疗法治疗-数据- 06062015. - html 2017 - 01 - 19 t10:44:27.126z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2015/astrazeneca糖尿病-数据-美国-糖尿病协会科学会议- 03062015. - html 2017 - 01 - 19 t11:34:39.484z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2015/astrazeneca免疫-肿瘤学组合-开发-项目- asco - 2015 - 02062015. - html 2017 - 01 - 19 t11:35:34.688z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2015/astrazeneca - -正-免疫-肿瘤学medimmune -组合-数据- asco - 30052015. - html 2017 - 01 - 19 t11:37:13.527z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2015/astrazeneca莉莉-免疫-肿瘤学临床试验-固体肿瘤- 29052015. - html 2017 - 01 - 19 t11:37:27.304z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2015/astrazeneca - brodalumab -开发-项目-牛皮癣关节炎- 22052015. - html 2017 - 01 - 19 t11:38:02.777z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2015/astrazeneca -生物-制造- sodertalje瑞典- 18052015. - html 2017 - 01 - 19 t11:38:29.617z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2015/astrazeneca免疫-肿瘤学管道组合-治疗asco - 2015 - 13052015. - html 2017 - 01 - 19 t11:38:42.906z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2015/astrazeneca -阿伯特-同伴诊断测试- tralokinumab严重哮喘- 13052015. - html 2017 - 01 - 19 t11:39:52.922z https://www.欧洲杯微信买球astrazeneca.com/media centre/press releases/2015/astrazeneca -蒙特利尔心脏研究所-心血管疾病糖尿病-遗传-筛选- 13052015. - html 2017 - 01 - 19 t11:40:08.315z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2015/us fda -优先审查brilinta -心-攻击-历史-病人- 29042015. - html 2017 - 01 - 19 t11:40:29.472z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2015/astrazeneca - plc -第一季-结果- 2015 - 24042015. - html 2017 - 07 - 06 - t12:56:48.489z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2015/astrazeneca celgene公司-公司-免疫-肿瘤-合作-血液癌症- 24042015. - html 2017 - 01 - 19 t11:41:26.506z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2015/astrazeneca先天制药公司-全球协作-免疫-肿瘤- 24042015. - html 2017 - 01 - 19 t11:42:08.263z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2015/astrazeneca -非小细胞肺癌症-医学数据-欧洲-肺癌症——国会- 17042015. - html 2017 - 01 - 19 t11:42:24.763z https://www.欧洲杯微信买球astrazeneca.com/media centre/press - releases/2015/selumetinib孤儿药物指定-美国fda -葡萄膜黑色素瘤治疗- 17042015. - html 2017 - 01 - 19 t11:42:40.376z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2015/medimmune immunocore免疫-肿瘤学组合-试验-黑素瘤- 16042015. - html 2017 - 01 - 19 t11:42:53.108z https://www.欧洲杯微信买球astrazeneca.com/media centre/press - releases/2015/tremelimumab孤儿药物指定-美国fda -恶性间皮瘤治疗- 15042015. - html 2017 - 01 - 19 t11:43:11.540z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2015/fda咨询委员会-评论saxagliptin - - 2型糖尿病- 14042015. - html 2017 - 01 - 19 t11:43:33.896z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2015/astrazeneca patientslikeme -研究-肿瘤糖尿病-狼疮呼吸道疾病- 13042015. - html 2017 - 01 - 19 t11:43:49.642z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2015/astrazeneca -肿瘤-科学-美国-协会-癌症研究年度会议- 2015 - 13042015. - html 2017 - 01 - 19 t11:44:15.668z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2015/astrazeneca基因组学-英国-协会- 26032015. - html 2017 - 01 - 19 t11:44:52.461z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2015/astrazeneca -哈佛干细胞-细胞研究所糖尿病- 25032015. - html 2017 - 01 - 19 t11:45:24.912z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2015/astrazeneca -福岛第一制药-商业化movantik - 19032015. - html 2017 - 01 - 19 t11:45:48.344z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2015/astrazeneca pt003 -结果-慢性阻塞性肺疾病- 18032015. - html 2017 - 01 - 19 t11:46:12.077z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2015/pegasus - timi - 54 -研究- brilinta长期治疗-减少心血管血栓性-事件- 14032015. - html 2017 - 01 - 19 t11:46:25.487z https://www.欧洲杯微信买球astrazeneca.com/media centre/press releases/2015/astrazeneca -美国食品及药物管理局fda -内分泌-代谢-药物咨询委员会- 04032015. - html 2017 - 01 - 19 t11:52:16.037z https://www.欧洲杯微信买球astrazeneca.com/media centre/press - releases/2015/astrazeneca actavis呼吸-投资-慢性阻塞性肺疾病- 03032015. - html 2017 - 01 - 19 t11:52:46.810z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2015/astrazeneca -董事会- -通用-年会- 17022015. - html 2017 - 01 - 19 t11:53:07.376z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2015/us -区-法院决定pulmicort respulses -专利诉讼- 13022015. - html 2017 - 01 - 19 t11:53:24.067z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2015/astrazeneca actavis aclidinium -呼吸系列- 05022015. - html 2017 - 01 - 19 t11:53:38.677z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2015/astrazeneca - plc -第四季度满岁的结果- 2014 - 05022015. - html 2017 - 07 - 06 - t12:56:48.517z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2015/astrazeneca -研究-开发-英国剑桥中心-企业-总部- - - 04022015. - html 2017 - 01 - 19 t11:54:58.324z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2015/astrazeneca crispr -技术-基因组-编辑- 29012015. - html 2017 - 01 - 19 t11:55:22.492z https://www.欧洲杯微信买球astrazeneca.com/media centre/press - releases/2015/lesinurad痛风治疗-欧洲-药物-机构- 22012015. - html 2017 - 01 - 19 t11:55:49.969z https://www.欧洲杯微信买球astrazeneca.com/media centre/press releases/2015/pegasus - timi 54 -研究- brilinta -减少-心血管血栓性-事件- 14012015. - html 2017 - 01 - 19 t11:56:10.790z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2015/medimmune omnis -药物-溶瘤细胞的病毒免疫-肿瘤学12012015. - html 2017 - 01 - 19 t12:01:35.191z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2015/astrazeneca喷雾疫苗-第一核电站- - - - -流感疫苗- 02092015. - html 2017 - 01 - 19 t12:02:00.615z https://www.欧洲杯微信买球astrazeneca.com/media centre/press - releases/2015/astrazeneca valeant制药- brodalumab皮肤病牛皮癣- 01092015. - html 2017 - 01 - 19 t12:02:18.211z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2015/astrazeneca游隼医药-免疫肿瘤学组合-临床试验- 24082015. - html 2017 - 01 - 19 t12:02:34.719z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2015/medimmune mirati肿瘤疗法-免疫组合-肺癌症- 05082015. - html 2017 - 01 - 19 t12:03:00.723z https://www.欧洲杯微信买球astrazeneca.com/media centre/press - releases/2015/astrazeneca heptares疗法-免疫-肿瘤学治疗- 06082015. - html 2017 - 01 - 19 t12:59:13.646z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2015/medimmune inovio -药物-癌症疫苗- 10082015. - html 2017 - 01 - 19 t13:09:37.059z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2015/astrazeneca伊希斯-药物-反义药物-心血管代谢-肾疾病- 03082015. - html 2017 - 01 - 19 t13:10:23.457z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2015/astrazeneca genzyme -罕见的疾病——医学caprelsa - 27072015. - html 2017 - 01 - 19 t13:10:50.110z https://www.欧洲杯微信买球astrazeneca.com/media centre/press - releases/2015/astrazeneca tillotts制药- entocort胃肠病学医学- 17072015. - html 2017 - 01 - 19 t13:12:00.175z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2015/astrazeneca kyowa白光-麒麟benralizumab -哮喘,慢性阻塞性肺疾病- 16072015. - html 2017 - 01 - 19 t13:14:31.965z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2015/astrazeneca tillotts制药- entocort胃肠病学- 09072015. - html 2017 - 01 - 19 t13:15:20.976z https://www.欧洲杯微信买球astrazeneca.com/media centre/press releases/2015/iressa - fda批准-非小细胞肺-癌症治疗- 13072015. - html 2017 - 01 - 19 t13:15:47.575z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2015/astrazeneca selumetinib -葡萄膜黑色素瘤肿瘤- 22072015. - html 2017 - 01 - 19 t13:16:27.331z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2015/astrazeneca - plc - h1 -结果- 2015 - 30072015. - html 2017 - 07 - 06 - t12:56:48.500z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2015/astrazeneca -博士-肖恩- bohen - -医学总监- 24082015. - html 2017 - 01 - 19 t13:17:24.828z https://www.欧洲杯微信买球astrazeneca.com/media centre/press releases/2015/astrazeneca -心血管事件-预防- esc -国会- 2015 - 29082015. - html 2017 - 01 - 19 t13:19:11.226z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2015/pegasus - timi - 54 - brilinta治疗后心脏-攻击- 31082015. - html 2017 - 01 - 19 t13:19:35.647z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2015/antibiotic医学- caz avi -复杂-泌尿道感染- 02092015. - html 2017 - 01 - 19 t13:20:10.590z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2015/us - fda批准brilinta -长期使用-心-攻击-历史-病人- 03092015. - html 2017 - 01 - 19 t13:20:51.138z https://www.欧洲杯微信买球astrazeneca.com/media centre/press releases/2015/astrazeneca -肺癌症-投资-世界-会议-肺癌症- 2015 - 04092015. - html 2017 - 01 - 19 t13:22:24.147z https://www.欧洲杯微信买球astrazeneca.com/media centre/press releases/2015/astrazeneca - -曼彻斯特大学临床肿瘤-生物信息学-合作- 08092015. - html 2017 - 01 - 19 t13:22:47.480z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2015/astrazeneca -生物-制造-博尔德科罗拉多- 11092015. - html 2017 - 01 - 19 t13:23:13.157z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2015/astrazeneca糖尿病-数据- pre -临床研究2 - 2015 - 11092015. - html 2017 - 01 - 19 t13:23:32.253z https://www.欧洲杯微信买球astrazeneca.com/media centre/press releases/2015/astrazeneca -呼吸道疾病-数据-欧洲-呼吸-社会-国际-国会- 2015 - 22092015. - html 2017 - 01 - 19 t13:23:52.535z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2015/new英格兰医学杂志- - brodalumab ustekinumab牛皮癣- 30092015. - html 2017 - 01 - 19 t13:24:13.500z https://www.欧洲杯微信买球astrazeneca.com/media centre/press releases/2015/astrazeneca -虎鲸药品-罗里-抑制剂-汽车-免疫疾病-治疗- 25022015. - html 2017 - 01 - 19 t13:24:48.633z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2015/astrazeneca剑桥-判断-业务-学校-生物技术-开始- ups - 03032015. - html 2017 - 01 - 19 t13:25:19.381z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2015/astrazeneca -新加坡-研究-组织-心-失败- 11032015. - html 2017 - 01 - 19 t13:26:20.894z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2015/astrazeneca -科学-评估-董事会-临床试验数据透明度- 19032015. - html 2017 - 01 - 19 t13:26:45.840z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2015/astrazeneca比娜-基因组-管理-解决方案- 21042015. - html 2017 - 01 - 19 t13:31:05.182z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2015/astrazeneca弥尼-潘加洛斯奖学金科学院-医学- 11052015. - html 2017 - 01 - 19 t13:31:32.478z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2015/astrazeneca -密歇根大学- - - - - - -慢性肾脏疾病-治疗- 17062015. - html 2017 - 01 - 19 t13:32:23.490z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2015/astrazeneca inserm - - 2型糖尿病慢性肾脏疾病-研究- 17062015. html 2017 - 01 - 19 t13:33:59.621z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2015/astrazeneca -大学-剑桥-博士-临床研究奖学金- 30062015. - html 2017 - 01 - 19 t13:34:18.071z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2015/astrazeneca人群-采购-挑战结合治疗癌症- 22092015. - html 2017 - 01 - 19 t13:34:55.405z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2015/astrazeneca接收-完成-反应-信-从16102015. - html 2017 - 01 - 19 t13:35:22.674z https://www.欧洲杯微信买球astrazeneca.com/media-centre/press-releases/2015/astrazeneca-opens-new-manufacturing-facility-to-support-continued20102015.html 2017 - 01 - 19 t13:35:41.486z https://www.欧洲杯微信买球astrazeneca.com/media centre/press releases/2015/astrazeneca -, -莉莉扩大免疫-肿瘤学研究collaborat - 22102015. - html 2017 - 01 - 19 t13:35:58.965z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2015/ - fda顾问委员会推荐-的-批准lesinurad - -痛风患者- 23102015. - html 2017 - 01 - 19 t13:36:22.677z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2015/year - -日期-和- q3 - 2015 - 05112015. - html结果 2017 - 07 - 06 - t12:56:48.514z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2015/astrazeneca -增强心血管和代谢疾病-组合——收购- - z -制药- 06112015.的html 2017 - 01 - 19 t13:37:04.941z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2015/astrazeneca礼物-正-新-数据-在- anifrolumab狼疮- -美国大学的风湿病学- -科学年会- 10112015. - html 2017 - 01 - 19 t13:37:22.873z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2015/tagrisso - azd9291批准- - -美国fda的病人-与表皮生长因子受体- t790m突变-正-转移性非小细胞肺-癌症13112015. - html 2017 - 01 - 13 t09:57:23.049z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2015/astrazeneca -膨胀-技术-投资- - - - - - -新-剑桥-铅-发现-中心- 20112015. - html 2018 - 03 - 05 - t09:21:00.970z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2015/astrazeneca -和-赛诺菲-交流- - - 20112015. - 200000 -化学化合物的html 2017 - 01 - 13 t09:04:50.926z https://www.欧洲杯微信买球astrazeneca.com/media-centre/press-releases/2015/AstraZeneca-enters-into-agreement-with-Perrigo-for-rights-to-Entocort-in-the-US.html 2017 - 01 - 13 t09:21:22.408z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2015/astrazeneca -和- voluntis - -测试-伴侣-移动-应用- -卵巢癌症研究- 07122015. - html 2017 - 01 - 13 t09:05:09.155z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2015/astrazeneca独自站- - - - - - -公司-小分子-早期阶段-抗生素-研究-开发- 26022015. - html 2017 - 01 - 19 t13:38:26.579z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2015/astrazeneca礼物—积极汇集-分析-展示效果-的- dapagliflozin蛋白尿- -高血压患者-与- 2型糖尿病- 17092015. - html 2017 - 01 - 13 t09:50:10.100z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2015/astrazeneca宣布-新-耐受性长期疗效-和-真正的世界——坚持——数据——exenatide - -每周在- 2型糖尿病病人————- 15092015. - html 2017 - 01 - 13 t09:05:25.978z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2015/astrazeneca检查参与组成分泌腺-利用-电源- - - - - - -发展-下一代生物制剂- 11122015. - html 2017 - 07 - 06 - t12:56:48.502z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2015/discussions - - acerta制药- bv - 14122015. - html 2017 - 01 - 17 t15:40:33.420z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2015/astrazeneca完成协议-与- perrigo权利- entocort——————我们- 15122015. - html 2017 - 01 - 13 t09:16:15.568z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2015/astrazeneca继续-战略-投资- - - - - - -中国-加速-交货- -创新-生物制剂和有针对性的药物- 16122015. - html 2017 - 01 - 13 t09:16:30.429z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2015/astrazeneca - -加强治疗区域特许经营-通过收购- -武田呼吸-业务- 16122015. - html 2017 - 01 - 13 t09:52:49.545z https://www.欧洲杯微信买球astrazeneca.com/media-centre/press-releases/2015/AstraZeneca-enhances-long-term-growth-through-Oncology-investment-in-Acerta-Pharma.html 2017 - 01 - 13 t09:21:02.005z https://www.欧洲杯微信买球astrazeneca.com/media centre/press releases/2015/astrazeneca -完成收购- - z -制药- 17122015.的html 2017 - 01 - 13 t09:15:58.977z https://www.欧洲杯微信买球astrazeneca.com/media-centre/press-releases/2015/Durvalumab-ATLANTIC-trial-supports-clinical-activity-and-AstraZenecas-overall-immuno-oncology-strategy.html 2017 - 01 - 13 t09:58:04.789z https://www.欧洲杯微信买球astrazeneca.com/media-centre/press-releases/2015/CHMP-issues-positive-opinion-on-lesinurad-for-Gout18122015.html 2017 - 01 - 13 t09:54:12.735z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2015/tagrisso osimertinib -接收积极- chmp意见- 18122015. - html 2017 - 01 - 13 t09:57:07.784z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2015/brilique ticagrelor -收到积极的欧洲联盟- chmp意见- -延长治疗- 18122015. - html 2017 - 01 - 13 t09:53:50.546z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2015/zurampic lesinurad - - - - - - -通过美国fda - - -与痛风病人22122015. - html 2017 - 01 - 13 t09:55:30.336z https://www.欧洲杯微信买球astrazeneca.com/media-centre/press-releases/2014.html 2016 - 11 - 22 - t17:01:35.567z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2014/medimmune immunocore -免疫疗法的小说——癌症疗法- 08012014. - html 2017 - 01 - 18 - t17:21:54.831z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2014/astrazeneca迈尔斯-布里斯托尔-施贵宝farxiga -美国fda批准- 08012014. - html 2017 - 01 - 19 t11:29:29.731z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2014/us fda批准- farxiga - - 2型糖尿病患者治疗- 13012014. - html 2017 - 01 - 11 t19:46:24.742z https://www.欧洲杯微信买球astrazeneca.com/media centre/press releases/2014/astrazenca -科学领导-成长- jp摩根-医疗保健会议- 14012014. - html 2017 - 01 - 19 t13:09:53.658z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2014/xigduo批准-欧洲联盟- - 2型糖尿病- 21012014. - html 2017 - 01 - 19 t13:55:44.186z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2014/astrazeneca取得迈尔斯-布里斯托尔-施贵宝公司-全球-糖尿病联盟- 03022014. - html 2017 - 01 - 19 t12:06:15.929z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2014/astrazeneca - plc -第四季度满岁的结果- 2013 - 06022014. - html 2017 - 07 - 06 - t12:56:48.481z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2014/us - fda批准myalept lepti -缺乏治疗- 25022014. - html 2017 - 01 - 19 t13:55:27.260z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2014/us fda批准- bydureon笔- - - 2型糖尿病治疗03032014. - html 2017 - 01 - 11 t19:46:46.158z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2014/astrazeneca alderley -公园-网站-柴郡-英国-销售- 11032014. - html 2017 - 01 - 19 t11:51:43.674z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2014/astrazeneca - -非执行董事-安-凯恩斯- 20032014. - html 2017 - 01 - 19 t13:09:37.429z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2014/forxiga -审批-日本- - 2型糖尿病治疗- 24032014. - html 2017 - 01 - 19 t13:35:40.883z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2014/astrazeneca住友化学物质-阿斯利康kk -日本- 26032014. - html 2017 - 01 - 19 t12:05:42.665z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2014/astrazeneca mrc -早期药物发现中心-剑桥大学英国- 31032014. - html 2017 - 01 - 19 t11:39:04.590z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2014/astrazeneca - plc -第一季-结果- 2014 - 24042014. - html 2017 - 07 - 06 - t12:56:48.509z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2014/astrazeneca声明-关于辉瑞宣布- 28042014. - html 2017 - 01 - 19 t13:52:37.493z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2014/astrazeneca声明-关于辉瑞提议-公告- 02052014. - html 2017 - 01 - 11 t19:38:09.991z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2014/astrazeneca -董事会-拒绝辉瑞提议- 02052014. - html 2017 - 01 - 19 t11:54:28.854z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2014/us - fda批准epanova -严重hypertriglyceridaemia治疗- 06052014. - html 2017 - 01 - 19 t13:54:56.894z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2014/astrazeneca更新-战略-价值-股东- 06052014. - html 2017 - 01 - 19 t12:08:59.358z https://www.欧洲杯微信买球astrazeneca.com/media centre/press releases/2014/astrazeneca -免疫治疗研究- medi4736 -肺癌症患者- 08052014. - html 2017 - 01 - 19 t12:06:44.509z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2014/astrazeneca安进brodalumab -研究结果-斑块牛皮癣患者- 09052014. - html 2017 - 01 - 19 t11:27:48.536z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2014/astrazeneca呼吸-数据- at - 2014国际会议- 12052014. - html 2017 - 01 - 19 t12:07:35.589z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2014/astrazeneca - - mavrilimumab medimmune sifalimumab -研究类风湿性关节炎-全球疾病- 12052014. - html 2017 - 01 - 19 t11:43:07.811z https://www.欧洲杯微信买球astrazeneca.com/media centre/press - releases/2014/astrazeneca saxagliptin dapagliflozin组合- - 2型糖尿病病人- 13052014. - html 2017 - 01 - 19 t11:51:11.464z https://www.欧洲杯微信买球astrazeneca.com/media centre/press releases/2014/astrazeneca -更新语句-关于辉瑞宣布- 13052014. - html 2017 - 01 - 11 t19:38:33.633z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2014/medimmune incyte免疫-肿瘤学组合-临床试验- 14052014. - html 2017 - 01 - 19 t13:41:11.600z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2014/astrazeneca肿瘤-管线-加速度asco - 2014 - 14052014. - html 2017 - 01 - 19 t13:27:41.573z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2014/astrazeneca mrc -实验室分子生物学-联合研究基金- 15052014. - html 2017 - 01 - 19 t11:39:29.904z https://www.欧洲杯微信买球astrazeneca.com/media centre/press releases/2014/astrazeneca -后期阶段-管线-加速度-战略- 15052014. - html 2017 - 01 - 19 t13:30:17.355z https://www.欧洲杯微信买球astrazeneca.com/media centre/press releases/2014/astrazeneca -董事会拒绝-辉瑞最终提案- 19052014. - html 2017 - 01 - 19 t12:05:26.895z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2014/astrazeneca澄清-关于辉瑞公司声明- 20052014. - html 2017 - 01 - 19 t13:30:02.094z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2014/astrazeneca声明-关于辉瑞撤军- 26052014. - html 2017 - 01 - 11 t19:38:41.791z https://www.欧洲杯微信买球astrazeneca.com/media centre/press - releases/2014/astrazeneca olaparib cediranib组合-数据-卵巢癌症治疗- 31052014. - html 2017 - 01 - 19 t13:28:14.615z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2014/astrazeneca肿瘤-管线-发展- asco - 2014 - 03062014. - html 2017 - 01 - 19 t13:27:55.375z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2014/astrazeneca小说-抗生素azd0914 -美国fda -快-轨道- 03062014. - html 2017 - 01 - 19 t13:28:29.392z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2014/astrazeneca糖尿病-数据-美国-糖尿病协会科学会议- 11062014. - html 2017 - 01 - 19 t12:08:25.402z https://www.欧洲杯微信买球astrazeneca.com/media centre/press releases/2014/brodalumab -治疗银屑病关节炎-研究-新英格兰医学杂志》- - - - - - - 11062014. - html 2017 - 01 - 19 t13:29:10.349z https://www.欧洲杯微信买球astrazeneca.com/media centre/press - releases/2014/astrazeneca synairgen sng001 -小说-免疫调节治疗哮喘- 12062014. - html 2017 - 01 - 19 t12:07:01.613z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2014/us - fda顾问委员会- movantik心血管-安全- 12062014. - html 2017 - 01 - 19 t13:53:32.980z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2014/fda -咨询委员会olaparib -卵巢癌症治疗- 25062014. - html 2017 - 01 - 19 t13:32:14.278z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2014/astrazeneca全球-研究-开发-中心-企业-总部-剑桥-英国- 18072014. - html 2017 - 01 - 19 t13:10:09.488z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2014/medimmune -和- advaxis伙伴- -免疫-肿瘤学结合临床-试验- 22072014. - html 2017 - 01 - 19 t13:40:32.287z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2014/astrazeneca试剂盒-肺癌症诊断-测试-艾瑞莎治疗- 28072014. - html 2017 - 01 - 19 t11:40:10.253z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2014/astrazeneca罗氏- azd9291同伴诊断-测试-肺癌症- 28072014. - html 2017 - 01 - 19 t11:40:57.792z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2014/astrazeneca kyowa白光-麒麟免疫-肿瘤学临床研究- 30072014. - html 2017 - 01 - 19 t11:36:35.794z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2014/astrazeneca almirall -呼吸道疾病- 30072014. - html 2017 - 01 - 19 t13:59:16.009z https://www.欧洲杯微信买球astrazeneca.com/media centre/press releases/2014/astrazeneca -第二季度一半年结果- 2014 - 31072014. - html 2018 - 07 - 05 - t13:26:52.063z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2014/astrazeneca lesinurad -黄嘌呤氧化酶-结果-痛风患者- 13082014. - html 2017 - 01 - 19 t11:52:00.207z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2014/astrazeneca tralokinumab -治疗严重哮喘- 14082014. - html 2017 - 01 - 19 t13:59:32.161z https://www.欧洲杯微信买球astrazeneca.com/media centre/press releases/2014/united -州司法部-关闭-调查- - - - - - -柏拉图-临床试验brilinta - 19082014. - html 2017 - 01 - 19 t13:53:08.322z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2014/astrazeneca caz avi -结果复杂- -腹腔内感染19082014. - html 2017 - 01 - 19 t11:51:28.236z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2014/astrazeneca illumina公司-基因测序-小组同伴肿瘤诊断-测试- 21082014. - html 2017 - 01 - 19 t11:50:53.105z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2014/brilinta brilique - stemi患者心脏病- 01092014. - html 2017 - 01 - 19 t13:45:05.417z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2014/benralizumab -研究-柳叶刀-呼吸医学- 08092014. - html 2017 - 01 - 19 t13:28:43.059z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2014/astrazeneca糖尿病研究- 2014会议-欧洲-协会-研究- 10092014. -糖尿病的html 2017 - 01 - 19 t12:07:52.365z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2014/astrazeneca莉莉-确定新基点抑制剂- azd3293老年痴呆症病- 16092014. - html 2017 - 01 - 19 t11:37:12.105z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2014/fda批准- movatnik阿片类诱导-便秘慢性-非癌症疼痛患者- 16092014. - html 2017 - 01 - 19 t13:34:11.957z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2014/astrazeneca exenatide byetta -研究-结果- - - 2型糖尿病病人- 19092014. - html 2017 - 01 - 19 t13:52:53.260z https://www.欧洲杯微信买球astrazeneca.com/media centre/press releases/2014/medimmune -英国癌症研究——cruk -媒体联盟-实验室-生物-癌症药物- 25092014. - html 2017 - 01 - 19 t13:38:22.309z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2014/iressa chmp -积极意见-血-基础-诊断-测试-欧洲- - 26092014. - html标签 2017 - 01 - 11 t18:47:49.048z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2014/moventig naloxegol chmp -积极意见-阿片类诱导-便秘治疗- 26092014. - html 2017 - 01 - 11 t18:48:03.305z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2014/astrazeneca肿瘤-管线-发展-国会esmo - 2014 - 27092014. - html 2017 - 01 - 19 t12:07:17.761z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2014/benralizumab -研究-积极的结果严重哮喘柳叶刀-呼吸医学- 09102014. - html 2017 - 01 - 19 t13:51:31.554z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2014/astrazeneca -大学-剑桥-合作- 16102014. - html 2017 - 01 - 19 t13:27:22.752z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2014/lynparza -积极chmp意见-卵巢癌症治疗- 24102014. - html 2017 - 01 - 19 t13:36:50.610z https://www.欧洲杯微信买球astrazeneca.com/media centre/press releases/2014/us - fda批准xigduo - - 2型糖尿病病人- 30102014. - html 2017 - 01 - 19 t13:55:12.029z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2014/astrazeneca -健康-心-非洲-计划-高血压- 28102014. - html 2017 - 01 - 19 t13:08:31.371z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2014/astrazeneca almirall -呼吸道疾病——事务-完成- 03112014. - html 2017 - 01 - 19 t12:05:59.702z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2014/astrazeneca pharmacyclics -肿瘤学临床-试验-合作- 04112014. - html 2017 - 01 - 19 t11:39:48.739z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2014/astrazeneca pharmacyclics -詹森-免疫- -试验-血液学的癌症肿瘤——组合- 04112014. - html 2017 - 01 - 19 t13:58:38.666z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2014/medimmune免疫-肿瘤-功能-定义- 04112014. - html 2017 - 01 - 19 t13:58:56.994z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2014/astrazeneca myalept aegerion -瘦素缺乏- 06112014. - html 2017 - 01 - 19 t12:08:40.465z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2014/astrazeneca - plc -第三季度- 9月-结果- 2014 - 06112014. - html 2017 - 07 - 06 - t12:56:48.482z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2014/astrazeneca -炎症-自身免疫-管线-数据-美国大学风湿病学- 2014 - 11112014. - html -年度会议 2017 - 01 - 19 t12:08:08.648z https://www.欧洲杯微信买球astrazeneca.com/media centre/press - releases/2014/astrazeneca安进brodalumab -研究-正-结果-斑块牛皮癣患者- 11112014. - html 2017 - 01 - 19 t11:28:24.400z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2014/astrazeneca伊希斯-药物-寡核苷酸-肿瘤-心血管代谢疾病- 13112014. - html 2017 - 01 - 19 t11:31:49.709z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2014/astrazeneca brilinta -开发-项目-心血管- 13112014. - html 2017 - 01 - 19 t11:42:27.681z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2014/astrazeneca -战略-更新机构投资者-金融分析师- 18112014. - html 2017 - 01 - 19 t13:10:43.747z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2014/astrazeneca中期成功-价格-欧元- - notes 19112014. - html 2017 - 01 - 19 t13:08:16.661z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2014/duaklir genuiar批准-欧洲联盟-慢性阻塞性肺疾病- 24112014. html 2017 - 01 - 19 t13:30:30.843z https://www.欧洲杯微信买球astrazeneca.com/media centre/press - releases/2014/astrazeneca安进brodalumab——最终——研究——积极的结果——斑块牛皮癣- 25112014. - html 2017 - 01 - 19 t11:28:41.731z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2014/medimmune -定义-取得-组织- phenomics - 26112014. - html 2017 - 01 - 19 t13:42:16.793z https://www.欧洲杯微信买球astrazeneca.com/media centre/press - releases/2014/astrazeneca eli lilly -临床试验早期老年痴呆症-疾病患者- 01122014. - html 2017 - 01 - 19 t11:30:13.348z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2014/us - fda接受-新-药物-应用程序-艾瑞莎-肺癌症- 02122014. - html 2017 - 01 - 19 t13:49:38.721z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2014/astrazeneca -埃索美拉唑-反垄断诉讼——陪审团裁决- 05122014. - html 2017 - 01 - 19 t13:35:55.715z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2014/moventig批准-欧洲联盟-阿片类诱导便秘- 09122014. - html 2017 - 01 - 19 t13:43:46.260z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2014/astrazeneca安进amagine - 1 -结果- brodalumab斑块-牛皮癣- 11122014. - html 2017 - 01 - 19 t11:29:10.972z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2014/lynparza批准-欧洲联盟- brca突变-卵巢癌症治疗- 18122014. - html 2017 - 01 - 19 t13:38:02.395z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2014/lynparza - -美国fda批准brca突变-卵巢癌症治疗- 19122014. - html 2017 - 01 - 19 t13:37:07.439z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2014/astrazeneca -马克斯-普朗克研究所-卫星-化学-单元-心血管代谢疾病- 08072014. - html 2017 - 01 - 19 t11:38:08.165z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2014/astrazeneca三菱-田边制药公司——糖尿病肾病- 20082014. - html 2017 - 01 - 19 t11:38:42.563z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2014/astrazeneca科学家——英国癌症研究————剑桥学院- 17022014. - html 2017 - 01 - 19 t13:10:29.310z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2014/astrazeneca -上海-机构-生物-科学-心血管-代谢疾病研究- 23012014. - html 2017 - 01 - 19 t11:41:17.922z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2014/astrazeneca -韩国-健康-产业发展研究所-肿瘤学研究计划- 06032014. - html 2017 - 01 - 19 t11:32:08.730z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2014/new -开放创新平台-复合-银行-合作-计划- 25032014. - html 2017 - 01 - 19 t13:50:03.333z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2014/astrazeneca -深圳-大学健康科学中心-慢性肾脏疾病- 27032014. - html 2017 - 01 - 19 t11:41:43.020z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2014/astrazeneca -天津-医学大学心血管研究-中国- 15052014. - html 2017 - 01 - 19 t11:42:01.762z https://www.欧洲杯微信买球astrazeneca.com/media centre/press releases/2014/nobel -奖得主蒂姆-亨特-诺贝尔奖——灵感-行动-阿斯利康中国03062014. - html 2017 - 01 - 19 t13:50:31.742z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2014/astrazeneca addc -小说-药物-发展-学术研究-社区- 17062014. - html 2017 - 01 - 18 - t15:31:50.233z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2014/astrazeneca mrc -技术-小说-目标-发现-研究- 03072014. - html 2017 - 01 - 19 t13:44:12.725z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2014/pharma -公司-阿斯利康虚拟图书馆-制药化合物- 22072014. - html 2017 - 01 - 19 t13:52:19.040z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2014/astrazeneca redx -制药-遗传-司机-肿瘤增长-研究- 03092014. - html 2017 - 01 - 19 t11:40:32.597z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2014/medimmune fda - medi3902院内肺炎-预防- 23092014. - html 2017 - 01 - 19 t13:43:06.590z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2014/astrazeneca英国癌症研究- -新癌症药物-筛选- mrc -英国-中心-铅-发现- 28112014. - html 2017 - 01 - 19 t13:57:34.794z https://www.欧洲杯微信买球astrazeneca.com/media-centre/press-releases/2013/astrazeneca-shionogi-crestor-licence-agreement26122013.html 2017 - 01 - 19 t09:57:24.079z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2013/astrazeneca迈尔斯-布里斯托尔-施贵宝公司-全球-糖尿病联盟-资产- 19122013. - html 2017 - 01 - 19 t09:58:09.323z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2013/astrazeneca声明-艾锶-产品-发射- 17122013. - html 2017 - 01 - 19 t09:58:23.737z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2013/astrazeneca lesinurad -研究-结果-痛风患者- 13122013. - html 2017 - 01 - 19 t09:59:15.199z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2013/fda -咨询委员会建议dapagliflozin - - 2型糖尿病治疗- 12122013. - html 2017 - 01 - 19 t09:59:32.607z https://www.欧洲杯微信买球astrazeneca.com/media centre/press releases/2013/fda -咨询委员会- metreleptin脂肪代谢障碍治疗- 12122013. - html 2017 - 01 - 19 t09:59:45.985z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2013/astrazeneca brixham -环境-实验室普利茅斯大学- 09122013. - html 2017 - 01 - 19 t10:00:00.800z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2013/fluenz -四-欧洲委员会批准-季节性流感预防——孩子——06122013. - html 2017 - 01 - 19 t10:00:21.002z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2013/astrazeneca -奥美拉唑-专利诉讼裁决- 03122013. - html 2017 - 01 - 19 t10:00:56.306z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2013/xigduo chmp -积极意见-欧洲联盟- - 2型糖尿病治疗- 22112013. - html 2017 - 01 - 19 t10:01:12.142z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2013/astrazeneca -研究-开发-英国剑桥中心-企业-总部- - -赫尔佐格-梅隆建筑师- 19112013. - html 2017 - 01 - 19 t10:02:41.007z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2013/us fda -新-药物-应用程序- naloxegol阿片类诱导-便秘治疗- 19112013. - html 2017 - 01 - 19 t10:03:01.971z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2013/astrazeneca -制造-设备-马格斯菲特zoladex -前列腺癌症治疗- 11112013. - html 2017 - 01 - 19 t10:04:18.201z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2013/astrazeneca - plc -第三季度- 9月-结果- 2013 - 31102013. - html 2017 - 01 - 19 t10:04:57.827z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2013/marc dunoyer -新- -财务总监-阿斯利康- 31102013. - html 2017 - 01 - 19 t10:05:36.841z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2013/us上诉法院- pulmicort respules -专利诉讼的决定- 30102013. - html 2017 - 01 - 19 t10:05:53.656z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2013/astrazeneca - - benralizumab medimmune的严重哮喘治疗- 30102013. - html 2017 - 01 - 19 t10:06:31.539z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2013/astrazeneca brixham -环境-实验室关闭- 24102013. - html 2017 - 01 - 19 t10:06:45.628z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2013/astrazeneca selumetinib -非小细胞肺-癌症治疗- 22102013. - html 2017 - 01 - 19 t10:07:10.273z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2013/astrazeneca肿瘤- - spirogen收购medimmune - 15102013. - html 2017 - 01 - 19 t10:07:26.834z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2013/astrazeneca -詹森-日本-前列腺癌症治疗- 11102013. - html 2017 - 01 - 19 t10:07:41.507z https://www.欧洲杯微信买球astrazeneca.com/media centre/press - releases/2013/medimmune amplimmune取得- 07102013. - html 2017 - 01 - 19 t10:07:57.071z https://www.欧洲杯微信买球astrazeneca.com/media centre/press - releases/2013/us上诉法院-电梯临时禁令hanmi - 505 b2 - nda -唑-锶- 02102013. - html 2017 - 01 - 19 t10:08:20.591z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2013/astrazeneca alderley -公园biohub -研究-开发-中心- 01102013. - html 2017 - 01 - 19 t10:08:33.853z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2013/olaparib -欧洲-药物-机构- brca突变-卵巢癌症治疗- 27092013. - html 2017 - 01 - 19 t10:08:48.159z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2013/naloxegol -欧洲-药物-机构-阿片类诱导-便秘治疗- 27092013. - html 2017 - 01 - 19 t10:09:07.936z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2013/onglyza低血糖胰腺炎- subanalyses品味-心血管试验结果- 2 - 26092013. - html 2017 - 01 - 19 t10:09:32.667z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2013/dapagliflozin糖化血红蛋白- - 2型糖尿病病人-二甲双胍-磺酰脲类- 24092013. - html 2017 - 01 - 19 t10:09:57.790z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2013/fluenz -四-鼻喷雾疫苗-欧盟- chmp积极意见-季节性流感-预防-儿童20092013. - html 2017 - 01 - 19 t10:10:20.858z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2013/fda -新-药物-应用程序- epanova -严重hypertriglyceridaemia治疗- 18092013. - html 2017 - 01 - 19 t10:10:35.145z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2013/us上诉法院-临时禁令hanmi - 505 b2 - nda -艾锶- 13092013. - html 2017 - 01 - 19 t10:11:29.707z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2013/astrazeneca默克- wee1 -激酶抑制剂治疗癌症- 11092013. - html 2017 - 01 - 19 t10:12:35.584z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2013/astrazeneca olaparib -临床项目- brca突变-卵巢癌症治疗- 04092013. - html 2017 - 01 - 19 t10:13:34.781z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2013/onglyza saxagliptin——安全——心血管-心-攻击-中风- 02092013. - html 2017 - 01 - 19 t10:13:53.926z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2013/medimmune -免疫介导的癌症疗法- amplimmune 26082013. - html 2017 - 01 - 19 t10:14:09.498z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2013/astrazeneca - plc -第二季度一半年结果- 2013 - 01082013. - html 2017 - 01 - 19 t10:14:28.144z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2013/astrazeneca fibrogen fg4592 -贫血治疗-慢性肾脏疾病-肾疾病- 31072013. - html 2017 - 01 - 19 t10:14:43.602z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2013/us fda -新-药物-应用程序- dapagliflozin - - 2型糖尿病治疗- 25072013. - html 2017 - 01 - 19 t10:15:02.786z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2013/astrazeneca迈尔斯-布里斯托尔-施贵宝dapagliflozin - - 2型糖尿病治疗- 25072013. - html 2017 - 01 - 19 t10:15:55.904z https://www.欧洲杯微信买球astrazeneca.com/media centre/press releases/2013/astrazeneca - -财务总监西蒙- lowth - 15072013. - html 2017 - 01 - 19 t10:16:17.992z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2013/astrazeneca -大学-剑桥大学癌症研究- 09072013. - html 2017 - 01 - 19 t10:16:53.674z https://www.欧洲杯微信买球astrazeneca.com/media centre/press releases/2013/astrazeneca -珍珠疗法-采购- 28062013. - html 2017 - 01 - 19 t10:18:07.349z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2013/astrazeneca迈尔斯-布里斯托尔-施贵宝公司享受- timi - 53 - - onglyza心血管试验结果-结果- 19062013. - html 2017 - 01 - 19 t10:20:21.169z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2013/astrazeneca -新-全球研究开发中心-企业-总部-剑桥-英国- 18062013. - html 2017 - 01 - 19 t10:21:08.999z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2013/astrazeneca - - ngm medimmune biopharamaceuticals -糖尿病,肥胖症治疗- 17062013. - html 2017 - 01 - 19 t10:21:33.964z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2013/astrazeneca珍珠-治疗呼吸道疾病- 10062013. - html 2017 - 01 - 19 t10:22:12.193z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2013/astrazeneca oskira -试验- fostamatinib -结果- 04062013. - html 2017 - 01 - 19 t10:22:30.023z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2013/astrazeneca hanmi -药物- amneal制药-美国-埃索美拉唑专利诉讼- 03062013. - html 2017 - 01 - 19 t10:22:50.653z https://www.欧洲杯微信买球astrazeneca.com/media centre/press - releases/2013/astrazeneca omthera制药-血脂异常治疗心血管- 28052013. - html 2017 - 01 - 19 t10:23:43.529z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2013/us -上诉法院临时禁令- pulmicort respules - 25052013. - html 2017 - 01 - 19 t10:23:15.215z https://www.欧洲杯微信买球astrazeneca.com/media centre/press releases/2013/astrazeneca -加速肿瘤-管线- 2013 asco年度会议- 16052013. - html 2017 - 01 - 19 t10:24:12.482z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2013/astrazeneca alderley公园-柴郡未来- 29042013. - html 2017 - 01 - 19 t10:24:38.099z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2013/astrazeneca - plc -第一季-结果- 2013 - 25042013. - html 2017 - 01 - 19 t10:24:56.404z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2013/astrazeneca绑定-治疗癌症纳米- accurin - 22042013. - html 2017 - 01 - 19 t10:25:13.131z https://www.欧洲杯微信买球astrazeneca.com/media centre/press - releases/2013/astrazeneca oskira - 1 -研究-结果- fostamatinib风湿性关节炎- 05042013. - html 2017 - 01 - 19 t10:25:35.137z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2013/astrazeneca medimmune alphacore -医药生物制剂- 03042013. - html 2017 - 01 - 19 t10:25:58.563z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2013/us区法院- pulmicort respules -专利无效- 02042013. - html 2017 - 01 - 19 t10:26:21.903z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2013/astrazeneca -可定专利诉讼-解决- 25032013. - html 2017 - 01 - 19 t10:26:39.622z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2013/astrazeneca -马克- dunoyer - -副总裁-全球投资组合产品——战略- 21032013. - html 2017 - 01 - 19 t10:26:55.694z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2013/astrazeneca增长-科学-领导策略- 21032013. - html 2017 - 01 - 19 t10:27:56.421z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2013/astrazeneca -卡罗林斯卡研究所研究中心-心血管代谢疾病- regnerative医学- 21032013. - html 2017 - 01 - 19 t10:29:22.187z https://www.欧洲杯微信买球astrazeneca.com/media centre/press releases/2013/astrazeneca -现代化疗法-代谢疾病疾病,癌症治疗- 21032013. - html 2017 - 01 - 19 t10:29:51.588z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2013/copd药物——痛苦——研究——医学杂志-内部- 19032013. - html 2017 - 01 - 19 t10:31:07.448z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2013/astrazeneca -研究-开发-中心-创新-管线- 18032013. - html 2017 - 01 - 19 t10:31:33.981z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2013/astrazeneca -研究-开发-中心全球总部——剑桥- 18032013. - html 2017 - 01 - 19 t10:32:58.874z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2013/australia联邦专利法院-可定- 05032013. - html 2017 - 01 - 19 t10:33:17.810z https://www.欧洲杯微信买球astrazeneca.com/media centre/press - releases/2013/astrazeneca naloxegol长期-安全-阿片类药物诱发便秘患者- 26022013. - html 2017 - 01 - 19 t10:33:44.953z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2013/us上诉法院-思瑞康专利- - - - - - - descision - 15022013. - html 2017 - 01 - 19 t10:34:01.469z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2013/astrazeneca - plc -第四季度满岁的结果- 2012 - 31012013. - html 2017 - 07 - 06 - t12:56:48.498z https://www.欧洲杯微信买球astrazeneca.com/media centre/press releases/2013/astrazeneca - -高管团队- 15012013. - html 2017 - 07 - 06 - t10:58:42.207z https://www.欧洲杯微信买球astrazeneca.com/media-centre/press-releases/2012.html 2016 - 11 - 22 - t17:02:18.764z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2012/astrazeneca重申- 12月- 2011 -金融-指导- - 2011 . html 2017 - 01 - 13 t08:32:51.014z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2012/astrazeneca -和- ims健康-宣布真正的世界-证据-合作- -欧洲- 11012015. - html 2017 - 01 - 13 t08:27:57.485z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2012/astrazeneca和迈尔斯-布里斯托尔-施贵宝公司收取-完成-响应-信- - -食品和药物管理局- 19012012. - dapagliflozin html 2017 - 01 - 13 t08:27:44.564z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2012/astrazeneca - plc -第四季度和全年-结果- 2011 - 02022012. - html 2017 - 07 - 06 - t12:56:48.536z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2012/astrazenecas -新-重组举措- -驱动生产力-和-支持-创新- 02022012. - html 2017 - 01 - 13 t08:33:27.895z https://www.欧洲杯微信买球astrazeneca.com/media centre/press releases/2012/european -委员会批准- - caprelsa vandetanib患者————高级——髓-甲状腺癌症- 21022012. - html 2017 - 01 - 13 t08:39:34.639z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2012/astrazeneca宣布-非执行变化——退休的董事长-和-任命继任者- 01032012. - html 2017 - 01 - 13 t08:29:42.144z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2012/fda批准——第一次——4 -应变-流感疫苗- 01032012. - html 2017 - 01 - 13 t08:54:19.469z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2012/fda -响应-阿斯利康公民请愿书-喹硫平-产品-标签- 09032012. - html 2017 - 01 - 13 t08:56:12.933z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2012/astrazeneca -文件-对- - fda的决定- - - - - - -喹硫平- 13032012. - html 2017 - 01 - 13 t08:31:04.091z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2012/remaining - tc - 5214 -相- iii -功效研究——做——不满足-端点管理-文件-——不——会追求- 20032012. - html 2017 - 01 - 13 t08:59:12.568z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2012/uk法院-发现-思瑞康- xr -配方专利无效- 22032012. - html 2017 - 01 - 13 t08:59:34.212z https://www.欧洲杯微信买球astrazeneca.com/media centre/press releases/2012/us -法院否认-初步禁令-应用程序- - - fda和驳斥了-阿斯利康诉讼——没有偏见- 26032012. - html 2017 - 01 - 13 t09:00:04.920z https://www.欧洲杯微信买球astrazeneca.com/media centre/press releases/2012/us -区法院-发现-思瑞康- xr -配方专利-有效和侵犯- 30032012. - html 2017 - 01 - 13 t09:00:23.425z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2012/astrazeneca -和-安进宣布-合作- 02042012. - html 2017 - 01 - 13 t08:26:59.671z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2012/forxiga dapagliflozin -接收积极- chmp意见- - -欧洲联盟- - - - - -的- 2型糖尿病治疗- 20042012. - html 2017 - 01 - 13 t08:56:59.604z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2012/astrazeneca - -获得ardea -生物科学- 23042012. - 10亿- html 2017 - 01 - 13 t08:34:19.556z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2012/astrazeneca - - - - -药物-公司宣布全球协作- -急性缺血性心脏疾病- 25042012. - html 2017 - 01 - 13 t08:29:11.414z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2012/astrazeneca - plc -第一季-结果- 2012 - 26042012. - html 2017 - 07 - 06 - t12:56:48.546z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2012/david -布伦南- - -阿斯利康首席执行官退休军官- 26042012. - html 2017 - 01 - 13 t08:38:45.397z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2012/innovative -公共-私人合作-发射- -解决-抗生素-研究- 24052012. - html 2017 - 01 - 13 t08:57:16.438z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2012/investigational -复合- dapagliflozin证明显著-减少-血- sugarlevels - 09062012. - html 2017 - 01 - 13 t08:58:24.948z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2012/zinforo ceftaroline fosamil -接收积极- chmp意见- - -欧洲联盟- - -治疗的患者- -严重皮肤感染或-社区-了-肺炎- 22062012. - html 2017 - 01 - 13 t09:00:39.497z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2012/astrazeneca -和-默克同意- -修改-二-选项- 27062012. - html 2017 - 01 - 13 t08:28:39.554z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2012/bristol -迈尔斯-施贵宝公司和阿斯利康-扩展-糖尿病联盟- 30062012. - html 2017 - 01 - 13 t08:34:34.545z https://www.欧洲杯微信买球astrazeneca.com/media centre/press - releases/2012/astrazeneca -完成- - - aptium肿瘤学资产出售- 06072012. - html 2017 - 01 - 13 t08:30:28.871z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2012/astrazeneca报告-条件-大卫-布伦南-退休- 16072012. - html 2017 - 01 - 13 t08:33:07.005z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2012/astrazeneca - plc -第二季度和半年- -结果- 2012 - 26072012. - html 2017 - 07 - 06 - t12:56:48.520z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2012/astrazeneca和迈尔斯-布里斯托尔-施贵宝公司-完成- - -糖尿病联盟通过扩张迈尔斯-布里斯托尔-施贵宝公司收购- -糊精-药物- 09082012.的html 2017 - 01 - 13 t08:27:31.129z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2012/astrazeneca -和-辉瑞进入-协议- - -反-埃索美拉唑-阿斯利康-培养- 2012 -指导- 13082012. - html 2017 - 01 - 13 t08:28:54.072z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2012/pascal soriot -任命首席执行官-官- 28082012. -阿斯利康的html 2017 - 01 - 13 t08:58:48.872z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2012/european委员会批准- zinforo ceftaroline fosamil - -成人患者-严重皮肤感染-或-社区-了-肺炎- 28082012. - html 2017 - 01 - 13 t08:43:06.453z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2012/astrazeneca - - - 20亿债券发行价格12092012. - html 2017 - 01 - 13 t08:32:20.773z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2012/astrazeneca暂停-股票回购计划- 01102012. - html 2017 - 01 - 13 t08:33:59.194z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2012/astrazeneca -和- ardelyx宣布-全球许可协议- - - - nhe3抑制剂-计划- - -肾疾病的并发症,包括糖尿病-诱导肾疾病——08102012. - html 2017 - 01 - 13 t08:27:12.996z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2012/astrazeneca -和-铁木宣布linaclotide -合作- 23102012. - html 2017 - 01 - 13 t08:28:10.726z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2012/astrazeneca - plc -第三季度-和- 9月-结果- 2012 - 25102012. - html 2017 - 07 - 06 - t12:56:48.495z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2012/astrazeneca宣布细节- -首席执行官官- pascal soriot薪酬- 29102012. - html 2017 - 01 - 13 t08:29:26.925z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2012/alzheimers癌症-和-罕见的疾病——研究——-好处——从地标- mrc -阿斯利康-复合-合作- 31102012. - html 2017 - 01 - 13 t08:26:47.935z https://www.欧洲杯微信买球astrazeneca.com/media centre/press releases/2012/definition - -核心金融措施- 12112012. - html 2017 - 01 - 13 t08:39:03.020z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2012/astrazeneca宣布-前-线-阶段- iii -结果-从- naloxegol关键-试验- - - -阿片类诱导便秘的患者- 12112012. - html 2017 - 01 - 13 t08:29:56.166z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2012/court - -德国-发现-思瑞康- xr -配方专利无效- 13112012. - html 2017 - 01 - 13 t08:35:54.975z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2012/forxiga dapagliflozin -现在-批准在欧洲联盟- - - -治疗- - 2型糖尿病- 14112012. - html 2017 - 01 - 13 t08:56:41.008z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2012/astrazeneca -和-伊西斯-药物- -战略联盟形式-对- rna治疗癌症- 11122012. - html 2017 - 01 - 13 t08:28:25.279z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2012/astrazeneca宣布-高级-线-结果- oskira - 4 - iib期研究- fostamatinib -作为一个单一疗法- 13122012. -类风湿性关节炎html 2017 - 01 - 13 t08:30:12.849z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2012/crestor -我们-专利维持- -法院的- - - - - - - -联邦巡回上诉- 14122012. - html 2017 - 01 - 13 t08:36:10.261z https://www.欧洲杯微信买球astrazeneca.com/media-centre/press-releases/2011.html 2016 - 11 - 22 - t17:02:28.272z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2011/us -食品-和药物管理局-扩展-审核-时间- 07012011. -湖html 2017 - 01 - 19 t13:43:19.199z https://www.欧洲杯微信买球astrazeneca.com/media centre/press - releases/2011/astrazeneca回复- - -美国fda -完成-响应-信- b - 21012011. - html 2017 - 01 - 19 t13:43:36.405z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2011/astrazeneca - plc -第四季度和全年-结果- 2010 - 27012011. - html 2017 - 01 - 19 t13:43:48.556z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2011/astrazeneca批准-鼻喷雾疫苗- fluenz -流感- 01022011. - html 2017 - 01 - 19 t13:43:59.966z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2011/us - fda -分配-新- pdufa -日期- - brilinta ticagrelor -平板电脑- 04022011. - html 2017 - 01 - 19 t13:44:18.030z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2011/astrazeneca -停止- - iii期临床试验——zibotentan -非转移性阉割-抗- 07022011. - html 2017 - 01 - 19 t13:44:37.026z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2011/astrazeneca -和- targacept启动- - iib期临床试验- - tc - 5214 - 07022011. - html 2017 - 01 - 19 t13:44:53.007z https://www.欧洲杯微信买球astrazeneca.com/media centre/press - releases/2011/onglyza_标签-更新提供了进一步的证据-关于使用html - 23022011. 2017 - 01 - 19 t13:45:07.790z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2011/astrazeneca - -停止-生产- - pulmicort pmdi -其他- 07032011. - html 2017 - 01 - 19 t13:45:20.758z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2011/onglyza - -第一dpp4 -抑制剂- 2型糖尿病- 04032011. - html 2017 - 01 - 19 t13:45:35.264z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2011/ - fda接受-新-药物-应用程序- -临床实验-复合- 08032011. - html 2017 - 01 - 19 t13:45:49.337z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2011/astrazeneca启动- - iii期临床-计划-评估- nk - 15032011. - html 2017 - 01 - 19 t13:46:03.053z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2011/uk -和-美国政府达成协议——在阿斯利康-税收-冰铜- 28032011. - html 2017 - 01 - 19 t13:46:17.832z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2011/fda -批准孤儿药物- vandetanib - 07042011. - html 2017 - 01 - 19 t13:48:59.815z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2011/astrazeneca - plc -第一季-结果- 2011 - 28042011. - html 2017 - 07 - 06 - t12:56:48.499z https://www.欧洲杯微信买球astrazeneca.com/media centre/press releases/2011/health -经济- substudy柏拉图-显示- brilique - - -成本-效果- 09052011. - html 2017 - 01 - 19 t13:49:27.463z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2011/astrazeneca - -协议迹象——日本——-第一核电站- - - - - co -促进- 24052011. - html 2017 - 01 - 19 t13:49:40.355z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2011/health -加拿大-批准brilinta ticagrelor -平板电脑- 01062011. - html 2017 - 01 - 19 t13:49:54.874z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2011/astrazeneca -扩展- -投资- -俄罗斯- - - - - - - - - -新-预测-科学中心- 16062011. - html 2017 - 01 - 19 t13:50:08.174z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2011/astrazeneca - - - astratech卖给dentsply国际- 22062011. - html 2017 - 01 - 19 t13:50:21.849z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2011/bristol -迈尔斯-施贵宝公司,阿斯利康ph3 -研究- - - - - - - dapagliflozin - 27062011. - html 2017 - 01 - 19 t13:50:37.816z https://www.欧洲杯微信买球astrazeneca.com/media centre/press - releases/2011/astrazeneca -埃索美拉唑-接收第一-管理-审批- -日本- 01072011. - html 2017 - 01 - 19 t13:51:08.153z https://www.欧洲杯微信买球astrazeneca.com/media centre/press releases/2011/fda -咨询委员会-让-推荐- -临床实验-复合- 20072011. - html 2017 - 01 - 19 t13:51:20.664z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2011/fda -批准新的医学- brilinta ticagrelor - -使用- - - - -我们- 20072011. - html 2017 - 01 - 19 t13:51:34.492z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2011/astrazeneca - plc -第二季度和半年- -结果- 2011 - 28072011. - html 2017 - 01 - 19 t13:51:47.625z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2011/positive协议-收到- -审批- - axanum -在-欧洲- 02082011. - html 2017 - 01 - 19 t13:52:01.383z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2011/sale - -阿斯特拉-科技- - dentsply国际-完成- 31082011. - html 2017 - 01 - 19 t13:52:14.033z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2011/astrazeneca宣布-高级-线-结果-土星-研究- 020920111. - html 2017 - 01 - 19 t13:52:26.794z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2011/astrazeneca宣布-高级-线-结果-土星-研究- 02092011. - html 2017 - 01 - 19 t13:52:52.336z https://www.欧洲杯微信买球astrazeneca.com/media centre/press - releases/2011/komboglyze saxagliptin -和-盐酸二甲双胍- -立即释放-接收积极- chmp意见- - -欧洲联盟- - - - - -的- 2型糖尿病治疗- 23092011. - html 2017 - 01 - 19 t13:53:06.560z https://www.欧洲杯微信买球astrazeneca.com/media centre/press - releases/2011/astrazeneca宣布第一-审批- faslodex fulvestrant - -日本- 26092011. - html 2017 - 01 - 19 t13:59:10.874z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2011/astrazeneca -输入-到- -和解协议-与-翰达岛-药物-关于我们-思瑞康- xr -专利诉讼- 29092011. - html 2017 - 01 - 19 t13:58:56.224z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2011/brilique接收- -正-初步医疗受益-评估- - -多数- - acs病人- -德国的一部分- -新- amnog审查-流程- 04102011. - html 2017 - 01 - 19 t13:58:40.729z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2011/astrazeneca进入- - -解决协议与协议-医疗保健公司-和-国际制药有限公司-关于我们-思瑞康- xr -专利诉讼- 05102011. - html 2017 - 01 - 19 t13:58:25.720z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2011/astrazeneca -增加-投资- - - - - - -中国- - - - - - -新- 2亿-制造-设备- 10102011. - html 2017 - 01 - 19 t13:57:15.656z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2011/astrazeneca -和-森林实验室-开始- - iii期临床试验——-头孢他啶avibactam - -治疗严重-克- - -细菌感染- 18102011. - html 2017 - 01 - 19 t13:57:01.312z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2011/astrazeneca - -现在-新-医疗经济学-数据-显示-成本-效率-的- brilique ispor -欧盟- 21102011. - html 2017 - 07 - 06 - t12:56:48.526z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2011/us -食品-和-药物-政府-扩展-行动-日期- dapagliflozin - -三个月- 26102011. - html 2017 - 01 - 19 t13:56:34.470z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2011/astrazeneca - plc -第三季度-和- 9月-结果- 2011 - 27102011. - html 2017 - 07 - 06 - t12:56:48.487z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2011/astrazeneca -和- targacept宣布第一-前-线-相- iii -结果-为- tc - 5214 - - -辅助治疗的患者- - - - - - -主要抑郁障碍- 08112011. - html 2017 - 01 - 19 t13:56:07.306z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2011/saturn演示-效应-密集的他汀类药物治疗- -减少-动脉粥样硬化- 15112011. html 2017 - 01 - 19 t13:55:54.432z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2011/caprelsa vandetanib -接收积极- chmp意见- - -欧洲联盟- - -高级-髓治疗甲状腺-癌症- 18112011. - html 2017 - 01 - 19 t13:55:39.622z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2011/astrazeneca提交- 1亿-美-企业- 28112011. - html 2017 - 01 - 19 t13:55:27.075z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2011/komboglyze接收-营销-授权- - -欧洲联盟的-成人患者- - - - - - - 2型糖尿病- 29112011. - html 2017 - 01 - 19 t13:55:13.566z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2011/groundbreaking -科学-合作-给了英国学术界访问-化合物- -推进医疗研究- 05122011. - html 2017 - 01 - 19 t13:55:00.834z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2011/astrazeneca - -简化-美国-销售-组织- 07122011. - html 2017 - 01 - 19 t13:54:47.537z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2011/astrazeneca - -获得仿制药公司- -扩大病人访问- -药物-在-中国- 08122011. - html 2017 - 01 - 19 t13:54:32.784z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2011/g - ba -问题-积极——最终——医学-效益-评估- - brilique - -德国- 15122011. - html 2017 - 01 - 19 t13:54:20.312z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2011/astrazeneca更新- - olaparib和tc - 5214 -开发-项目- 20122010. - html 2017 - 01 - 19 t13:54:07.467z https://www.欧洲杯微信买球astrazeneca.com/media-centre/press-releases/2010.html 2016 - 11 - 22 - t17:02:41.616z https://www.欧洲杯微信买球astrazeneca.com/media centre/press releases/2010/astrazeneca -达到协议——-梯瓦制药- -埃索美拉唑和奥美拉唑-美国专利诉讼- 07012010. - html 2017 - 01 - 19 t12:52:13.821z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2010/astrazeneca - plc -第四季度和全年-结果- 2009 - 28012010. - html 2017 - 07 - 06 - t12:56:48.529z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2010/us - fda批准-新-显示-可定伐-钙- 09022010. - html 2017 - 01 - 19 t12:52:43.366z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2010/astrazeneca和参宿七-制药签署-全球许可协议- - - -发展阶段后期产品- fostamatinib二钠- r788 - - - -类风湿性关节炎的治疗- 16022010. - html 2017 - 01 - 19 t12:53:08.092z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2010/astrazeneca达到协议-与-英国税务当局-在转让定价- 23022010. - html 2017 - 01 - 19 t12:54:44.161z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2010/astrazeneca -提供一个更新- - -状态- - -安排的默克- 01032010. - html 2017 - 01 - 19 t12:54:57.308z https://www.欧洲杯微信买球astrazeneca.com/media - - centre/press releases/2010/recentin -不- -主-端点在地平线- iii -学习- -转移性结肠直肠癌症- 08032010. - html 2017 - 01 - 19 t12:55:10.372z https://www.欧洲杯微信买球astrazeneca.com/media centre/press - releases/2010/astrazeneca评论- - fda -联合咨询委员会会议-在post -营销-安全-研究- - -使用- -腊八粥的哮喘- 11032010. - html 2017 - 01 - 19 t12:55:30.783z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2010/astrazeneca -扩展-品牌仿制药-能力-与- bt协议- 11032010. - html 2017 - 01 - 19 t12:55:45.502z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2010/new柏拉图-子-分析- - cabg患者-呈现- 16032010. - acc - html 2017 - 01 - 19 t12:56:01.401z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2010/jury -规则- -支持- - -阿斯利康的第一个-我们-思瑞康-产品-责任-试验- 18032010. - html 2017 - 01 - 19 t12:56:17.032z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2010/astrazeneca -和-阿伯特-收到fda -完成-响应-信- certriad -新-药物-应用程序- 30032010. - html 2017 - 01 - 19 t12:56:29.736z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2010/seroquel - xr -推荐- - - - - - - - -欧盟的批准一个-添加-对- - -主要抑郁障碍的治疗- 23042010. - html 2017 - 01 - 19 t12:56:49.347z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2010/astrazeneca -已敲定协议- -思瑞康-营销- 27042010. - html 2017 - 01 - 19 t12:57:05.003z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2010/crestor收益-新-欧盟-显示- -预防主要心血管事件- -高-风险-患者27042010. - html 2017 - 01 - 19 t12:57:21.544z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2010/astrazeneca -第一季-结果- 2010 - 29042010. - html 2017 - 07 - 06 - t12:56:48.525z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2010/fda -批准vimovo - -关节炎患者-风险- - -发展-非甾体抗炎药的相关-胃溃疡- 30042010. - html 2017 - 01 - 19 t12:57:53.133z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2010/astrazeneca -达到协议-和-梯瓦制药就entocort - ec -胶囊- 18052010. - html 2017 - 01 - 19 t12:58:08.143z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2010/martin -麦凯-铅-阿斯利康-研究-和-发展-组织- 26052010. - html 2017 - 01 - 19 t12:58:23.561z https://www.欧洲杯微信买球astrazeneca.com/media centre/press releases/2010/notice -咨询委员会-简报-材料- - motavizumab bla可用- -美国fda - web -网站- 28052010. - html 2017 - 01 - 19 t12:58:36.872z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2010/astrazeneca宣布-结果- recentin地平线- ii - iii期试验- -转移性结肠直肠癌症- 28052010. - html 2017 - 01 - 19 t12:58:52.256z https://www.欧洲杯微信买球astrazeneca.com/media centre/press releases/2010/astrazeneca -收到fda -完成-响应-信- axanum -新-药物-应用程序- 01062010. - html 2017 - 01 - 19 t12:59:07.817z https://www.欧洲杯微信买球astrazeneca.com/media centre/press releases/2010/fda -更新-产品-标签的腊八包含-药物-包括阿斯利康symbicort - 02062010. - html 2017 - 01 - 19 t12:59:23.855z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2010/fda -咨询委员会审查-美- motavizumab - 02062010. - html 2017 - 01 - 19 t12:59:41.734z https://www.欧洲杯微信买球astrazeneca.com/media centre/press releases/2010/astrazeneca -提交营销授权-应用程序-欧洲联盟- -心血管药物axanum - 04062010. - html 2017 - 01 - 19 t12:59:58.957z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2010/federal法院- -加拿大-规则- -应用程序-通用- esomep - 17062010. - html 2017 - 01 - 19 t13:00:12.978z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2010/astrazeneca -和- targacept启动- - 3期临床-发展- 23062010. - html 2017 - 01 - 19 t13:00:27.065z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2010/fda重置-的-决策-日期- motavizumab - 25062010. - html 2017 - 01 - 19 t13:00:40.096z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2010/astrazeneca -和- mmv加入努力- - - - - -打击疟疾- 28072010. - html 2017 - 01 - 19 t13:00:55.887z https://www.欧洲杯微信买球astrazeneca.com/media centre/press releases/2010/crestor -专利维持- -美国法院- 30072010. - html 2017 - 01 - 19 t13:28:55.736z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2010/astrazeneca和mrc -技术-形成战略联盟- 05072010. - html 2017 - 01 - 19 t13:29:25.541z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2010/advisory委员会-简报-材料- - brilinta ticagrelor - 26072010. - html 2017 - 01 - 19 t13:29:58.044z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2010/astrazeneca - plc -任命新-非执行董事- 29072010. - html 2017 - 01 - 19 t13:28:23.676z https://www.欧洲杯微信买球astrazeneca.com/media centre/press releases/2010/astrazeneca -第二季度,半岁的结果- 2010 - 29072010. - html 2017 - 07 - 06 - t12:56:48.479z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2010/fda -咨询委员会建议-美国fda批准- 29072010. - brilinta html 2017 - 01 - 19 t13:27:45.611z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2010/astrazeneca宣布——协议-原理- -思瑞康- 09082010. - html 2017 - 01 - 19 t13:25:27.517z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2010/genetic substudy -显示-减少-主要心血管事件- 29082010. - ticagrelor brilinta html 2017 - 01 - 19 t13:24:40.573z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2010/medimmune接收-完成-响应-信- motavizumab - 30082010. - html 2017 - 01 - 19 t13:24:19.792z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2010/european委员会-问题-正-决策-审批- -思瑞康- xr -作为一个-添加-对- - -主要抑郁障碍的治疗- 02092010. - html 2017 - 01 - 19 t13:23:59.354z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2010/us - fda -扩展-审核-时间- 15092010. - brilinta html 2017 - 01 - 19 t13:23:40.974z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2010/24 -星期- - 3期研究发现-临床实验的- - - - - - - dapagliflozin -改进-糖化血红蛋白糖化血红蛋白-时-添加- - glimepiride在成人- - - 2型糖尿病患者糖尿病- 20092010. - html 2017 - 01 - 19 t13:23:12.736z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2010/us -和-欧盟-管理-提交vandetanib -在-高级-髓-甲状腺癌症- 23092010. - html 2017 - 01 - 19 t13:22:44.348z https://www.欧洲杯微信买球astrazeneca.com/media centre/press releases/2010/52week - - 3期研究发现-临床实验的- - - - - - - dapagliflozin - 24092010. - html 2017 - 01 - 19 t13:21:27.696z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2010/brilique ticagrelor -收到积极的观点——从欧洲- chmp治疗- - - - - - - - -急性冠状动脉综合症- 24092010. - html 2017 - 01 - 19 t13:21:14.142z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2010/results - - zibotentan - iii期临床试验——在阉割-抗前列腺癌- 27092010. - html 2017 - 01 - 19 t13:21:01.106z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2010/astrazeneca启动- - iii期临床-发展- - fostamatinib - 29092010. - html 2017 - 01 - 19 t13:18:48.115z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2010/new -结果-研究- - - - - - - ticagrelor brilinta - 01102010. - html 2017 - 01 - 19 t13:18:32.911z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2010/positive协议-收到- -审批- - vimovo -在-欧洲- 11102010. - html 2017 - 01 - 19 t13:18:18.847z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2010/european监管机构-支持-鼻喷雾疫苗fluenz - 22102010. - html 2017 - 01 - 19 t13:10:58.735z https://www.欧洲杯微信买球astrazeneca.com/media centre/press - releases/2010/astrazeneca启动- - iib期研究- 25102010. - azd9773 cytofab html 2017 - 01 - 19 t13:10:44.197z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2010/astrazeneca第三季度-和- 9月-结果- 2010 - 28102010. - html 2017 - 07 - 06 - t12:56:48.516z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2010/astrazeneca宣布- copromotion协议- 29102010. -第一核电站- - - - - html 2017 - 01 - 19 t13:10:11.073z https://www.欧洲杯微信买球astrazeneca.com/media centre/press - releases/2010/us上诉法院肯定-初步禁令-对- apotex - 02112010. - html 2017 - 01 - 19 t13:09:59.017z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2010/kombiglyze - xr -平板电脑-批准- - -我们- 05112010. - html 2017 - 01 - 19 t13:09:47.180z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2010/astrazeneca -开始-复习- -战略-选项-的-阿斯特拉-科技- 19112010. - html 2017 - 01 - 19 t13:09:04.154z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2010/us - fda顾问委员会-让-推荐- -新-药物-应用程序- vandetanib -在-高级-髓-甲状腺癌症- 02122010. - html 2017 - 01 - 19 t13:08:50.269z https://www.欧洲杯微信买球astrazeneca.com/media centre/press releases/2010/public -相信——中国和印度——设置————成为世界领袖- -创新-调查-显示- 06122010. - html 2017 - 01 - 19 t13:08:36.739z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2010/european -委员会批准brilique - 06122010. - html 2017 - 01 - 19 t13:07:01.797z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2010/astrazeneca - plc -任命新-非执行董事- 17122010. - html 2017 - 01 - 19 t13:06:40.787z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2010/astrazeneca收到信-完成-反应- - -美国食品及药物管理局的brilinta ticagrelor -平板电脑17122010. - html 2017 - 01 - 19 t13:06:27.908z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2010/astrazeneca -今年motavizumab rsv - 21122010. - html 2017 - 01 - 19 t13:06:15.632z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2010/astrazeneca结束协议-与-阿伯特certriad - 22122010. - html 2017 - 01 - 19 t13:06:00.758z https://www.欧洲杯微信买球astrazeneca.com/media-centre/press-releases/2009.html 2016 - 11 - 22 - t17:02:50.568z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2009/medimmune提交-营销-授权-应用程序- 06012009. - html 2017 - 01 - 19 t09:59:08.785z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2009/astrazeneca - plc -第四季度和全年-结果- 2008 - 29012009. - html 2017 - 07 - 06 - t12:56:48.509z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2009/astrazenecas伙伴-波曾告知-由fda - -胃——溃疡有效- 29062009. - html 2017 - 01 - 19 t10:00:03.058z https://www.欧洲杯微信买球astrazeneca.com/media centre/press releases/2009/astrazenecas -合作伙伴地图-制药宣布- 24022009. - html 2017 - 01 - 19 t10:00:15.135z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2009/astrazeneca - - -参与初步fda -心理药物-药物- 25022009. - html 2017 - 01 - 19 t10:01:00.451z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2009/astrazeneca - plc -董事会-改变- 27022009. - html 2017 - 01 - 19 t10:01:13.399z https://www.欧洲杯微信买球astrazeneca.com/media centre/press releases/2009/astrazeneca -收到fda -完成-响应-信-思瑞康- 27022009. - html 2017 - 01 - 19 t10:01:36.766z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2009/fda批准-慢性阻塞性- - symbicort pulmon - 02032009. - html 2017 - 01 - 19 t10:01:48.957z https://www.欧洲杯微信买球astrazeneca.com/media centre/press releases/2009/astrazeneca -问题- 2008年度报告- 04032009. - html 2017 - 01 - 19 t10:02:01.629z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2009/astrazeneca - - -参与初步fda -心理药理学-药物咨询委员会- 30032009. - html 2017 - 01 - 19 t10:02:16.036z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2009/onglyza saxagliptin -心血管概要文件可以接受的- 02042009. - html 2017 - 01 - 19 t10:02:45.015z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2009/david -布伦南-当选委员会主席- - -制药03042009.的html 2017 - 01 - 19 t10:02:59.290z https://www.欧洲杯微信买球astrazeneca.com/media centre/press releases/2009/astrazeneca -收到fda -完成-响应-信- symbicort - 06042009. - html 2017 - 01 - 19 t10:03:15.491z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2009/sale - -阿斯利康otc产品的组合-清除- 06042009. - html 2017 - 01 - 19 t10:03:32.899z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2009/astrazeneca -文件-适应-对- apotex - -确认-判断- 07042009. - html 2017 - 01 - 19 t10:03:45.394z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2009/fda咨询委员会-推荐-思瑞康- xr - 09042009. - html 2017 - 01 - 19 t10:03:58.044z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2009/court授予-阿斯利康临时-限制-订单- 17042009. - html 2017 - 01 - 19 t10:04:15.648z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2009/iressa -吉非替尼-推荐- - - - - - - - 23042009. - html批准 2017 - 01 - 19 t10:04:31.184z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2009/us -食品-和-药物-政府-扩展-评估-时间- 23042009. - html 2017 - 01 - 19 t10:04:44.032z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2009/astrazeneca - plc -第一季-结果- 2009 - 23042009. - html 2017 - 07 - 06 - t12:56:48.550z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2009/astrazeneca宣布-高级-线-结果-关键- 11052009. - html 2017 - 01 - 19 t10:06:12.492z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2009/court授予-阿斯利康初步禁令-再- 20052009. - html 2017 - 01 - 19 t10:06:46.170z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2009/astrazeneca监管-更新-思瑞康- xr - 29052009. - html 2017 - 01 - 19 t10:07:12.750z https://www.欧洲杯微信买球astrazeneca.com/media centre/press releases/2009/astrazeneca -和-默克公司-公司-先锋-合作- 01062009. - html形式 2017 - 01 - 19 t10:07:26.423z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2009/astrazeneca -和-艾伯特-提交-新-药物-应用程序- 04062009. - html 2017 - 01 - 19 t10:07:39.917z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2009/astrazeneca -和-艾伯特-扩展-关系- - - - - - -包括04062009. - html 2017 - 01 - 19 t10:07:52.903z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2009/favourable - - - fda顾问委员会投票-思瑞康- 10062009. - html 2017 - 01 - 19 t10:08:14.039z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2009/onglyza saxagliptin -收到积极的意见——在欧洲- 25062009. - html 2017 - 01 - 19 t10:08:30.795z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2009/astrazeneca -发展-合作伙伴-波曾-公司-提交-新-药物- 30062009. - html 2017 - 01 - 19 t10:08:57.640z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2009/iressa吉非替尼-接收营销授权- 01072009. - html 2017 - 01 - 19 t10:09:13.587z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2009/astrazeneca - -推进- azd3480 adhd - 08072009. - html 2017 - 01 - 19 t10:11:45.641z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2009/astrazeneca - -许可协议终止与地图- 09072009. - html 2017 - 01 - 19 t10:15:54.500z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2009/astrazeneca - plc -第二季度和半年- -结果- 2009 - 30072009. - html 2017 - 07 - 06 - t12:56:48.489z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2009/fda批准- onglyza治疗- - - - - - - - - - - - - - - 2型糖尿病- 01082009. - html 2017 - 01 - 19 t10:22:10.255z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2009/astrazeneca -和-阿斯特拉-输入-协议copromo - 04082009. - html 2017 - 01 - 19 t10:22:40.874z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2009/astrazeneca -和-森林实验室- -伙伴和商业化- 12082009. - html 2017 - 01 - 19 t10:23:06.594z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2009/phase - iii -头-头-试验-显示- ticagrelor -减少- 30082009. - html 2017 - 01 - 19 t10:24:27.945z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2009/astrazeneca宣布- fda -验收- -新-药物-应用程序- 31082009. - html 2017 - 01 - 19 t10:24:59.490z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2009/astrazeneca -和-内克塔签署-全球协议- -内克塔- 21092009. - html 2017 - 01 - 19 t10:25:28.092z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2009/us上诉法院肯定-总结-的-判断-决策- 25092009. - html 2017 - 01 - 19 t10:25:55.686z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2009/brilinta -减少心血管死亡- - - -心-攻击- 25092009. - html 2017 - 01 - 19 t10:26:25.712z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2009/seroquel - xr -和-思瑞康批准- -欧洲- - - - - - -预防- 29092009. - html 2017 - 01 - 19 t10:26:57.566z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2009/onglyza saxagliptin -接收营销授权- 05102009. - html 2017 - 01 - 19 t10:28:23.479z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2009/study -发现-时- onglyza saxagliptin -添加-二甲双胍- 05102009. - html 2017 - 01 - 19 t10:28:51.937z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2009/us -食物-和-药物管理局批准可定- 16102009. - html 2017 - 01 - 19 t10:31:11.524z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2009/astrazeneca提交-营销-授权-应用程序- 16102009. - html 2017 - 01 - 19 t10:40:10.549z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2009/patients -带- vimovotm -显示- - -发病率减少19102009. - html 2017 - 01 - 19 t10:42:14.780z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2009/astrazeneca撤回——管理——提交zactima - 28102009. - html 2017 - 01 - 19 t10:43:13.372z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2009/astrazeneca - plc -第三季度- 2009 - 29102009. - html 2017 - 07 - 06 - t12:56:48.517z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2009/discovery -研究-领袖让-阿斯利康- 13112009. - html 2017 - 01 - 19 t10:57:38.266z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2009/brilinta演示-更大的功效-对-氯吡格雷- 16112009. - html 2017 - 01 - 19 t10:57:58.346z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2009/results -从- 2 - ii期试验-添加-理解- 18112009. - html 2017 - 01 - 19 t10:58:19.220z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2009/astrazeneca -提交新-药物-应用程序- - brilinta - 19112009. - html 2017 - 01 - 19 t10:58:38.436z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2009/astrazeneca -和- targacept形式-全球合作和- 03122009. - html -许可证协议 2017 - 01 - 19 t10:58:57.098z https://www.欧洲杯微信买球astrazeneca.com/media centre/press releases/2009/us - fda批准-插件-思瑞康- xr - - -主要抑郁障碍的治疗- 04122009. - html 2017 - 01 - 19 t10:59:14.893z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2009/us fda批准-思瑞康- -儿科治疗- 04122009. - html 2017 - 01 - 19 t10:59:57.400z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2009/advisory委员会简报-材料-可定snd - 11122009. - html 2017 - 01 - 19 t11:00:25.010z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2009/favourable票- - fda顾问委员会-在- 15122009. - html中获益 2017 - 01 - 19 t11:00:57.050z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2009/astrazeneca - -获得感染-研究-公司- novexel - 23122009. - html 2017 - 01 - 19 t11:01:18.206z https://www.欧洲杯微信买球astrazeneca.com/media - centre/press releases/2009/medimmune回复- fda -完成-响应-信- motavizumab - 24122009. - html 2017 - 01 - 19 t11:01:44.039z https://www.欧洲杯微信买球astrazeneca.com/media-centre/articles.html 2021 - 03 - 21 - t13:51:09.721z https://www.欧洲杯微信买球astrazeneca.com/media-centre/articles/2018/dealing-with-risk-and-giving-diligence-its-due.html 2020 - 09 - 22 - t13:59:39.550z https://www.欧洲杯微信买球astrazeneca.com/media-centre/articles/2018/mitigating-partnership-risks-it-only-takes-a-minute20112018.html 2020 - 09 - 22 - t14:03:12.413z https://www.欧洲杯微信买球astrazeneca.com/media centre/articles/2018/cambridge -生命科学集群-设置-提供一个额外的-英镑- 10亿- - -英国-经济-的- 2032 - 03052018. - html 2018 - 05 - 20 - t08:05:32.365z https://www.欧洲杯微信买球astrazeneca.com/media-centre/articles/2018/survey-insights-help-deepen-our-understanding-of-patients-experience-of-anaemia-in-chronic-kidney-disease-to-address-this-critical-unmet-need04122018.html 2021 - 03 - 24 - t12:13:08.898z https://www.欧洲杯微信买球astrazeneca.com/media - centre/articles/2019/breast癌症-为什么-我们不能自满——————进步-日期- 25032019. - html 2019 - 07 - 01 - t16:14:31.160z https://www.欧洲杯微信买球astrazeneca.com/media-centre/articles/2019/lighting-the-path-to-simplified-chemical-reactions16042019.html 2019 - 04 - 23 - t08:53:11.138z https://www.欧洲杯微信买球astrazeneca.com/media - centre/articles/2019/ponente -试验-突出- - at -作为潜在的路标- -减少或消除慢性-口服皮质类固醇-使用-在-严重哮喘- 20052019. - html 2019 - 05 - 20 - t05:38:06.873z https://www.欧洲杯微信买球astrazeneca.com/media centre/articles/2019/azpride -是全球- 310519. - html 2019 - 05 - 31 - t10:48:54.003z https://www.欧洲杯微信买球astrazeneca.com/media - centre/articles/2019/the革命-试验-设计- 31052019. - html 2019 - 11 - 08 - t11:10:39.671z https://www.欧洲杯微信买球astrazeneca.com/media-centre/articles/2019/do-you-want-to-be-part-of-the-next-big-scientific-breakthrough05062019.html 2019 - 08 - 20 - t08:02:21.139z https://www.欧洲杯微信买球astrazeneca.com/media-centre/articles/2019/pascal-soriot-ranked-one-of-uks-top-ceos-by-glassdoor19062019.html 2019 - 06 - 28 - t17:01:56.450z https://www.欧洲杯微信买球astrazeneca.com/media - centre/articles/2019/leading——欧洲杯足彩冠军可持续性- 01072019. - html 2020 - 03 - 03 - t09:35:50.349z https://www.欧洲杯微信买球astrazeneca.com/media - centre/articles/2019/leading - -中国- 26082019. - html 2020 - 08 - 17 - t11:32:45.472z https://www.欧洲杯微信买球astrazeneca.com/media - centre/articles/2019/i校园-我们-新-健康-创新-中心-发射- -无锡-中国- 09092019. - html 2019 - 11 - 03 - t11:30:29.646z https://www.欧洲杯微信买球astrazeneca.com/media-centre/articles/2019/demonstrating-healthcare-iot-leadership-in-china10092019.html 2019 - 11 - 03 - t11:33:12.605z https://www.欧洲杯微信买球astrazeneca.com/media-centre/articles/2019/addressing-the-burden-of-asthma-attacks-in-asthma-patients18092019.html 2019 - 11 - 29 - t15:57:50.070z https://www.欧洲杯微信买球astrazeneca.com/media - centre/articles/2019/astrazeneca继续- - -认可的可持续性和-重申其承诺-透明- 1809欧洲杯足彩冠军2019. - html 2020 - 03 - 03 - t09:35:50.352z https://www.欧洲杯微信买球astrazeneca.com/media - centre/articles/2019/astrazeneca认可——制药公司-前交易撮合者- 20082019. - html 2019 - 09 - 20 - t10:52:55.493z https://www.欧洲杯微信买球astrazeneca.com/media centre/articles/2019/seeking -改进-保健-人- -严重哮喘患者- 03102019. - html 2020 - 03 - 03 - t12:14:31.180z https://www.欧洲杯微信买球astrazeneca.com/media-centre/articles/2019/supporting-adolescent-health-around-the-world.html 2021 - 06 - 08 - t15:21:21.903z https://www.欧洲杯微信买球astrazeneca.com/media-centre/articles/2019/q-a-with-sir-mene-pangalos.html 2019 - 12 - 27 - t22:51:06.351z https://www.欧洲杯微信买球astrazeneca.com/media centre/articles/2019/creating通过-生产-合作-谈判-价值- 08072019. - html 2020 - 09 - 22 - t15:47:12.562z https://www.欧洲杯微信买球astrazeneca.com/media-centre/articles/2019/data-science-taking-centre-stage-in-cancer-combination-predictions.html 2020 - 09 - 22 - t12:55:28.863z https://www.欧洲杯微信买球astrazeneca.com/media-centre/articles/2019/contract-considerations-for-resolving-partnership-disputes15042019.html 2020 - 09 - 22 - t14:04:46.604z https://www.欧洲杯微信买球astrazeneca.com/media-centre/articles/2019/dispute-resolution-settling-differences-collaboratively.html 2020 - 09 - 22 - t14:04:03.588z https://www.欧洲杯微信买球astrazeneca.com/media-centre/articles/2019/riding-the-wave-of-chinese-research-innovation.html 2020 - 09 - 22 - t13:57:09.123z https://www.欧洲杯微信买球astrazeneca.com/media-centre/articles/2020/future-focused-rd-capabilities-pushing-the-boundaries-of-science.html 2020 - 09 - 23 - t18:51:45.864z https://www.欧洲杯微信买球astrazeneca.com/media-centre/articles/2020/surpassing-survival-expectations-in-oncology-as-we-match-patients-to-the-right-treatment.html 2020 - 10 - 29 - t15:48:02.895z https://www.欧洲杯微信买球astrazeneca.com/media-centre/articles/2020/ambition-zero-carbon-progress-accelerated-delivery-of-our-renewable-energy-sourcing-targets.html 2021 - 06 - 08 - t10:32:02.737z https://www.欧洲杯微信买球astrazeneca.com/media-centre/articles/2020/mapping-the-economic-burden-of-systemic-lupus-erythematosus.html 2020 - 09 - 21 - t19:55:08.037z https://www.欧洲杯微信买球astrazeneca.com/media-centre/articles/2020/collaborative-research-to-advance-innovation-in-oncology.html 2020 - 09 - 22 - t12:54:04.612z https://www.欧洲杯微信买球astrazeneca.com/media-centre/articles/2020/why-health-system-resilience-is-key-to-a-sustainable-future.html 2020 - 11 - 09 - t12:17:30.059z https://www.欧洲杯微信买球astrazeneca.com/media-centre/articles/2020/how-will-covid-impact-youth-around-the-world-long-term.html 2021 - 06 - 08 - t15:20:26.334z https://www.欧洲杯微信买球astrazeneca.com/media-centre/articles/2020/ocs-in-severe-asthma-care-time-to-end-over-reliance.html 2021 - 06 - 11 - t15:42:28.287z https://www.欧洲杯微信买球astrazeneca.com/media-centre/articles/2020/exploiting-the-dna-damage-response-ddr-to-transform-the-treatment-paradigm.html 2020 - 05 - 29 - t18:09:38.114z https://www.欧洲杯微信买球astrazeneca.com/media-centre/articles/2020/beyond-june-pride-is-a-year-round-event.html 2020 - 06 - 10 - t19:56:01.353z https://www.欧洲杯微信买球astrazeneca.com/media-centre/articles/2020/transforming-treatment-together-for-her2-targetable-cancers.html 2020 - 06 - 01 - t09:54:27.397z https://www.欧洲杯微信买球astrazeneca.com/media-centre/articles/2020/ceo-pascal-soriot-addresses-ongoing-racial-injustice.html 2020 - 06 - 03 - t21:45:21.158z https://www.欧洲杯微信买球astrazeneca.com/media-centre/articles/2020/covid-19-frequently-asked-questions.html 2020 - 09 - 03 - t14:37:14.870z https://www.欧洲杯微信买球astrazeneca.com/media centre/articles/2020/investigating -一个现有cvrm -医学作为- - -潜在治疗covid - 19. - html 2020 - 11 - 22 - t23:10:36.221z https://www.欧洲杯微信买球astrazeneca.com/media-centre/articles/2020/astrazeneca-and-oxford-university-announce-landmark-agreement-for-covid-19-vaccine.html 2020 - 11 - 22 - t23:10:05.263z https://www.欧洲杯微信买球astrazeneca.com/media-centre/articles/2020/investing-in-a-sustainable-future-for-patients-with-respiratory-disease.html 2020 - 10 - 29 - t12:25:28.108z https://www.欧洲杯微信买球astrazeneca.com/media centre/articles/2020/ambition - 0 -碳- 22012020. - html 2020 - 02 - 12 - t10:31:52.700z https://www.欧洲杯微信买球astrazeneca.com/media-centre/articles/2020/az-one-of-only-three-companies-to-achieve-double-a-listing-for-both-climate-change-and-water-security-for-the-fourth-year-running-by-cdp.html 2020 - 02 - 12 - t10:32:21.892z https://www.欧洲杯微信买球astrazeneca.com/media-centre/articles/2020/az-forest-kicks-off-with-planting-of-first-trees-in-australia.html 2020 - 12 - 16 - t10:38:15.765z https://www.欧洲杯微信买球astrazeneca.com/media-centre/articles/2020/astrazeneca-singapore-establish-strategic-partnerships-to-improve-health-through-innovation.html 2020 - 02年- 13 - t06:37:43.856z https://www.欧洲杯微信买球astrazeneca.com/media-centre/articles/2020/lvng-with-lung-cancer.html 2020 - 10 - 29 - t12:23:58.849z https://www.欧洲杯微信买球astrazeneca.com/media centre/articles/2020/our -更新- - covid 19. - html 2020 - 10 - 29 - t12:22:20.946z https://www.欧洲杯微信买球astrazeneca.com/media-centre/articles/2020/covid-19-information-hub.html 2020 - 11 - 06 - t07:50:47.536z https://www.欧洲杯微信买球astrazeneca.com/media - centre/articles/2020/researching抗体- -目标- covid - 19. - html 2020 - 11 - 22 - t23:08:03.715z https://www.欧洲杯微信买球astrazeneca.com/media centre/articles/2020/investigating -一个现有医学- -一个潜在的治疗- 19. - covid html 2020 - 11 - 22 - t23:07:29.961z https://www.欧洲杯微信买球astrazeneca.com/media-centre/articles/2020/water-stewardship-to-be-focus-of-new-wwf-sweden-partnership.html 2020 - 04 - 22 - t08:36:09.265z https://www.欧洲杯微信买球astrazeneca.com/media-centre/articles/2020/astrazeneca-joins-uk-governments-accord-trial-platform.html 2020 - 11 - 22 - t23:06:56.812z https://www.欧洲杯微信买球astrazeneca.com/media-centre/articles/2020/exploring-the-role-of-eosinophils.html 2021 - 04 - 30 - t13:50:43.994z https://www.欧洲杯微信买球astrazeneca.com/media centre/articles/2020/addressing - -脆弱的人- -心血管疾病和并发症- covid - 19. - html 2020 - 11 - 22 - t23:05:59.325z https://www.欧洲杯微信买球astrazeneca.com/media-centre/articles/2020/astrazeneca-advances-response-to-global-covid-19-challenge-as-it-receives-first-commitments-for-oxfords-potential-new-vaccine.html 2020 - 11 - 22 - t23:05:26.785z https://www.欧洲杯微信买球astrazeneca.com/media centre/articles/2020/planning - - -可持续未来covid后19. - html 2021 - 02 - 10 - t17:14:05.543z https://www.欧洲杯微信买球astrazeneca.com/media centre/articles/2020/advancing -我们-发现- -小说-冠状病毒中和抗体-对- covid - 19. - html 2020 - 11 - 22 - t23:04:32.988z https://www.欧洲杯微信买球astrazeneca.com/media centre/articles/2020/astrazeneca - -欧洲-提供- - - 4亿- - -牛津-大学-潜在的剂量covid vaccine.html——19 2020 - 11 - 22 - t23:03:24.117z https://www.欧洲杯微信买球astrazeneca.com/media-centre/articles/2020/astrazeneca-takes-next-steps-towards-broad-and-equitable-access-to-oxford-universitys-potential-covid-19-vaccine.html 2020 - 11 - 22 - t23:02:57.867z https://www.欧洲杯微信买球astrazeneca.com/media-centre/articles/2020/exacerbations-and-mortality-in-chronic-obstructive-pulmonary-disease.html 2020 - 10 - 29 - t12:18:11.917z https://www.欧洲杯微信买球astrazeneca.com/media-centre/articles/2020/bridging-the-gap-in-heart-failure-awareness.html 2020 - 07 - 08 - t21:23:39.693z https://www.欧洲杯微信买球astrazeneca.com/media-centre/articles/2020/acute-myocardial-infarction-managing-a-life-changing-event-and-additional-risks.html 2020 - 10 - 29 - t12:17:25.234z https://www.欧洲杯微信买球astrazeneca.com/media-centre/articles/2020/new-research-project-between-astrazeneca-and-cambridge-institute-for-欧洲杯足彩冠军sustainability-leadership.html 2020 - 07 - 28 - t09:14:11.791z https://www.欧洲杯微信买球astrazeneca.com/media-centre/articles/2020/astrazeneca-leverages-digital-health-to-improve-continuum-of-care-for-people-with-heart-failure.html 2020 - 10 - 29 - t12:16:48.047z https://www.欧洲杯微信买球astrazeneca.com/media-centre/articles/2020/how-the-covid-19-pandemic-is-changing-the-shape-of-cancer-clinical-trials.html 2020 - 11 - 22 - t23:01:19.386z https://www.欧洲杯微信买球astrazeneca.com/media-centre/articles/2020/breaking-the-cycle-of-over-reliance-on-saba-inhalers-for-asthma-treatment.html 2020 - 09 - 30 - t09:12:48.346z https://www.欧洲杯微信买球astrazeneca.com/media-centre/articles/2020/a-new-tool-to-tackle-saba-over-reliance-in-asthma-management.html 2020 - 10 - 29 - t12:29:22.512z https://www.欧洲杯微信买球astrazeneca.com/media-centre/articles/2020/putting-a-global-spotlight-on-heart-failure.html 2020 - 08 - 20 - t09:27:30.957z https://www.欧洲杯微信买球astrazeneca.com/media-centre/articles/2020/putting-quality-of-life-into-focus-for-cardiovascular-disease.html 2020 - 10 - 29 - t12:15:33.196z https://www.欧洲杯微信买球astrazeneca.com/media-centre/articles/2020/mitigating-the-risk-of-pharmaceuticals-in-the-environment.html 2020 - 09 - 01 - t06:27:56.086z https://www.欧洲杯微信买球astrazeneca.com/media-centre/articles/2020/university-of-oxford-potential-covid-19-vaccine-phase-iii-clinical-trial-initiated-in-the-us.html 2020 - 11 - 22 - t23:00:47.284z https://www.欧洲杯微信买球astrazeneca.com/media-centre/articles/2020/no-time-to-wait-for-stroke-prevention.html 2020 - 11 - 11 - t10:25:30.141z https://www.欧洲杯微信买球astrazeneca.com/media-centre/articles/2020/advancing-treatment-strategies-for-patients-with-acute-heart-failure.html 2021 - 06 - 11 - t15:45:13.363z https://www.欧洲杯微信买球astrazeneca.com/media-centre/articles/2020/the-importance-of-stem-and-how-we-are-influencing-the-next-generation.html 2020 - 11 - 30 - t18:38:48.792z https://www.欧洲杯微信买球astrazeneca.com/media-centre/articles/2020/astrazeneca-recognised-with-top-5-ranking-in-the-dow-jones-欧洲杯足彩冠军sustainability-indices.html 2020 - 11 - 16 - t14:02:11.894z https://www.欧洲杯微信买球astrazeneca.com/media-centre/articles/2020/covid-19-vaccine-azd1222-is-better-tolerated-in-older-adults-than-younger-adults-with-similar-immune-responses-across-all-age-groups.html 2020 - 11 - 22 - t22:59:51.578z https://www.欧洲杯微信买球astrazeneca.com/media-centre/articles/2020/building-an-inclusive-diverse-culture-is-a-never-ending-journey.html 2020 - 11 - 19 - t15:22:37.609z https://www.欧洲杯微信买球astrazeneca.com/media-centre/articles/2020/inclusion-and-diversity-what-can-we-learn-from-our-own-cells.html 2020 - 11 - 30 - t20:03:01.463z https://www.欧洲杯微信买球astrazeneca.com/media-centre/articles/2020/astrazeneca-named-company-of-the-year-by-scrip.html 2020 - 12 - 02 - t22:16:56.588z https://www.欧洲杯微信买球astrazeneca.com/media-centre/articles/2020/transforming-the-breast-cancer-patient-experience-requires-a-collective-collaborative-approach.html 2020 - 12 - 10 - t14:02:34.346z https://www.欧洲杯微信买球astrazeneca.com/media-centre/articles/2020/gold-standard-recognition-for-global-climate-and-water-stewardship.html 2020 - 12 - 08 - t11:18:16.703z https://www.欧洲杯微信买球astrazeneca.com/media-centre/articles/2020/developing-versatile-immunisation-programmes-against-covid-19-through-potential-vaccine-combinations.html 2020 - 12 - 11 - t09:33:54.894z https://www.欧洲杯微信买球astrazeneca.com/media - centre/articles/2020/az森林树木-印尼- 2000万-被- 2025. - html -种植 2021 - 06 - 08 - t15:18:06.371z https://www.欧洲杯微信买球astrazeneca.com/media-centre/articles/2020/update-on-application-for-conditional-marketing-authorisation-for-the-astrazeneca-covid-19-vaccine-to-the-european-medicines-agency.html 2021 - 04 - 15 - t14:57:32.033z https://www.欧洲杯微信买球astrazeneca.com/media-centre/articles/2021/vaccinating-the-world.html 2021 - 06 - 11 - t14:34:03.515z https://www.欧洲杯微信买球astrazeneca.com/media-centre/articles/2021/recognition-for-our-commitment-to-access-to-healthcare-and-support-for-sustainable-health-systems.html 2021 - 01 - 26 t12:16:03.809z https://www.欧洲杯微信买球astrazeneca.com/media-centre/articles/2021/astrazenecas-covid-19-vaccine-european-union-supply-commitment.html 2021 - 04 - 15 - t14:58:44.739z https://www.欧洲杯微信买球astrazeneca.com/media-centre/articles/2021/2021-Access-to-Medicine-Index-highlighting-our-progress-in-advancing-access-to-healthcare.html 2021 - 02 - 01 - t11:14:22.900z https://www.欧洲杯微信买球astrazeneca.com/media-centre/articles/2021/covid-19-vaccine-astrazeneca-receives-interim-recommendations-for-use-by-world-health-organization-experts.html 2021 - 02 - 11 - t14:54:56.057z https://www.欧洲杯微信买球astrazeneca.com/media-centre/articles/2021/covid-19-vaccine-astrazeneca-receives-provisional-approval-for-use-in-australia.html 2021 - 02 - 16 - t15:21:51.187z https://www.欧洲杯微信买球astrazeneca.com/media centre/articles/2021/first -的-世界-研究- covid - 19 -疫苗-阿斯利康-显示- 94 -在hospitalisations.html减少 2021 - 03 - 21 - t13:30:16.300z https://www.欧洲杯微信买球astrazeneca.com/media-centre/articles/2021/transforming-care-in-severe-asthma-our-job-is-not-yet-done.html 2021 - 06 - 11 - t15:39:31.837z https://www.欧洲杯微信买球astrazeneca.com/media-centre/articles/2021/earlier-diagnosis-and-intervention-is-needed-in-chronic-kidney-disease.html 2021 - 03 - 21 - t13:34:51.237z https://www.欧洲杯微信买球astrazeneca.com/media-centre/articles/2021/update-on-eu-supply-of-covid-19-vaccine-astrazeneca.html 2021 - 04 - 15 - t14:59:02.063z https://www.欧洲杯微信买球astrazeneca.com/media-centre/articles/2021/prime-minister-boris-johnson-celebrates-astrazenecas-investment-in-advanced-medicines-manufacturing-during-macclesfield-campus-visit.html 2021 - 04 - 06 - t14:21:10.329z https://www.欧洲杯微信买球astrazeneca.com/media-centre/articles/2021/update-following-mhra-and-ema-decisions-on-astrazenecas-covid-19-vaccine.html 2021 - 04 - 15 - t14:59:17.619z https://www.欧洲杯微信买球astrazeneca.com/media - centre/articles/2021/significant里程碑达到- - 100国家接受疫苗covax.html——通过 2021 - 04 - 08 - t17:21:58.221z https://www.欧洲杯微信买球astrazeneca.com/media-centre/articles/2021/unity-is-delivering-for-the-world.html 2021 - 04 - 21 - t14:39:53.745z https://www.欧洲杯微信买球astrazeneca.com/media-centre/articles/2021/putting-patient-perspectives-into-action-to-address-the-global-burden-of-chronic-kidney-disease.html 2021 - 04 - 23 - t10:35:49.426z https://www.欧洲杯微信买球astrazeneca.com/media-centre/articles/2021/az-joined-united-nations-global-compact-sustainable-infrastructure-action-platform.html 2021 - 04 - 23 - t13:40:13.853z https://www.欧洲杯微信买球astrazeneca.com/media-centre/articles/2021/ema-reaffirm-that-the-overall-benefits-of-az-covid-19-vaccine-continues-to-outweigh-risks.html 2021 - 04 - 29 - t08:47:12.031z https://www.欧洲杯微信买球astrazeneca.com/media-centre/articles/2021/astrazeneca---slush-to-generate-new-opportunities-for-developing.html 2021 - 05 - 06 - t09:21:18.828z https://www.欧洲杯微信买球astrazeneca.com/media-centre/articles/2021/global-lupus-advocates-call-for-new-era.html 2021 - 06 - 11 - t15:47:50.883z https://www.欧洲杯微信买球astrazeneca.com/media-centre/articles/2021/statement-on-astrazenecas-continued-support-for-the-people-of-india.html 2021 - 06 - 08 - t15:44:17.115z https://www.欧洲杯微信买球astrazeneca.com/media-centre/articles/2021/infants-need-protection-against-rsv-charting-a-path-beyond-covid.html 2021 - 05 - 13 - t16:20:16.154z https://www.欧洲杯微信买球astrazeneca.com/media - centre/articles/2021/protecting癌症-服务-从-影响- - - - - - - covid - 19. - html 2021 - 06 - 11 - t15:46:59.661z https://www.欧洲杯微信买球astrazeneca.com/media-centre/articles/2021/Ensuring-environmental-safety-of-medicines.html 2021 - 06 - 04 - t11:51:28.974z https://www.欧洲杯微信买球astrazeneca.com/media-centre/articles/2021/step-up-global-grants-programme-opens-for-applications.html 2021 - 06 - 09 - t08:17:12.396z https://www.欧洲杯微信买球astrazeneca.com/media-centre/articles/2021/astrazeneca-joins-g7-leaders-summit-calling-for-urgent-action-on-climate-crisis.html 2021 - 06 - 11 - t18:17:00.090z https://www.欧洲杯微信买球astrazeneca.com/media-centre/articles/2021/8-az-uk-employees-recognised-in-the-queens-birthday-honours.html 2021 - 06 - 14 - t08:25:20.698z https://www.欧洲杯微信买球astrazeneca.com/media-centre/statements.html 2021 - 04 - 21 - t10:35:50.957z https://www.欧洲杯微信买球astrazeneca.com/media-centre/statements/2021/statement-on-eu-legal-action.html 2021 - 04 - 26 - t12:22:58.375z https://www.欧洲杯微信买球astrazeneca.com/media-centre/medical-releases.html 2021 - 04 - 21 - t10:18:32.566z https://www.欧洲杯微信买球astrazeneca.com/media - centre/medical releases/arthritis和风湿病学-发布积极的-相- ii -数据-在- anifrolumab狼疮- 14112016. - html 2019 - 07 - 09 - t09:53:30.169z https://www.欧洲杯微信买球astrazeneca.com/media-centre/medical-releases/durvalumab-monotherapy-demonstrates-efficacy-in-urothelial-bladder-cancer.html 2019 - 07 - 09 - t09:57:12.701z https://www.欧洲杯微信买球astrazeneca.com/media - centre/medical releases/astrazenecas组合-的- durvalumab tremelimumab -显示-临床-活动- -非小细胞肺癌症-不管- pd - l1 -状态-癌症- 0120160. - html 2019 - 07 - 10 - t09:17:07.216z https://www.欧洲杯微信买球astrazeneca.com/media - centre/medical releases/durvalumab -显示-承诺-初步数据-在早期肺- -头部和颈部癌症- 10102016. - html 2019 - 07 - 17 - t13:48:06.228z https://www.欧洲杯微信买球astrazeneca.com/media-centre/medical-releases/euclid-trial-results-for-brilinta-brilique-presented-at-the-american.html 2019 - 07 - 09 - t10:17:47.232z https://www.欧洲杯微信买球astrazeneca.com/media - centre/medical releases/early -数据-演示临床-活动- - acalabrutinib的困难- -治疗慢性淋巴细胞白血病- 05122016. - html 2019 - 07 - 09 - t10:19:47.229z https://www.欧洲杯微信买球astrazeneca.com/media - centre/medical releases/astrazeneca -支持-的-出版物- - - 2017黄金-战略-改善copd诊断- - -管理- - - -预防- 09122016. - html 2019 - 07 - 09 - t10:21:29.315z https://www.欧洲杯微信买球astrazeneca.com/media - centre/medical releases/us fda批准- symbicort布地奈德- formoterol治疗- - - - - - - - - -在儿科哮喘患者- 300120170. - html 2019 - 07 - 09 - t10:40:02.530z https://www.欧洲杯微信买球astrazeneca.com/media centre/medical - releases/lynparza olaparib -维护-处理-提供- - -的生活质量与持续改善——发展——自由——生存——女性——brca突变-卵巢癌症- 02072017. - html 2019 - 07 - 09 - t10:42:04.001z https://www.欧洲杯微信买球astrazeneca.com/media - centre/medical releases/astrazeneca礼物- tagrisso osimertinib -数据-在病人与表皮生长因子受体- t790m突变-正-肺癌症-和-中央神经系统-转移- 06062017. - html 2019 - 07 - 09 - t10:43:40.689z https://www.欧洲杯微信买球astrazeneca.com/media - centre/medical releases/new -数据-支持-长期功效- - ticagrelor的病人- - 5年-后- -心-攻击- 06092017. - html 2021 - 02年- 13 - t10:52:55.924z https://www.欧洲杯微信买球astrazeneca.com/media-centre/medical-releases/astrazeneca-presents-new-evidence-on-symbicort-budesonide-formoterol-in-copd-patients-at-risk-of-exacerbation.html 2019 - 07 - 09 - t11:03:21.354z https://www.欧洲杯微信买球astrazeneca.com/media centre/medical releases/forxiga -描述1 -试验-显示-改善血糖控制-不增加低血糖- 14092017. - html 2019 - 07 - 09 - t11:04:48.807z https://www.欧洲杯微信买球astrazeneca.com/media - centre/medical releases/astrazeneca -和- chi -药物- savolitinib -显示-鼓励临床-活动- 2号线- egfr突变-积极-肺癌症- - -放大- 171017. - html 2019 - 07 - 09 - t11:06:27.768z https://www.欧洲杯微信买球astrazeneca.com/media - centre/medical releases/zs - 9 -钠-锆环硅酸盐-相- iii -长期-安全-和-疗效数据呈现在asn -肾周- 201702112017. - html 2019 - 07 - 09 - t11:07:55.531z https://www.欧洲杯微信买球astrazeneca.com/media - centre/medical releases/faslodex fulvestrant -接收-欧盟-审批- - - - - - - -治疗的激素-受体阳性-高级-乳腺癌癌症- -组合与palbociclib - 14112017. - html 2019 - 07 - 09 - t11:09:48.780z https://www.欧洲杯微信买球astrazeneca.com/media - centre/medical releases/new -数据-显示- - - tagrisso的病人受益与- egfr突变-非小细胞肺癌症-和-中央神经系统-转移- 20112017. - html 2019 - 07 - 09 - t11:12:40.117z https://www.欧洲杯微信买球astrazeneca.com/media - centre/medical releases/new英格兰医学杂志-的-发布结果- - - iii - flaura阶段试验- - - 1号线-治疗- egfr突变-非小细胞肺-癌症- 20112017. - html 2019 - 07 - 09 - t11:14:20.314z https://www.欧洲杯微信买球astrazeneca.com/media-centre/medical-releases/risk-of-repeat-heart-attack-twice-as-likely-from-occlusions-in-arteries-that-did-not-cause-initial-event.html 2019 - 07 - 09 - t11:15:54.421z https://www.欧洲杯微信买球astrazeneca.com/media - centre/medical releases/astrazeneca注册入读-新-第一个病人brilinta - ticagrelor中风-试验- 23012018. - html 2019 - 12 - 13 - t12:09:32.572z https://www.欧洲杯微信买球astrazeneca.com/media-centre/medical-releases/brilinta-meets-primary-endpoint-in-phase-iii-thrombolysis-trial.html 2019 - 07 - 09 - t12:37:06.473z https://www.欧洲杯微信买球astrazeneca.com/media - centre/medical releases/brilinta ticagrelor——减少相关的————————————心血管事件的风险——-对-氯吡格雷- -心-攻击-幸存者- -中度肾疾病- 090418. - html 2019 - 07 - 09 - t12:39:04.163z https://www.欧洲杯微信买球astrazeneca.com/media - centre/medical releases/astrazeneca礼物- imfinzi durvalumab - + - tremelimumab组合-数据- - aacr -年度会议上- 170418. - html 2019 - 07 - 09 - t12:40:46.206z https://www.欧洲杯微信买球astrazeneca.com/media - centre/medical releases/astrazeneca -和-美-呈现-相- ii -数据-在ada - 2018 - medi0382展示重要-改进-血糖控制-和-重量损失——患者————- 2 diabetes.html类型 2019 - 07 - 09 - t12:42:02.062z https://www.欧洲杯微信买球astrazeneca.com/media-centre/medical-releases/farxiga-in-combination-with-onglyza-demonstrates-similar-glycaemic-control-with-additional-benefits-vs-insulin-glargine-in-patients-with-type-2-diabetes25062018.html 2019 - 07 - 09 - t12:43:35.998z https://www.欧洲杯微信买球astrazeneca.com/media-centre/medical-releases/astrazeneca-expands-heart-failure-research-with-new-phase-iii-deliver-trial-of-forxiga-in-patients-with-and-without-type-2-diabetes23082018.html 2019 - 07 - 09 - t12:55:31.792z https://www.欧洲杯微信买球astrazeneca.com/media - centre/medical releases/new -数据-从现实世界-证据表明需要- -更好的二级预防,减少长期-缺血性风险- - - - - - -心-攻击-幸存者- 29082018. - html 2019 - 07 - 09 - t12:56:58.318z https://www.欧洲杯微信买球astrazeneca.com/media - centre/medical releases/european呼吸-期刊出版阶段- iii -终极审判——pt009 -双-组合疗法- -温和的很严重-慢性阻塞性肺疾病- 16092018. html 2019 - 07 - 09 - t14:11:02.286z https://www.欧洲杯微信买球astrazeneca.com/media centre/medical - releases/first患者-注册- - -希望-波南脱风期试验-评估-的-消除口服皮质类固醇- - fasenra在严重哮喘- 18092018. - html——嗜酸性 2019 - 07 - 09 - t14:12:19.948z https://www.欧洲杯微信买球astrazeneca.com/media-centre/medical-releases/new-pegasus-timi-54-sub-analyses-provide-direction-on-selecting-patients-most-likely-to-benefit-from-long-term-treatment-with-brilinta-ticagrelor.html 2019 - 07 - 09 - t14:13:53.753z https://www.欧洲杯微信买球astrazeneca.com/media - centre/medical releases/imfinzi演示-临床-活动- - - - - - -阶段- iv - 1号线-非小细胞肺——癌症-相- iii -神秘-试验- 13122018. - html 2019 - 07 - 09 - t14:15:55.190z https://www.欧洲杯微信买球astrazeneca.com/media-centre/medical-releases/phase-iii-treat-trial-provides-evidence-on-the-use-of-brilinta-in-high-risk-patients-treated-with-pharmacological-thrombolysis18032019.html 2019 - 07 - 09 - t14:17:21.027z https://www.欧洲杯微信买球astrazeneca.com/media-centre/medical-releases/astrazeneca-supports-new-global-recommendations-on-asthma-care12042019.html 2019 - 07 - 09 - t14:18:46.398z https://www.欧洲杯微信买球astrazeneca.com/media-centre/medical-releases/phase-iii-combination-trial-of-bydureon-and-forxiga-shows-signif.html 2019 - 07 - 09 - t14:20:12.454z https://www.欧洲杯微信买球astrazeneca.com/media-centre/medical-releases/socrates-trial-results-for-brilinta-brilique-presented-at-europe.html 2019 - 07 - 09 - t14:21:28.396z https://www.欧洲杯微信买球astrazeneca.com/media-centre/medical-releases/astrazeneca-announces-two-new-phase-iiib-trials-for-forxiga-in-c.html 2019 - 07 - 09 - t14:22:50.646z https://www.欧洲杯微信买球astrazeneca.com/media-centre/medical-releases/astrazeneca-receives-approval-in-the-eu-for-qtern--saxagliptin-a.html 2019 - 07 - 09 - t14:23:51.378z https://www.欧洲杯微信买球astrazeneca.com/media-centre/medical-releases/positive-chmp-opinion-in-eu-for-saxa-dapa--saxagliptin-and-dapag.html 2019 - 07 - 09 - t14:26:24.299z https://www.欧洲杯微信买球astrazeneca.com/media-centre/medical-releases/acalabrutinib-recommended-for-orphan-drug-designation-in-Europe-for-three-indications.html 2019 - 07 - 09 - t14:28:19.623z https://www.欧洲杯微信买球astrazeneca.com/media-centre/medical-releases/Tagrisso-osimertinib-shows-clinical-activity-in-patients-with-leptomeningeal-disease-from-lung-cancer.html 2019 - 07 - 09 - t14:29:44.761z https://www.欧洲杯微信买球astrazeneca.com/media-centre/medical-releases/AstraZeneca-presents-further-evidence-for-the-potential-of-AZD9291-in-first-line-and-pre-treated-non-small-cell-lung-cancer.html 2019 - 07 - 09 - t14:31:27.849z https://www.欧洲杯微信买球astrazeneca.com/media - centre/medical releases/astrazeneca礼物- - -肿瘤学研究进展在ecc - 2015 -数据- azd9291 durvalumab -和- lynparza olaparib.html 2019 - 07 - 09 - t14:32:39.947z https://www.欧洲杯微信买球astrazeneca.com/media - centre/medical releases/astrazeneca礼物-积极tagrisso osimertinib -跟随- -数据-在-肺癌症- -得- 2016. - html 2019 - 07 - 09 - t14:34:09.790z https://www.欧洲杯微信买球astrazeneca.com/media-centre/medical-releases/Lynparza-olaparib-latest-data-suggest-potential-overall-survival-advantage-in-patients-with-platinum-sensitive-ovarian-cancer.html 2019 - 07 - 09 - t14:36:05.565z https://www.欧洲杯微信买球astrazeneca.com/media - centre/medical releases/astrazeneca - -现在- anifrolumab狼疮-数据- -年度欧洲国会- -风湿病的欧拉- 2016. - html 2019 - 07 - 09 - t14:37:23.200z https://www.欧洲杯微信买球astrazeneca.com/media-centre/medical-releases/farxiga-heart-failure-research-broadened-with-new-phase-iii-determine-trials.html 2019 - 07 - 09 - t14:42:59.337z https://www.欧洲杯微信买球astrazeneca.com/media-centre/medical-releases/astrazeneca-announces-two-lancet-oncology-publications-of-phase-i-dose-expansion-results-of-trastuzumab-deruxtecan-in-her2-positive-metastatic-breast-and-gastric-cancer.html 2019 - 07 - 09 - t14:46:09.365z https://www.欧洲杯微信买球astrazeneca.com/media-centre/medical-releases/astrazeneca-enters-strategic-collaboration-with-transgene-to-develop-innovative-oncolytic-virus-immunotherapies30042019.html 2019 - 07 - 09 - t14:47:16.717z https://www.欧洲杯微信买球astrazeneca.com/media-centre/medical-releases/fasenra-reduces-oral-corticosteroid-use-and-maintains-long-term-efficacy-and-safety-profile-in-severe-eosinophilic-asthma.html 2019 - 07 - 09 - t14:48:29.260z https://www.欧洲杯微信买球astrazeneca.com/media-centre/medical-releases/farxiga-study-showed-reduced-progression-of-kidney-disease-or-renal-death-in-patients-with-type-2-diabetes10062019.html 2019 - 07 - 09 - t14:49:39.032z https://www.欧洲杯微信买球astrazeneca.com/media-centre/medical-releases/archive.html 2021 - 03 - 21 - t13:50:47.405z https://www.欧洲杯微信买球astrazeneca.com/media - centre/medical releases/positive -结果——从两个roxadustat - - iii期临床试验——在中国- - -治疗的贫血-发表——————新英格兰医学杂志-的- 24072019. - html 2019 - 07 - 24 - t21:23:41.234z https://www.欧洲杯微信买球astrazeneca.com/media - centre/medical releases/new -数据-显示- symbicort -使用- - -反-炎症-释放-的-轻-中度哮喘- -更多-有效防止-严重哮喘-攻击- 27082019. - html 2019 - 09 - 02 - t16:13:54.082z https://www.欧洲杯微信买球astrazeneca.com/media - centre/medical releases/forxiga -减少- -风险- - -复合- -心血管死亡或住院- -心-失败-在- 2型糖尿病病人——————————和——不——肾脏疾病- 31082019. - html 2019 - 08 - 31 - t15:09:47.751z https://www.欧洲杯微信买球astrazeneca.com/media-centre/medical-releases/new-analysis-of-fasenra-phase-iii-galathea-and-terranova-copd-trials-identifies-factors-associated-with-exacerbation-rate-reductions.html 2019 - 09 - 29 - t07:16:31.931z https://www.欧洲杯微信买球astrazeneca.com/media-centre/medical-releases/brilinta-monotherapy-in-high-bleeding-risk-patients-who-underwent-pci-had-reduced-risk-of-clinically-relevant-bleeding-than-with-dual-antiplatelet-therapy-in-the-twilight-trial.html 2019 - 09 - 26 - t17:56:45.535z https://www.欧洲杯微信买球astrazeneca.com/media-centre/medical-releases/new-data-from-the-phase-iii-dapa-hf-trial-showed-farxiga-dapagliflozin-reduced-the-worsening-of-heart-failure-or-cv-death-in-hfref-patients-with-and-without-ckd.html 2019 - 11 - 11 - t16:20:39.725z https://www.欧洲杯微信买球astrazeneca.com/media-centre/medical-releases/subgroup-analysis-of-twilight-trial-patients-with-nste-acs.html 2019 - 11 - 17 - t21:38:11.371z https://www.欧洲杯微信买球astrazeneca.com/media-centre/medical-releases/consistent-effects-of-farxiga-in-heart-failure-patients-with-reduced-ejection-fraction-shown-in-new-analyses-from-landmark-phase-iii-dapa-hf-trial.html 2019 - 11 - 18 - t16:10:51.212z https://www.欧洲杯微信买球astrazeneca.com/media-centre/medical-releases/three-clinical-trials-announced-for-fasenra-in-eosinophil-driven-skin-diseases.html 2020 - 01 - 17 t06:50:26.734z https://www.欧洲杯微信买球astrazeneca.com/media-centre/medical-releases/lokelma-us-label-updated-to-include-dosing-guidance-for-the-treatment-of-hyperkalaemia-in-patients-with-end-stage-renal-disease-on-haemodialysis.html 2020 - 04 - 26 - t11:24:58.673z https://www.欧洲杯微信买球astrazeneca.com/media-centre/medical-releases/lokelma-label-update-approved-in-eu-for-patients-with-hyperkalaemia-on-stable-haemodialysis.html 2020 - 05 - 01 - t16:00:45.827z https://www.欧洲杯微信买球astrazeneca.com/media-centre/medical-releases/anifrolumab-showed-early-and-sustained-treatment-benefit-for-patients-with-systemic-lupus-erythematosus-in-the-tulip-clinical-trial-programme.html 2020 - 06 - 03 - t13:08:20.953z https://www.欧洲杯微信买球astrazeneca.com/media-centre/medical-releases/astrazeneca-licenses-preclinical-porcupine-inhibitor-rxc006-for-idiopathic-pulmonary-fibrosis.html 2020 - 08 - 04 - t06:17:53.559z https://www.欧洲杯微信买球astrazeneca.com/media-centre/medical-releases/fasenra-significantly-reduced-exacerbation-rate-for-severe-eosinophilic-asthma-patients-in-phase-iiib-andhi-trial.html 2020 - 08 - 05 - t09:26:59.609z https://www.欧洲杯微信买球astrazeneca.com/media-centre/medical-releases/Anifrolumab-reduces-disease-flares-in-patients-with-systemic-lupus-erythematosus-while-allowing-oral-corticosteroid-tapering.html 2020 - 11 - 02 - t14:31:47.685z https://www.欧洲杯微信买球astrazeneca.com/media-centre/medical-releases/brilinta-reduced-subsequent-disabling-stroke-or-death-in-patients-who-had-an-acute-ischaemic-stroke-or-transient-ischaemic-attack-in-phase-iii-thales-trial-sub-analysis.html 2020 - 11 - 07 - t14:00:56.859z https://www.欧洲杯微信买球astrazeneca.com/media-centre/medical-releases/farxiga-showed-cardiovascular-and-renal-benefit-in-patients-with-chronic-kidney-disease-irrespective-of-cardiovascular-disease-status.html 2020 - 11 - 13 - t22:16:07.551z https://www.欧洲杯微信买球astrazeneca.com/media-centre/medical-releases/brilinta-reduced-the-composite-of-stroke-and-death-in-patients-with-head-and-neck-artery-atherosclerosis.html 2020 - 11 - 16 - t20:17:48.666z https://www.欧洲杯微信买球astrazeneca.com/media-centre/medical-releases/lokelma-label-update-approved-in-china-for-patients-with-hyperka.html 2021 - 02年- 13 - t10:49:01.072z https://www.欧洲杯微信买球astrazeneca.com/media-centre/medical-releases/first-patients-dosed-in-phase-iii-trials-evaluating-fasenra.html 2020 - 12 - 15 - t20:04:08.254z https://www.欧洲杯微信买球astrazeneca.com/media - centre/medical releases/new -数据-显示- - -释放药物过度使用——哮喘——————负责- 250 k -吨- -温室气体排放——每一个————————uk.html 2021 - 02 - 16 - t23:05:34.234z https://www.欧洲杯微信买球astrazeneca.com/media-centre/medical-releases/first-patients-dosed-in-three-dermatology-trials-evaluating-fasenra-in-bullous-pemphigoid-atopic-dermatitis-and-chronic-spontaneous-urticaria.html 2021 - 04 - 21 - t19:18:59.231z https://www.欧洲杯微信买球astrazeneca.com/media-centre/medical-releases/new-tezepelumab-data-continue-to-strengthen-profile-for-a-broad-population-of-severe-asthma-patients.html 2021 - 06 - 01 - t12:52:44.050z https://www.欧洲杯微信买球astrazeneca.com/media-centre/medical-releases/new-fasenra-data-from-the-meltemi-extension-trial-confirm-long-term-safety-and-efficacy-in-severe-eosinophilic-asthma-for-up-to-5-years.html 2021 - 05 - 19 - t11:56:31.953z https://www.欧洲杯微信买球astrazeneca.com/media-centre/image-and-broadcast-library.html 2021 - 04 - 16 - t16:25:45.835z https://www.欧洲杯微信买球astrazeneca.com/media-centre/covid-19-media.html 2021 - 06 - 11 - t11:24:09.693z https://www.欧洲杯微信买球astrazeneca.com/media-centre/Broadcast.html 2021 - 03 - 21 - t13:48:13.851z https://www.欧洲杯微信买球astrazeneca.com/media-centre/archive.html 2021 - 03 - 21 - t13:47:33.416z https://www.欧洲杯微信买球astrazeneca.com/media-centre/social-media-community-guidelines.html 2019 - 10 - 15 - t17:29:01.051z https://www.欧洲杯微信买球astrazeneca.com/media-centre/contacts.html 2021 - 03 - 10 - t20:34:56.321z https://www.欧洲杯微信买球astrazeneca.com/欧洲杯足彩冠军sustainability.html 2021 - 04 - 11 - t18:50:17.831z https://www.欧洲杯微信买球astrazeneca.com/欧洲杯足彩冠军sustainability/access-to-healthcare.html 2021 - 03 - 04 - t22:48:01.446z https://www.欧洲杯微信买球astrazeneca.com/欧洲杯足彩冠军sustainability/access-to-healthcare/healthy-heart-africa.html 2021 - 05 - 14 - t08:06:31.120z https://www.欧洲杯微信买球astrazeneca.com/欧洲杯足彩冠军sustainability/access-to-healthcare/young-health-programme.html 2021 - 03 - 04 - t22:51:44.232z https://www.欧洲杯微信买球astrazeneca.com/欧洲杯足彩冠军sustainability/access-to-healthcare/environments-impact-on-health.html 2021 - 03 - 04 - t22:56:17.622z https://www.欧洲杯微信买球astrazeneca.com/欧洲杯足彩冠军sustainability/access-to-healthcare/affordability.html 2021 - 04 - 26 - t15:55:06.462z https://www.欧洲杯微信买球astrazeneca.com/欧洲杯足彩冠军sustainability/access-to-healthcare/disease-treatment-and-prevention.html 2021 - 03 - 04 - t23:04:33.864z https://www.欧洲杯微信买球astrazeneca.com/欧洲杯足彩冠军sustainability/access-to-healthcare/responsible-rd.html 2021 - 03 - 04 - t23:06:42.415z https://www.欧洲杯微信买球astrazeneca.com/欧洲杯足彩冠军sustainability/access-to-healthcare/investments-in-health-systems.html 2021 - 05 - 18 - t08:11:41.441z https://www.欧洲杯微信买球astrazeneca.com/欧洲杯足彩冠军sustainability/environmental-protection.html 2021 - 03 - 05 - t09:43:50.468z https://www.欧洲杯微信买球astrazeneca.com/欧洲杯足彩冠军sustainability/environmental-protection/greenhouse-gas-reduction.html 2021 - 03 - 05 - t09:46:39.111z https://www.欧洲杯微信买球astrazeneca.com/欧洲杯足彩冠军sustainability/environmental-protection/greenhouse-gas-reduction/az-forest.html 2020 - 12 - 16 - t09:55:45.645z https://www.欧洲杯微信买球astrazeneca.com/欧洲杯足彩冠军sustainability/environmental-protection/product-environmental-stewardship.html 2021 - 03 - 05 - t09:48:47.279z https://www.欧洲杯微信买球astrazeneca.com/欧洲杯足彩冠军sustainability/environmental-protection/water-stewardship.html 2021 - 03 - 05 - t09:58:19.022z https://www.欧洲杯微信买球astrazeneca.com/欧洲杯足彩冠军sustainability/environmental-protection/waste-management.html 2021 - 03 - 05 - t09:59:04.758z https://www.欧洲杯微信买球astrazeneca.com/欧洲杯足彩冠军sustainability/environmental-protection/pharmaceuticals-in-the-environment.html 2021 - 04 - 19 - t17:24:58.051z https://www.欧洲杯微信买球astrazeneca.com/欧洲杯足彩冠军sustainability/ethics-and-transparency.html 2021 - 04 - 13 - t04:53:06.876z https://www.欧洲杯微信买球astrazeneca.com/欧洲杯足彩冠军sustainability/ethics-and-transparency/data-and-ai-ethics.html 2021 - 03 - 12 - t16:07:00.196z https://www.欧洲杯微信买球astrazeneca.com/欧洲杯足彩冠军sustainability/ethics-and-transparency/astrazeneca-and-global-transparency.html 2021 - 05 - 28 - t05:18:47.086z https://www.欧洲杯微信买球astrazeneca.com/欧洲杯足彩冠军sustainability/ethics-and-transparency/ethical-business-culture.html 2021 - 03 - 12 - t16:37:43.619z https://www.欧洲杯微信买球astrazeneca.com/欧洲杯足彩冠军sustainability/ethics-and-transparency/workforce-wellbeing-and-safety.html 2021 - 03 - 05 - t10:09:57.608z https://www.欧洲杯微信买球astrazeneca.com/欧洲杯足彩冠军sustainability/ethics-and-transparency/responsible-supply-chain.html 2021 - 04 - 14 - t06:09:19.618z https://www.欧洲杯微信买球astrazeneca.com/欧洲杯足彩冠军sustainability/ethics-and-transparency/inclusion-and-diversity.html 2021 - 04 - 29 - t11:10:17.342z https://www.欧洲杯微信买球astrazeneca.com/欧洲杯足彩冠军sustainability/ethics-and-transparency/talent-and-workforce-evolution.html 2021 - 03 - 05 - t10:13:12.930z https://www.欧洲杯微信买球astrazeneca.com/欧洲杯足彩冠军sustainability/ethics-and-transparency/human-rights.html 2021 - 03 - 05 - t10:14:42.913z https://www.欧洲杯微信买球astrazeneca.com/欧洲杯足彩冠军sustainability/ethics-and-transparency/bioethics.html 2021 - 03 - 05 - t10:17:00.410z https://www.欧洲杯微信买球astrazeneca.com/欧洲杯足彩冠军sustainability/ethics-and-transparency/animals-in-research.html 2021 - 03 - 16 - t17:06:38.101z https://www.欧洲杯微信买球astrazeneca.com/欧洲杯足彩冠军sustainability/ethics-and-transparency/our-commitment-to-clinical-trial-transparency.html 2021 - 03 - 05 - t10:21:22.801z https://www.欧洲杯微信买球astrazeneca.com/欧洲杯足彩冠军sustainability/supporting-our-communities.html 2021 - 06 - 08 - t15:25:52.754z https://www.欧洲杯微信买球astrazeneca.com/欧洲杯足彩冠军sustainability/resources.html 2021 - 05 - 20 - t12:48:10.162z https://www.欧洲杯微信买球astrazeneca.com/欧洲杯足彩冠军sustainability/dunga-beach.html 2020 - 03 - 02 - t15:05:13.240z https://www.欧洲杯微信买球astrazeneca.com/careers.html 2020 - 09 - 16 - t08:19:27.473z https://www.欧洲杯微信买球astrazeneca.com/investor-relations.html 2021 - 06 - 14 - t08:32:36.611z https://www.欧洲杯微信买球astrazeneca.com/investor-relations/meet-azn-management-biopharmaceuticals.html 2021 - 06 - 08 - t14:50:30.317z https://www.欧洲杯微信买球astrazeneca.com/investor - relations/astrazeneca q1 - 2021 results.html 2021 - 06 - 09 - t10:04:28.489z https://www.欧洲杯微信买球astrazeneca.com/investor-relations/astrazeneca-to-acquire-alexion.html 2021 - 05 - 27 - t15:53:00.872z 2020 - resul欧洲杯微信买球ts.html //www.vivelima.com/investor relations/full高龄 2021 - 02 - 11 - t21:31:56.957z https://www.欧洲杯微信买球astrazeneca.com/investor-relations/resources.html 2021 - 02 - 10 - t21:33:38.059z https://www.欧洲杯微信买球astrazeneca.com/investor-relations/leading-in-欧洲杯足彩冠军sustainability-virtual-webcast.html 2021 - 02 - 10 - t18:49:14.598z https://www.欧洲杯微信买球astrazeneca.com/investor relations/year - -日期和第三季度- 2020 results.html 2020 - 11 - 20 - t16:30:54.901z https://www.欧洲杯微信买球astrazeneca.com/investor-relations/meet-azn-management-at-asco20-virtual-scientific-program.html 2020 - 06 - 04 - t09:15:40.083z https://www.欧洲杯微信买球astrazeneca.com/investor results.html——relations/astrazeneca - h1 - 2020 2020 - 07 - 30 - t12:00:10.211z https://www.欧洲杯微信买球astrazeneca.com/investor - relations/astrazeneca q1 - 2020 results.html 2020 - 04 - 29 - t13:37:44.280z https://www.欧洲杯微信买球astrazeneca.com/investor relations/investor -科学会议-电话-美国-社会- 2019. -血液学的html 2019 - 12 - 10 - t13:15:15.845z https://www.欧洲杯微信买球astrazeneca.com/investor relations/astrazeneca -完整的年和第四季度- 2019 results.html 2020 - 02 - 14 - t14:42:50.305z https://www.欧洲杯微信买球astrazeneca.com/investor relations/year - -日期和第三季度- 2019 results.html 2020 - 11 - 05 - t08:39:15.362z https://www.欧洲杯微信买球astrazeneca.com/investor-relations/emerging-markets-expansion-innovation-and-partnership.html 2020 - 06 - 03 - t16:35:55.365z https://www.欧洲杯微信买球astrazeneca.com/investor-relations/IR-archive/for-investors.html 2020 - 09 - 25 - t13:04:28.432z https://www.欧洲杯微信买球astrazeneca.com/investor - relations/ir archive/previous results/q1 - 2019 results.html 2019 - 04 - 26 - t21:53:52.175z https://www.欧洲杯微信买球astrazeneca.com/investor - relations/ir archive/previous results/h1 - 2019 results.html 2019 - 10 - 23 - t14:30:27.613z https://www.欧洲杯微信买球astrazeneca.com/investor-relations/stock-exchange-announcements.html 2020 - 08 - 04 - t11:33:59.743z https://www.欧洲杯微信买球astrazeneca.com/investor relations/stock -交流- announcements/2019/results - - -一般年会举行- 4月- 26 - 2019. - html 2019 - 04 - 26 - t17:34:15.238z https://www.欧洲杯微信买球astrazeneca.com/investor-relations/stock-exchange-announcements/2016/AstraZeneca-enters-licensing-agreements-with-LEO-Pharma-in-skin-diseases.html 2016 - 11 - 11 - t18:41:02.588z https://www.欧洲杯微信买球astrazeneca.com/investor relations/stock -交流- announcements/2016/astrazeneca进入到协议- -解决- faslodex专利诉讼——————我们- 13072016. - html 2016 - 11 - 11 - t18:41:03.016z https://www.欧洲杯微信买球astrazeneca.com/investor relations/stock -交流- announcements/2016/fda接受- -评估-新-药物-应用程序- 18102016. -钠-锆- html 2016 - 11 - 11 - t18:41:08.319z https://www.欧洲杯微信买球astrazeneca.com/investor relations/stock -交流- announcements/2016/astrazeneca -完成-协议-与- aralez -β-阻滞剂医学-术前- xl - - -我们- 31102016. - html 2016 - 11 - 11 - t18:41:09.504z https://www.欧洲杯微信买球astrazeneca.com/investor relations/stock -交流- announcements/2016/astrazeneca头部和颈部癌症-试验- 27102016. html 2016 - 11 - 11 - t18:41:09.929z https://www.欧洲杯微信买球astrazeneca.com/investor relations/stock -交流- announcements/2016/transparency指令-投票权利-和-资本- 01082016. - html 2016 - 11 - 11 - t18:41:10.425z https://www.欧洲杯微信买球astrazeneca.com/investor - relations/stock交易所- announcements/2016/transaction -人-放电-管理-责任信息披露规则(dtr) 3 - 1 - 4 - 01082016. - html 2016 - 11 - 11 - t18:41:10.930z https://www.欧洲杯微信买球astrazeneca.com/investor relations/stock -交流- announcements/2016/transparency指令-投票权利-和-资本- 01112016. - html 2016 - 11 - 11 - t18:41:11.386z https://www.欧洲杯微信买球astrazeneca.com/investor - relations/stock交易所- announcements/2016/transaction -人-密切相关——-人- -管理职责- 01112016. - html 2016 - 11 - 11 - t18:41:12.104z https://www.欧洲杯微信买球astrazeneca.com/investor relations/stock -交流- announcements/2016/transparency指令-投票权利-和-资本- 01092016. - html 2016 - 11 - 11 - t18:41:12.560z https://www.欧洲杯微信买球astrazeneca.com/investor relations/stock -交流- announcements/2016/transparency指令-投票权利-和-资本- 03102016. - html 2016 - 11 - 11 - t18:41:13.059z https://www.欧洲杯微信买球astrazeneca.com/investor - relations/stock交换announcements/2016/new -外部董事会任命- 18082016. - html 2016 - 11 - 11 - t18:41:13.808z https://www.欧洲杯微信买球astrazeneca.com/investor - relations/stock交换announcements/2016/new -外部董事会任命- 22092016. - html 2016 - 11 - 11 - t18:41:14.192z https://www.欧洲杯微信买球astrazeneca.com/investor - relations/stock交易所- announcements/2016/transaction -人-放电-管理-责任信息披露规则(dtr) 3 - 1 - 4 - 26092016. - html 2016 - 11 - 11 - t18:41:14.936z https://www.欧洲杯微信买球astrazeneca.com/investor relations/stock -交流- announcements/2016/astrazeneca完成商业化协议-与-阿斯彭麻醉学组合- 01092016. - html 2016 - 11 - 11 - t18:41:16.007z https://www.欧洲杯微信买球astrazeneca.com/investor relations/stock -交流- announcements/2016/lynparza - - iii -个人- 2期试验-显示-重要进展-免费-生存受益- 261020161. - html 2016 - 11 - 11 - t19:26:34.420z https://www.欧洲杯微信买球astrazeneca.com/investor - relations/stock交换announcements/2016/medimmune -完成- -许可协议-与-爱力根- medi2070 - 17112016. - html 2016 - 11 - 17 - t07:19:58.215z https://www.欧洲杯微信买球astrazeneca.com/investor relations/stock -交流- announcements/2016/astrazeneca头部和颈部癌症——-试验-恢复-新-病人-报名- - fda电梯-部分临床- - 22112016. - html 2016 - 11 - 22 - t07:13:00.915z https://www.欧洲杯微信买球astrazeneca.com/investor relations/stock -交流- announcements/2016/transparency指令-投票权利-和-资本- 01122016. - html 2016 - 12 - 01 - t14:49:10.973z https://www.欧洲杯微信买球astrazeneca.com/investor relations/stock -交流- announcements/2016/astrazeneca完成协议-与- cilag gmbh是一家国际——权利-外- rhinocort -水- - -我们- 05122016. - html 2016 - 12 - 05 - t05:56:34.998z https://www.欧洲杯微信买球astrazeneca.com/investor-relations/stock-exchange-announcements/2016/US-FDA-accepts-first-biologics-license-application-for-AstraZenecas-durvalumab-in-bladder-cancer09122012.html 2016 - 12 - 09 - t15:40:16.956z https://www.欧洲杯微信买球astrazeneca.com/investor relations/stock -交流- announcements/2016/block清单- 6月-返回- 12122016. - html 2016 - 12 - 13 - t17:23:08.681z https://www.欧洲杯微信买球astrazeneca.com/investor relations/stock -交流- announcements/2016/transaction - - - - -人- -管理职责- 161220161. - html 2016 - 12 - 16 - t13:23:21.179z https://www.欧洲杯微信买球astrazeneca.com/investor relations/stock -交流- announcements/2016/astrazeneca -完成-销售- -小分子-抗生素-业务-辉瑞- 23122016. - html 2016 - 12 - 22 - t15:06:30.306z https://www.欧洲杯微信买球astrazeneca.com/investor relations/stock -交流- announcements/2016/astrazeneca进入协议-与- cilag gmbh是一家国际-剥离权利-外- rhinocort -水- - -我们- 071020161. - html 2017 - 01 - 11 t16:56:53.223z https://www.欧洲杯微信买球astrazeneca.com/investor relations/stock -交流- announcements/2016/astrazeneca进入协议-与- aralez -β-阻滞剂医学- - -我们04102016. - html 2017 - 01 - 11 t16:57:18.993z https://www.欧洲杯微信买球astrazeneca.com/investor relations/stock -交流- announcements/2016/astrazeneca报告-高级-线-结果- - - brilinta欧几里得——试验——————-周边动脉疾病的患者- 04102016. - html 2017 - 01 - 11 t16:59:13.390z https://www.欧洲杯微信买球astrazeneca.com/investor - relations/stock交换announcements/2016/medimmune - -许可证潜在医学- -炎症疾病-爱力根- 03102016. - html 2017 - 01 - 11 t17:00:51.098z https://www.欧洲杯微信买球astrazeneca.com/investor relations/stock -交流- announcements/2016/change -阿斯利康-董事会-的- 28092016. - html 2017 - 01 - 11 t17:01:32.959z https://www.欧洲杯微信买球astrazeneca.com/investor - relations/stock交换announcements/2016/astrazeneca -销售-小分子-抗生素-业务- -辉瑞- 24082016. - html 2017 - 01 - 11 t17:09:29.208z https://www.欧洲杯微信买球astrazeneca.com/investor relations/stock -交流- announcements/2016/astrazeneca宣布——投资——现代化- 10082016. - html 2017 - 01 - 11 t17:11:35.141z https://www.欧洲杯微信买球astrazeneca.com/investor - relations/stock交换- announcements/2016/astrazeneca提供更新- - - iii期临床试验————selumetinib -非小细胞肺-癌症- 09082016. - html 2017 - 01 - 11 t17:12:16.126z https://www.欧洲杯微信买球astrazeneca.com/investor relations/stock -交流- announcements/2016/astrazeneca收到审批- - -欧盟- qtern saxagliptin -和- dapagliflozin -处理- - - 2型糖尿病- 19072016. - html 2017 - 01 - 11 t17:14:57.302z https://www.欧洲杯微信买球astrazeneca.com/investor - relations/stock交换announcements/2016/tagrisso - -主-端点在阶段- iii - 2 -线-肺癌症-试验- 18072016. - html 2017 - 01 - 11 t17:15:52.987z https://www.欧洲杯微信买球astrazeneca.com/investor relations/stock -交流- announcements/2016/tagrisso展示优势- -化疗的表皮生长因子受体- t790m突变-正-非小细胞肺-癌症- 06122016. - html 2017 - 07 - 20 - t09:28:10.391z https://www.欧洲杯微信买球astrazeneca.com/investor relations/stock -交流- announcements/2016/change -阿斯利康-董事会-的- 09112016. - html 2017 - 07 - 26 - t15:29:08.821z https://www.欧洲杯微信买球astrazeneca.com/investor relations/stock -交流- announcements/2016/astrazeneca -完成-全球许可协议——-利奥制药- 160820161. - tralokinumab html 2018 - 07 - 02 - t11:41:05.192z https://www.欧洲杯微信买球astrazeneca.com/investor relations/stock announcements/2016/q3 - 2016 results.html——交换 2018 - 07 - 05 - t11:50:11.959z https://www.欧洲杯微信买球astrazeneca.com/investor relations/stock announcements/2016/h1 - 2016 results.html——交换 2018 - 07 - 05 - t11:55:12.058z https://www.欧洲杯微信买球astrazeneca.com/investor relations/stock -交流- announcements/2017/transparency指令-投票权利-和-资本- 03012017. - html 2017 - 01 - 03 - t15:52:51.436z https://www.欧洲杯微信买球astrazeneca.com/investor - relations/stock交换announcements/2017/astrazeneca -膨胀- 1号线-肺癌症免疫-肿瘤-计划- - 17012017. - html的机会 2017 - 01 - 17 t06:16:48.328z https://www.欧洲杯微信买球astrazeneca.com/investor relations/stock -交流- announcements/2017/symbicort授予-儿科排他性- - -我们- 26012017. - html 2017 - 01 - 26 t09:50:31.303z https://www.欧洲杯微信买球astrazeneca.com/investor relations/stock -交流- announcements/2017/transparency指令-投票权利-和-资本- 01022017. - html 2017 - 02 - 01 - t14:48:58.705z https://www.欧洲杯微信买球astrazeneca.com/investor relations/stock -交流- announcements/2017/siliq brodalumab批准- - -美国fda的-成人患者- - - - - - -中度-重度斑块牛皮癣- 16022017. - html 2017 - 02 - 16 - t11:36:48.301z https://www.欧洲杯微信买球astrazeneca.com/investor relations/stock -交流- announcements/2017/lynparza满足-主-端点- iii期临床试验——在——brca突变-转移性乳腺癌癌症- 17022017. - html 2017 - 02年- 17 - t06:42:48.520z https://www.欧洲杯微信买球astrazeneca.com/investor relations/stock -交流- announcements/2017/astrazeneca进入协议-与- tersera疗法- zoladex - - -美国和加拿大- 20022017. - html 2017 - 02年- 20 - t06:33:13.561z https://www.欧洲杯微信买球astrazeneca.com/investor relations/stock -交流- announcements/2017/fda批准-一旦每日qtern dapagliflozin -和- saxagliptin平板电脑——成年人————- 2型糖尿病- 240217. - html 2017 - 02 - 28 - t06:33:05.893z https://www.欧洲杯微信买球astrazeneca.com/investor relations/stock -交流- announcements/2017/transparency指令-投票权利-和-资本- 01032017. - html 2017 - 03 - 02 - t15:19:58.920z https://www.欧洲杯微信买球astrazeneca.com/investor relations/stock -交流- announcements/2017/zs - 9 -钠-锆环硅酸盐-接收积极- chmp意见- - -治疗的高钾血症- 24022017. - html 2017 - 03 - 03 - t06:32:25.976z https://www.欧洲杯微信买球astrazeneca.com/investor relations/stock -交流- announcements/2017/medimmune和赛诺菲-巴斯德-形成联盟- -开发和商业化潜力——下一代-呼吸道合胞病毒抗体- medi8897 03032017. - html 2017 - 03 - 03 - t06:43:07.670z https://www.欧洲杯微信买球astrazeneca.com/investor relations/stock -交流- announcements/2017/changes -阿斯利康-董事会-的- 06032017. - html 2017 - 03 - 06 - t08:18:08.067z https://www.欧洲杯微信买球astrazeneca.com/investor - relations/stock交换- announcements/2017/annual -金融- - 07032017. - html报告 2017 - 03 - 07 - t16:23:10.698z https://www.欧洲杯微信买球astrazeneca.com/investor-relations/stock-exchange-announcements/2017/filing-of-annual-report-on-form-20-f-with-the-us-securities-and-exchange-commission.html 2017 - 03 - 08 - t14:59:35.763z https://www.欧洲杯微信买球astrazeneca.com/investor relations/stock -交流- announcements/2017/lynparza阶段- iii -个人- 2 -数据-展示-发展-免费-生存受益- - brca突变-卵巢癌症- -维护-治疗- 15032017. - html 2017 - 03 - 14 - t19:03:30.468z https://www.欧洲杯微信买球astrazeneca.com/investor relations/stock -交流- announcements/2017/notice -通用-年会- 16032017. - html 2017 - 03 - 16 - t10:10:05.765z https://www.欧洲杯微信买球astrazeneca.com/investor relations/stock -交流- announcements/2017/astrazeneca接收-完成-反应-信- -美国fda的z -钠-锆环硅酸盐-高钾血症- 17032017. - html 2017 - 03 - 17 - t07:07:44.399z https://www.欧洲杯微信买球astrazeneca.com/investor relations/stock -交流- announcements/2017/transactions - -人-管理职责- 27032017. - html 2017 - 03 - 27 - t18:22:31.075z https://www.欧洲杯微信买球astrazeneca.com/investor relations/stock -交流- announcements/2017/transactions - -人-管理职责- 28032017. - html 2017 - 03 - 29 - t10:48:31.150z https://www.欧洲杯微信买球astrazeneca.com/investor - relations/stock交换announcements/2017/astrazeneca -完成-协议-与- tersera疗法- -商业权利- zoladex - - -美国和加拿大- 31032017. - html 2017 - 03 - 31 - t05:41:25.503z https://www.欧洲杯微信买球astrazeneca.com/investor relations/stock -交流- announcements/2017/tagrisso osimertinib -收到fda -全部-审批- 31032017. - html 2017 - 03 - 31 - t06:04:42.927z https://www.欧洲杯微信买球astrazeneca.com/investor-relations/stock-exchange-announcements/2017/transparency-directive-voting-rights-and-capital.html 2017 - 04 - 25 - t12:16:29.765z https://www.欧洲杯微信买球astrazeneca.com/investor relations/stock -交流- announcements/2017/results - - -一般年会举行- 4月- 27 - 2017 - 270417. - html 2017 - 04 - 28 - t11:43:03.718z https://www.欧洲杯微信买球astrazeneca.com/investor relations/stock announcements/2017/q1 - 2017 results.html——交换 2017 - 05 - 02 - t12:13:25.391z https://www.欧洲杯微信买球astrazeneca.com/investor relations/stock -交流- announcements/2017/transparency指令-投票权利-和-资本- 02052017. - html 2017 - 05 - 02 - t15:57:10.989z https://www.欧洲杯微信买球astrazeneca.com/investor relations/stock -交流- announcements/2017/notice -结果- 27072016. - html 2017 - 05 - 04 - t12:09:25.948z https://www.欧洲杯微信买球astrazeneca.com/investor relations/stock -交流- announcements/2017/astrazenecas imfinzi durvalumab -收到我们之前fda -加速-审批- - - - - - - -治疗患者- - - - - - -高级-膀胱癌症- 01052017. - html 2017 - 05 - 08 - t09:38:28.400z https://www.欧洲杯微信买球astrazeneca.com/investor relations/stock -交流- announcements/2017/tagrisso接收-全部-审批- - -欧盟- 25042017. - html 2017 - 05 - 10 - t05:59:53.846z https://www.欧洲杯微信买球astrazeneca.com/investor-relations/stock-exchange-announcements/2017/astrazeneca-provides-update-on-stratos-1-phase-iii-trial-of-tralokinumab-in-severe-uncontrolled-asthma.html 2017 - 05 - 12 - t05:14:30.774z https://www.欧洲杯微信买球astrazeneca.com/investor-relations/stock-exchange-announcements/2017/director-pdmr-shareholding.html 2017 - 05 - 16 - t14:28:14.143z https://www.欧洲杯微信买球astrazeneca.com/investor relations/stock -交流- announcements/2017/imfinzi显著降低- -风险的疾病-恶化或死亡- - -阶段- iii -太平洋-试验- -阶段- iii -不可切除的肺癌症- 12052017. - html 2017 - 05 - 22 - t06:18:34.337z https://www.欧洲杯微信买球astrazeneca.com/investor relations/stock -交流- announcements/2017/astrazeneca进入协议-与- recordati seloken - -欧洲- 22052017. - html 2017 - 05 - 22 - t06:33:22.467z https://www.欧洲杯微信买球astrazeneca.com/investor relations/stock -交流- announcements/2017/bydureon exscel -试验-与-主-安全-目标- - - 2型糖尿病病人- -宽距离——心血管风险- 23052017. - html 2017 - 05 - 23 - t06:35:41.170z https://www.欧洲杯微信买球astrazeneca.com/investor relations/stock -交流- announcements/2017/directorate变化- 31052017. - html 2017 - 05 - 31 - t05:22:10.715z https://www.欧洲杯微信买球astrazeneca.com/investor relations/stock -交流- announcements/2017/lynparza显著降低的风险——-疾病恶化或死亡- - - - - - - - - brca突变的患者转移——乳房癌症- 05062017. - html 2017 - 06 - 04 - t20:39:16.508z https://www.欧洲杯微信买球astrazeneca.com/investor relations/stock -交流- announcements/2017/director pdmr股权- 24052017. - html 2017 - 06 - 06 - t05:14:33.840z https://www.欧洲杯微信买球astrazeneca.com/investor relations/stock -交流- announcements/2017/astrazeneca - - - 20亿债券发行价格06062017. - html 2017 - 06 - 06 - t06:03:22.506z https://www.欧洲杯微信买球astrazeneca.com/investor relations/stock - - announcements/2017/astrazeneca进入交换协议——grunenthal - -剥离的权利——偏头痛治疗-佐米格- 07062017. - html 2017 - 06 - 07 - t06:24:52.259z https://www.欧洲杯微信买球astrazeneca.com/investor relations/stock -交流- announcements/2017/transparency指令-投票权利-和-资本- 01062017. - html 2017 - 06 - 30 - t11:07:38.497z https://www.欧洲杯微信买球astrazeneca.com/investor relations/stock -交流- announcements/2017/block清单- 6月-返回- 01062017. - html 2017 - 06 - 30 - t11:07:56.674z https://www.欧洲杯微信买球astrazeneca.com/investor relations/stock -交流- announcements/2017/astrazeneca完成协议-与- recordati seloken - -欧洲- 03072017. - html 2017 - 07 - 03 - t05:23:58.954z https://www.欧洲杯微信买球astrazeneca.com/investor relations/stock -交流- announcements/2017/astrazeneca -完成-撤资协议-与- grunenthal偏头痛治疗-佐米格- 03072017. - html 2017 - 07 - 03 - t05:24:23.031z https://www.欧洲杯微信买球astrazeneca.com/investor relations/stock -交流- announcements/2017/transparency指令-投票权利-和-资本- 03072017. - html 2017 - 07 - 04 - t08:54:08.878z https://www.欧洲杯微信买球astrazeneca.com/investor relations/stock -交流- announcements/2017/faslodex收到欧盟批准- -第一线疗法-高级-乳腺癌癌症- 26072017. - html 2017 - 07 - 26 - t16:44:15.361z https://www.欧洲杯微信买球astrazeneca.com/investor - relations/stock交换announcements/2017/astrazeneca -报告初步结果- - -持续的神秘——试验——在第四阶段——-肺癌症- 27072017. - html 2017 - 07 - 27 - t05:48:46.821z https://www.欧洲杯微信买球astrazeneca.com/investor relations/stock -交流- announcements/2017/tagrisso显著改善生存-发展-自由- - - - - - - iii - flaura阶段试验- -肺癌症- 27072017. - html 2017 - 07 - 27 - t05:55:02.126z https://www.欧洲杯微信买球astrazeneca.com/investor relations/stock -交流- announcements/2017/astrazeneca -和-默克公司建立战略-肿瘤-合作- 27072017. - html 2017 - 07 - 27 - t06:16:39.772z https://www.欧洲杯微信买球astrazeneca.com/investor relations/stock -交流- announcements/2017/director pdmr股权- 28072017. - html 2017 - 07 - 28 - t10:33:51.539z https://www.欧洲杯微信买球astrazeneca.com/investor relations/stock -交流- announcements/2017/acalabrutinib授予-突破-治疗-设计-由美国食品药品管理局- - -治疗的病人- -套细胞淋巴瘤- 01082017. - html 2017 - 08 - 01 - t06:09:06.089z https://www.欧洲杯微信买球astrazeneca.com/investor relations/stock -交流- announcements/2017/transparency指令-投票权利-和-资本- 01082017. - html 2017 - 08 - 01 - t12:29:35.532z https://www.欧洲杯微信买球astrazeneca.com/investor relations/stock announcements/2017/h1 - 2017 results.html——交换 2017 - 08 - 01 - t14:03:29.366z https://www.欧洲杯微信买球astrazeneca.com/investor relations/stock -交流- announcements/2017/us fda接受监管-提交acalabrutinib -和-赠款优先审查- 02082017. - html 2017 - 08 - 02 - t05:56:40.744z https://www.欧洲杯微信买球astrazeneca.com/investor - relations/stock交换announcements/2017/imfinzi -授予-突破-治疗-美国fda - -指定的患者- - - - - - -本地先进-不可切除的非小细胞肺-癌症31072017. - html 2017 - 08 - 02 - t13:05:45.047z https://www.欧洲杯微信买球astrazeneca.com/investor relations/stock -交流- announcements/2017/publication招股说明书- 10082017. - html 2017 - 08 - 10 - t12:30:44.821z https://www.欧洲杯微信买球astrazeneca.com/investor relations/stock -交流- announcements/2017/holding -公司- 21072017. - html 2017 - 08 - 14 - t15:19:43.323z https://www.欧洲杯微信买球astrazeneca.com/investor - relations/stock交换announcements/2017/astrazeneca -非执行董事退休- 16082017. - html 2017 - 08 - 16 - t05:12:36.285z https://www.欧洲杯微信买球astrazeneca.com/investor-relations/stock-exchange-announcements/2017/lynparza-receives-additional-and-broad-approval-in-the-us-for-ovarian-cancer.html 2017 - 08 - 17 - t20:17:19.824z https://www.欧洲杯微信买球astrazeneca.com/investor relations/stock -交流- announcements/2017/transparency指令-投票权利-和-资本- 01092017. - html 2017 - 09 - 01 - t13:56:55.982z https://www.欧洲杯微信买球astrazeneca.com/investor relations/stock -交流- announcements/2017/directorate变化- 05092017. - html 2017 - 09 - 04 - t14:19:23.415z https://www.欧洲杯微信买球astrazeneca.com/investor relations/stock -交流- announcements/2017/faslodex接收-美国fda -审批-作为单一疗法-扩展-使用- -乳腺癌癌症- 28082017. - html 2017 - 09 - 06 - t13:19:26.623z https://www.欧洲杯微信买球astrazeneca.com/investor relations/stock -交流- announcements/2017/tezepelumab显著减少-哮喘急性加重- - -广泛的人口- - - -严重控制哮喘患者- 06092017. - html 2017 - 09 - 07 - t05:02:02.535z https://www.欧洲杯微信买球astrazeneca.com/investor relations/stock -交流- announcements/2017/duaklir显著改善肺功能- -慢性阻塞性肺病患者07092017. - html 2017 - 09 - 07 - t05:46:29.461z https://www.欧洲杯微信买球astrazeneca.com/investor relations/stock -交流- announcements/2017/celgene和阿斯利康-提供-更新- -融合-临床试验计划- 07092017. - html 2017 - 09 - 07 - t12:02:50.293z https://www.欧洲杯微信买球astrazeneca.com/investor relations/stock -交流- announcements/2017/astrazeneca tagrisso -显示潜在的- - -新标准- 1号线- -保健的表皮生长因子受体突变-肺癌症——在国会esmo - 2017 - 11092017. - html 2017 - 09 - 11 - t04:57:32.320z https://www.欧洲杯微信买球astrazeneca.com/investor-relations/stock-exchange-announcements/2017/astrazeneca-and-aspen-enter-agreement-for-remaining-rights-to-anaesthetics-medicines14092017.html 2017 - 09 - 14 - t05:14:25.053z https://www.欧洲杯微信买球astrazeneca.com/investor relations/stock -交流- announcements/2017/director pdmr股权- 260917. - html 2017 - 09 - 26 - t10:45:53.943z https://www.欧洲杯微信买球astrazeneca.com/investor relations/stock -交流- announcements/2017/transparency指令-投票权利-和-资本- 02102017. - html 2017 - 10 - 02 - t13:47:18.053z https://www.欧洲杯微信买球astrazeneca.com/investor relations/stock -交流- announcements/2017/tagrisso授予-突破-治疗-设计-由美国食品药品管理局- - - 1号线-治疗的患者- - - - - - - egfr突变阳性-非小细胞肺-癌症- 09102017. - html 2017 - 10 - 09 - t05:41:03.784z https://www.欧洲杯微信买球astrazeneca.com/investor relations/stock -交流- announcements/2017/us fda接受补充-生物制品许可-应用程序- imfinzi - -本地先进不可切除的非小细胞-肺癌症- 171017. - html 2017 - 10 - 17 - t05:37:22.993z https://www.欧洲杯微信买球astrazeneca.com/investor relations/stock -交流- announcements/2017/us fda接受——管理——提交- - lynparza在转移性乳腺癌癌症-和-赠款优先审查- 18102017. - html 2017 - 10 - 18 - t06:07:26.606z https://www.欧洲杯微信买球astrazeneca.com/investor relations/stock -交流- announcements/2017/us fda批准-新-容易使用——一旦-每周bydureon bcise -注射药物- - - - - 2型糖尿病患者231017. - html 2017 - 10 - 22 - t21:37:37.130z https://www.欧洲杯微信买球astrazeneca.com/investor - relations/stock交换announcements/2017/astrazeneca -和- - -迅速推进- lynparza -日本-与-第二个监管提交- 231017. - html 2017 - 10 - 23 - t06:11:15.156z https://www.欧洲杯微信买球astrazeneca.com/investor relations/stock -交流- announcements/2017/us fda批准-阿斯利康calquence acalabrutinib - -成人患者与先前- -地幔-细胞淋巴瘤治疗24102017. - html 2017 - 10 - 31 - t17:49:03.619z https://www.欧洲杯微信买球astrazeneca.com/investor-relations/stock-exchange-announcements/2017/astrazeneca-and-aspen-complete-agreement-for-residual-rights-to-anaesthetic-medicines31102017.html 2017 - 10 - 31 - t18:38:30.436z https://www.欧洲杯微信买球astrazeneca.com/investor - relations/stock交换announcements/2017/astrazeneca -提供-更新tralokinumab -相- iii -计划- - -不受控制的哮喘严重01112017. - html 2017 - 11 - 01 - t06:16:53.521z https://www.欧洲杯微信买球astrazeneca.com/investor relations/stock -交流- announcements/2017/astrazeneca礼物-高级-发展-免费-生存——imfinzi————-太平洋-试验- - - -本地先进不可切除的病人肺癌症-在国会esmo - 2017 - 11092017. - html 2017 - 11 - 01 - t06:59:47.458z https://www.欧洲杯微信买球astrazeneca.com/investor relations/stock -交流- announcements/2017/transparency指令-投票权利-和-资本- 01112017. - html 2017 - 11 - 01 - t14:37:34.628z https://www.欧洲杯微信买球astrazeneca.com/investor relations/stock -交流- announcements/2017/fasenra benralizumab -收到fda审批- - - - - - -严重失控——嗜酸性哮喘- 14112017. - html 2017 - 11 - 15 - t06:56:31.144z https://www.欧洲杯微信买球astrazeneca.com/investor relations/stock -交流- announcements/2017/astrazeneca -让-管理-提交tagrisso -在- 1 -线- egfr突变-非小细胞肺——癌症-日本- 27112017. - html 2017 - 11 - 27 - t06:23:21.023z https://www.欧洲杯微信买球astrazeneca.com/investor - relations/stock交换announcements/2017/the -欧洲-药物-机构-接受监管-提交tagrisso -在- 1 -线- egfr突变-非小细胞肺-癌症- 24112017. - html 2017 - 11 - 28 - t06:06:28.369z https://www.欧洲杯微信买球astrazeneca.com/investor relations/stock -交流- announcements/2017/transparency指令-投票权利-和-资本- 01122017. - html 2017 - 12 - 01 - t15:02:20.426z https://www.欧洲杯微信买球astrazeneca.com/investor relations/stock -交流- announcements/2017/block清单-返回- 01122017. - html 2017 - 12 - 01 - t15:05:59.577z https://www.欧洲杯微信买球astrazeneca.com/investor relations/stock -交流- announcements/2017/director pdmr股权- 281217. - html 2017 - 12 - 28 - t11:46:48.996z https://www.欧洲杯微信买球astrazeneca.com/investor - relations/stock交换announcements/2017/year - -日期和第三季度- 2017 results.html 2018 - 02年- 23 - t07:23:17.981z https://www.欧洲杯微信买球astrazeneca.com/investor relations/stock -交流- announcements/2017/us fda接受——管理——提交tagrisso -在- 1 -线- egfr突变-非小细胞肺-癌症- 18122017. - html 2018 - 02年- 23 - t07:30:28.216z https://www.欧洲杯微信买球astrazeneca.com/investor relations/stock交易所- announcements/2017/transaction -人-管理职责-披露-下- - 19条- -欧盟市场滥用监管- 15122017. - html 2018 - 02年- 23 - t07:31:40.838z https://www.欧洲杯微信买球astrazeneca.com/investor relations/stock -交流- announcements/2017/benralizumab收到积极的欧盟- chmp意见- - -控制-嗜酸性哮喘严重10112017. - html 2018 - 04 - 30 - t08:54:18.064z https://www.欧洲杯微信买球astrazeneca.com/investor relations/stock -交流- announcements/2017/faslodex fulvestrant接收积极- chmp意见- -使用-在- 1 -行激素-受体阳性-高级-乳腺癌癌症- 23062017. - html 2018 - 05 - 02 - t12:53:07.409z https://www.欧洲杯微信买球astrazeneca.com/investor relations/stock -交流- announcements/2017/year - -日期和第四季度- 2016 - 02022017. - html结果 2018 - 07 - 05 - t13:09:10.855z https://www.欧洲杯微信买球astrazeneca.com/investor relations/stock -交流- announcements/2018/transparency指令-投票权利-和-资本- 02012018. - html 2018 - 01 - 10 - t09:53:06.978z https://www.欧洲杯微信买球astrazeneca.com/investor relations/stock -交流- announcements/2018/lynparza接收-审批- -日本- - - - - -高级-卵巢癌症的治疗- - 19012018. - html 2018 - 01 - 18 - t22:10:29.095z https://www.欧洲杯微信买球astrazeneca.com/investor relations/stock -交流- announcements/2018/fasenra接收-审批- -日本- 19012018. - html 2018 - 01 - 19 t06:50:11.511z https://www.欧洲杯微信买球astrazeneca.com/investor relations/stock -交流- announcements/2018/transparency指令-投票权利-和-资本- 01022018. - html 2018 - 02 - 01 - t12:54:13.245z https://www.欧洲杯微信买球astrazeneca.com/investor relations/stock -交流- announcements/2018/director pdmr股权- 05022018. - html 2018 - 02年- 05 - t12:49:22.205z https://www.欧洲杯微信买球astrazeneca.com/investor relations/stock -交流- announcements/2018/selumetinib授予孤儿-药物-设计- - -美国fda的神经纤维瘤-类型1 - 15022018. - html 2018 - 02年- 23 - t07:05:55.188z https://www.欧洲杯微信买球astrazeneca.com/investor relations/stock -交流- announcements/2018/us fda批准- imfinzi - -不可切除的阶段- iii -非小细胞肺-癌症- 19022018. - html 2018 - 02年- 23 - t07:10:12.859z https://www.欧洲杯微信买球astrazeneca.com/investor - relations/stock交换announcements/2018/full年- 2017 results.html 2018 - 02年- 23 - t07:24:03.283z https://www.欧洲杯微信买球astrazeneca.com/investor relations/stock -交流- announcements/2018/astrazeneca报告-前-线- - iii -二氧化钛-阶段试验结果- - - - - - - pt010三-组合疗法-在-慢性阻塞性肺疾病- 26012018. - html 2018 - 02年- 23 - t07:25:41.528z https://www.欧洲杯微信买球astrazeneca.com/investor relations/stock -交流- announcements/2018/lynparza批准- -美国fda在生殖系- brca突变-转移性乳腺癌癌症- 12012018. - html 2018 - 02年- 23 - t07:26:49.386z https://www.欧洲杯微信买球astrazeneca.com/investor - relations/stock交换announcements/2018/astrazeneca -接收-欧盟-审批-的- fasenra - -严重嗜酸性哮喘- 10012018. - html 2018 - 02年- 23 - t07:28:42.973z https://www.欧洲杯微信买球astrazeneca.com/investor relations/stock -交流- announcements/2018/lynparza接收积极-欧盟- chmp意见-铂敏感复发-卵巢癌症- 23022018. - html 2018 - 02年- 23 - t12:25:21.194z https://www.欧洲杯微信买球astrazeneca.com/investor relations/stock -交流- announcements/2018/transparency指令-投票权利-和-资本- 01032018. - html 2018 - 03 - 01 - t13:56:34.867z https://www.欧洲杯微信买球astrazeneca.com/investor - relations/stock交换- announcements/2018/annual -金融- - 06032018. - html报告 2018 - 03 - 06 - t11:17:37.201z https://www.欧洲杯微信买球astrazeneca.com/investor - relations/stock交换announcements/2018/filing - -年度报告的形式——20 - f - - -美国证券和交易委员会——07032018. - html 2018 - 03 - 07 - t06:17:01.658z https://www.欧洲杯微信买球astrazeneca.com/investor relations/stock -交流- announcements/2018/astrazeneca -提供-神秘-试验- -更新时间表- 12032018. - html 2018 - 03 - 12 - t06:35:34.724z https://www.欧洲杯微信买球astrazeneca.com/investor - relations/stock交换- announcements/2018/lokelma批准- - -欧盟- - - - - - -成人的高钾血症治疗- 22032018. - html 2018 - 03 - 22 - t16:56:58.985z https://www.欧洲杯微信买球astrazeneca.com/investor relations/stock -交流- announcements/2018/transactions - -人-管理职责- 26032018. - html 2018 - 03 - 26 - t12:25:21.009z https://www.欧洲杯微信买球astrazeneca.com/investor relations/stock -交流- announcements/2018/transactions - -人-管理职责- 28032018. - html 2018 - 03 - 28 - t12:37:30.439z https://www.欧洲杯微信买球astrazeneca.com/investor - relations/stock交换announcements/2018/the -欧洲-药物-机构-接受监管提交- - lynparza的brca突变her2 - - -转移性乳腺癌癌症- 03042018. - html 2018 - 04 - 03 - t05:42:46.455z https://www.欧洲杯微信买球astrazeneca.com/investor relations/stock -交流- announcements/2018/us fda接受-生物制品许可-应用程序- moxetumomab pasudotox - -毛细胞白血病- 03042018. - html 2018 - 04 - 03 - t06:02:11.906z https://www.欧洲杯微信买球astrazeneca.com/investor relations/stock -交流- announcements/2018/transparency指令-投票权利-和-资本- 030418. - html 2018 - 04 - 03 - t13:18:09.011z https://www.欧洲杯微信买球astrazeneca.com/investor relations/stock -交流- announcements/2018/directorate变化- 050418. - html 2018 - 04 - 04 - t17:31:41.073z https://www.欧洲杯微信买球astrazeneca.com/investor relations/stock -交流- announcements/2018/notice -通用-年会- 13042018. - html 2018 - 04 - 13 - t09:25:22.152z https://www.欧洲杯微信买球astrazeneca.com/investor-relations/stock-exchange-announcements/2018/astrazeneca-reports-results-from-the-arctic-trial-in-third-line-non-small-cell-lung-cancer24042018.html 2018 - 09 - 12 - t16:51:33.058z https://www.欧洲杯微信买球astrazeneca.com/investor relations/stock -交流- announcements/2018/us fda批准tagrisso——- 1号线-治疗- - - - - - - egfr突变-非小细胞肺-癌症- 19042018. - html 2018 - 04 - 27 - t09:29:17.187z https://www.欧洲杯微信买球astrazeneca.com/investor-relations/stock-exchange-announcements/2018/transparency-directive-voting-rights-and-capital01052018.html 2018 - 05 - 01 - t12:48:56.743z https://www.欧洲杯微信买球astrazeneca.com/investor relations/stock -交流- announcements/2018/director宣言- 04052018. - html 2018 - 05 - 04 - t14:51:29.473z https://www.欧洲杯微信买球astrazeneca.com/investor-relations/stock-exchange-announcements/2018/tagrisso-receives-positive-eu-chmp-opinion-for-1st-line-treatment-of-egfr-mutated-non-small-cell-lung-cancer27042018.html 2018 - 05 - 07 - t12:13:11.849z https://www.欧洲杯微信买球astrazeneca.com/investor-relations/stock-exchange-announcements/2018/astrazeneca-and-luye-pharma-group-enter-agreement-for-rights-to-seroquel-and-seroquel-xr-in-the-uk-china-and-othe-international-markets.html 2018 - 05 - 08 - t14:48:09.351z https://www.欧洲杯微信买球astrazeneca.com/investor - relations/stock交换announcements/2018/astrazeneca -提供-更新galathea - - iii期临床试验——fasenra -在-慢性阻塞性肺疾病- 11052018. - html 2018 - 08 - 22 - t13:53:18.415z https://www.欧洲杯微信买球astrazeneca.com/investor-relations/stock-exchange-announcements/2018/lynparza-tablets-receive-eu-approval-for-the-treatment-of-platinum-sensitive-relapsed-ovarian-cancer08052018.html 2018 - 05 - 10 - t18:17:49.162z https://www.欧洲杯微信买球astrazeneca.com/investor relations/stock announcements/2018/q1 - 2018 results.html——交换 2018 - 05 - 18 - t06:21:36.168z https://www.欧洲杯微信买球astrazeneca.com/investor relations/stock -交流- announcements/2018/results - - -一般年会举行的5月- 18 - 2018. - html 2018 - 09 - 12 - t16:11:20.250z https://www.欧洲杯微信买球astrazeneca.com/investor - relations/stock交换- announcements/2018/regulatory提交- -日本- - - - - - - forxiga - - - 1型糖尿病- 21052018. - html 2018 - 08 - 22 - t13:45:06.939z https://www.欧洲杯微信买球astrazeneca.com/investor relations/stock -交流- announcements/2018/lokelma批准————————————成年人的-治疗高钾血症- 21052018. html 2018 - 08 - 22 - t13:39:31.387z https://www.欧洲杯微信买球astrazeneca.com/investor relations/stock -交流- announcements/2018/imfinzi显著提高整体生存-在-相- iii -太平洋-试验- -不可切除的阶段- iii -非小细胞肺-癌症- 25052018. - html 2018 - 05 - 25 - t05:33:17.429z https://www.欧洲杯微信买球astrazeneca.com/investor - relations/stock交换- announcements/2018/update•艾伯特- - iii期临床试验——fasenra -在-慢性阻塞性肺疾病- 30052018. - html 2018 - 08 - 22 - t13:51:16.206z https://www.欧洲杯微信买球astrazeneca.com/investor-relations/stock-exchange-announcements/2018/director-declaration01062018.html 2018 - 06 - 01 - t09:59:52.547z https://www.欧洲杯微信买球astrazeneca.com/investor relations/stock -交流- announcements/2018/block清单-临时审查- 01062018. - html 2018 - 06 - 01 - t11:37:19.456z https://www.欧洲杯微信买球astrazeneca.com/investor relations/stock -交流- announcements/2018/transparency指令-投票权利-和-资本- 01062018. - html 2018 - 06 - 01 - t11:39:26.223z https://www.欧洲杯微信买球astrazeneca.com/investor relations/stock -交流- announcements/2018/director宣言- 08062018. - html 2018 - 06 - 07 - t17:47:55.339z https://www.欧洲杯微信买球astrazeneca.com/investor - relations/stock交换announcements/2018/the -欧盟批准tagrisso - -第一线治疗的- egfr突变-非小细胞肺-癌症- 08062018. - html 2018 - 06 - 08 - t16:39:11.797z https://www.欧洲杯微信买球astrazeneca.com/investor relations/stock -交流- announcements/2018/update - - - iii期临床试验————lanabecestat - -老年痴呆症病- 12062018. - html 2018 - 06 - 18岁t16:23:45.192z https://www.欧洲杯微信买球astrazeneca.com/investor relations/stock -交流- announcements/2018/publication招股说明书- 21062018. - html 2018 - 06 - 25 - t17:20:06.822z https://www.欧洲杯微信买球astrazeneca.com/investor-relations/stock-exchange-announcements/2018/astrazeneca-prices-a- bn -债券-问题- 15082018. - 3美元的html 2018 - 08 - 15 - t05:30:49.131z https://www.欧洲杯微信买球astrazeneca.com/investor relations/stock -交流- announcements/2018/director宣言- 26062018. - html 2018 - 06 - 26 - t05:08:36.176z https://www.欧洲杯微信买球astrazeneca.com/investor-relations/stock-exchange-announcements/2018/lynparza-significantly-delays-disease-progression-in-phase-iii-1st-line-solo-1-trial-for-ovarian-cancer27062018.html 2018 - 06 - 27 - t06:22:04.501z https://www.欧洲杯微信买球astrazeneca.com/investor - relations/stock交换announcements/2018/agreement -与-绿叶制药集团——权利-思瑞康-和-思瑞康- xr - - -英国-中国-和-其他-国际市场-完成- 28062018. - html 2018 - 06 - 27 - t15:15:09.279z https://www.欧洲杯微信买球astrazeneca.com/investor relations/stock -交流- announcements/2018/bydureon接收积极-欧盟- chmp意见-新- bcise -设备- - - - - - - - - - 2型糖尿病患者29062018. - html 2018 - 06 - 29 t12:45:08.989z https://www.欧洲杯微信买球astrazeneca.com/investor relations/stock -交流- announcements/2018/lynparza批准-在-日本- brca突变-转移性乳腺癌癌症- 02072018. - html 2018 - 06 - 29 t16:07:54.615z https://www.欧洲杯微信买球astrazeneca.com/investor - relations/stock交换- announcements/2018/imfinzi批准- -日本- - - -不可切除的阶段- iii -非小细胞肺-癌症- 02072018. - html 2018 - 06 - 29 t16:28:35.390z https://www.欧洲杯微信买球astrazeneca.com/investor-relations/stock-exchange-announcements/2018/transparency-directive-voting-rights-and-capital02072018.html 2018 - 07 - 02 - t13:50:41.018z https://www.欧洲杯微信买球astrazeneca.com/investor relations/stock -交流- announcements/2018/tr - 1 - - -通知- - - -主要股权- 18072018. - html 2018 - 07 - 23 - t16:13:34.122z https://www.欧洲杯微信买球astrazeneca.com/investor relations/stock -交流- announcements/2018/atacand被转让股权- - cheplapharm在欧洲- 240718. - html 2018 - 08 - 10 - t14:03:15.455z https://www.欧洲杯微信买球astrazeneca.com/investor - relations/stock交换announcements/2018/h1 - 2018 - 26072018. - html结果 2018 - 07 - 26 - t06:27:43.439z https://www.欧洲杯微信买球astrazeneca.com/investor relations/stock -交流- announcements/2018/imfinzi收到积极的欧盟- chmp意见- -本地先进-不可切除的非小细胞肺-癌症27072018. - html 2018 - 08 - 01 - t11:18:24.788z https://www.欧洲杯微信买球astrazeneca.com/investor-relations/stock-exchange-announcements/2018/transparency-directive-voting-rights-and-capital01082018.html 2018 - 08 - 01 - t11:09:04.816z https://www.欧洲杯微信买球astrazeneca.com/investor relations/stock -交流- announcements/2018/selumetinib授予孤儿——指定-欧洲- -神经纤维瘤类型1 - 03082018. - html 2018 - 08 - 03 - t05:51:38.974z https://www.欧洲杯微信买球astrazeneca.com/investor - relations/stock交换- announcements/2018/tagrisso批准- -日本- 1号线-治疗-的- egfr突变-非小细胞肺-癌症- 21082018. - html 2018 - 08 - 21 - t05:58:05.632z https://www.欧洲杯微信买球astrazeneca.com/investor-relations/stock-exchange-announcements/2018/astrazeneca-provides-update-on-aeristo-phase-iiib-trial-for-bevespi-aerosphere-in-chronic-obstructive-pulmonary-disease23082018.html 2018 - 09 - 12 - t12:24:26.157z https://www.欧洲杯微信买球astrazeneca.com/investor-relations/stock-exchange-announcements/2018/european-commission-approves-new-easy-to-use-once-weekly-bydureon-bcise-device-for-patients-with-type-2-diabetes30082018.html 2018 - 08 - 30 - t05:01:55.026z https://www.欧洲杯微信买球astrazeneca.com/investor relations/stock -交换- announcements/2018/update郁金香- 1 - - iii期临床试验——anifrolumab -系统性红斑狼疮- 31082018. - html 2018 - 08 - 30 - t21:48:16.908z https://www.欧洲杯微信买球astrazeneca.com/investor relations/stock -交流- announcements/2018/transparency指令-投票权利-和-资本- 03092018. - html 2018 - 09 - 03 - t12:54:29.659z https://www.欧洲杯微信买球astrazeneca.com/investor relations/stock -交流- announcements/2018/board约会- 06092018. - html 2018 - 09 - 05 - t17:31:02.202z https://www.欧洲杯微信买球astrazeneca.com/investor relations/stock -交流- announcements/2018/tezepelumab授予-突破-治疗名称- 07092018. -美国fda - html 2018 - 09 - 07 - t05:14:24.851z https://www.欧洲杯微信买球astrazeneca.com/investor-relations/stock-exchange-announcements/2018/us-fda-approves-lumoxiti-moxetumomab-pasudotox-tdfk-for-certain-patients-with-relapsed-or-refractory-hairy-cell-leukaemia.html 2018 - 09 - 14 - t06:25:49.529z https://www.欧洲杯微信买球astrazeneca.com/investor-relations/results-and-presentations.html 2021 - 06 - 14 - t08:38:55.562z https://www.欧洲杯微信买球astrazeneca.com/investor-relations/annual-reports.html 2021 - 02 - 14 - t20:31:29.758z https://www.欧洲杯微信买球astrazeneca.com/investor - relations/annual reports/annual - - 2015. - html报告 2017 - 04 - 21 - t12:45:51.045z https://www.欧洲杯微信买球astrazeneca.com/investor-relations/annual-reports/annual-report-2015/cautionary-statement.html 2017 - 02年- 27 - t14:22:30.013z https://www.欧洲杯微信买球astrazeneca.com/investor-relations/annual-reports/annual-report-2015/reader-information.html 2017 - 04 - 21 - t12:45:51.043z https://www.欧洲杯微信买球astrazeneca.com/investor-relations/annual-reports/annual-report-2015/contact-information.html 2017 - 02年- 15 - t10:16:47.190z https://www.欧洲杯微信买球astrazeneca.com/investor - relations/annual reports/annual - - 2016. - html报告 2017 - 04 - 21 - t12:45:51.046z https://www.欧洲杯微信买球astrazeneca.com/investor-relations/annual-reports/annual-report-2016/contact-information.html 2017 - 03 - 02 - t13:14:01.195z https://www.欧洲杯微信买球astrazeneca.com/investor-relations/annual-reports/annual-report-2016/annual-report-and-cautionary-statement.html 2017 - 03 - 03 - t09:05:22.380z https://www.欧洲杯微信买球astrazeneca.com/investor - relations/annual reports/annual - - 2017. - html报告 2018 - 04 - 13 - t09:36:51.904z https://www.欧洲杯微信买球astrazeneca.com/investor - relations/annual reports/annual - - 2018. - html报告 2019 - 04 - 15 - t11:32:45.801z https://www.欧洲杯微信买球astrazeneca.com/investor - relations/annual reports/annual - - 2019. - html报告 2020 - 03 - 16 - t10:07:34.828z https://www.欧洲杯微信买球astrazeneca.com/investor - relations/annual reports/annual - - 2020. - html报告 2021 - 04 - 07 - t10:27:00.528z https://www.欧洲杯微信买球astrazeneca.com/investor-relations/corporate-governance.html 2021 - 05 - 11 - t20:21:12.597z https://www.欧洲杯微信买球astrazeneca.com/investor-relations/shareholder-information.html 2021 - 06 - 14 - t08:50:56.321z https://www.欧洲杯微信买球astrazeneca.com/investor-relations/dividend-policy.html 2021 - 02 - 11 - t11:49:55.140z https://www.欧洲杯微信买球astrazeneca.com/investor-relations/key-facts.html 2021 - 06 - 14 - t08:52:50.445z https://www.欧洲杯微信买球astrazeneca.com/investor-relations/faqs.html 2021 - 02年- 19 - t17:12:28.182z https://www.欧洲杯微信买球astrazeneca.com/investor-relations/debt-investors.html 2021 - 06 - 07 - t10:58:28.958z https://www.欧洲杯微信买球astrazeneca.com/investor-relations/debt-investors/emtn-programme.html 2021 - 06 - 02 - t09:29:56.886z https://www.欧洲杯微信买球astrazeneca.com/investor-relations/events.html 2021 - 06 - 14 - t08:49:56.995z https://www.欧洲杯微信买球astrazeneca.com/investor-relations/astrazeneca-adr-programme.html 2021 - 06 - 14 - t08:53:18.570z https://www.欧洲杯微信买球astrazeneca.com/investor-relations/AIR.html 2021 - 02 - 11 - t14:29:41.019z https://www.欧洲杯微信买球astrazeneca.com/investor-relations/AIR/欧洲杯足彩冠军sustainability.html 2021 - 02年- 05 - t09:59:12.665z https://www.欧洲杯微信买球astrazeneca.com/investor-relations/AIR/欧洲杯足彩冠军sustainability/access-to-health-care.html 2021 - 02年- 05 - t09:59:58.998z https://www.欧洲杯微信买球astrazeneca.com/investor-relations/AIR/欧洲杯足彩冠军sustainability/access-to-health-care/disease-prevention-and-treatment.html 2021 - 02 - 09 - t07:55:12.630z https://www.欧洲杯微信买球astrazeneca.com/investor-relations/AIR/欧洲杯足彩冠军sustainability/access-to-health-care/affordability.html 2021 - 02 - 09 - t07:41:33.822z https://www.欧洲杯微信买球astrazeneca.com/investor-relations/AIR/欧洲杯足彩冠军sustainability/access-to-health-care/investment-in-health-systems.html 2021 - 02 - 09 - t07:41:55.215z https://www.欧洲杯微信买球astrazeneca.com/investor-relations/AIR/欧洲杯足彩冠军sustainability/environmental-protection.html 2021 - 02年- 08 - t07:34:44.103z https://www.欧洲杯微信买球astrazeneca.com/investor-relations/AIR/欧洲杯足彩冠军sustainability/environmental-protection/environmental-compliance.html 2021 - 02 - 09 - t07:51:07.327z https://www.欧洲杯微信买球astrazeneca.com/investor-relations/AIR/欧洲杯足彩冠军sustainability/environmental-protection/green-house-gas-reduction.html 2021 - 02 - 09 - t07:51:36.826z https://www.欧洲杯微信买球astrazeneca.com/investor-relations/AIR/欧洲杯足彩冠军sustainability/environmental-protection/pharmaceutical-in-the-environment.html 2021 - 02 - 09 - t07:51:55.467z https://www.欧洲杯微信买球astrazeneca.com/investor-relations/AIR/欧洲杯足彩冠军sustainability/environmental-protection/product-environmental-stewardship.html 2021 - 02 - 09 - t07:52:17.028z https://www.欧洲杯微信买球astrazeneca.com/investor-relations/AIR/欧洲杯足彩冠军sustainability/environmental-protection/waste-management.html 2021 - 02 - 09 - t07:52:30.975z https://www.欧洲杯微信买球astrazeneca.com/investor-relations/AIR/欧洲杯足彩冠军sustainability/environmental-protection/water-stewardship.html 2021 - 02 - 09 - t08:39:15.797z https://www.欧洲杯微信买球astrazeneca.com/investor-relations/AIR/欧洲杯足彩冠军sustainability/ethics-and-transparency.html 2021 - 02年- 05 - t12:16:08.406z https://www.欧洲杯微信买球astrazeneca.com/investor-relations/AIR/欧洲杯足彩冠军sustainability/ethics-and-transparency/bio-ethics.html 2021 - 02 - 09 - t07:55:21.445z https://www.欧洲杯微信买球astrazeneca.com/investor-relations/AIR/欧洲杯足彩冠军sustainability/ethics-and-transparency/inclusion-and-diversity.html 2021 - 02 - 09 - t08:04:59.120z https://www.欧洲杯微信买球astrazeneca.com/investor-relations/AIR/欧洲杯足彩冠军sustainability/ethics-and-transparency/talent-and-workforce-evolution.html 2021 - 02 - 09 - t16:02:40.869z https://www.欧洲杯微信买球astrazeneca.com/investor-relations/AIR/欧洲杯足彩冠军sustainability/ethics-and-transparency/workforce-wellbeing-and-safety.html 2021 - 02 - 09 - t08:05:19.137z https://www.欧洲杯微信买球astrazeneca.com/investor-relations/AIR/欧洲杯足彩冠军sustainability/ethics-and-transparency/human-rights.html 2021 - 02 - 09 - t08:05:43.924z https://www.欧洲杯微信买球astrazeneca.com/investor-relations/AIR/欧洲杯足彩冠军sustainability/ethics-and-transparency/responsible-supply-chain.html 2021 - 02 - 09 - t08:06:01.673z https://www.欧洲杯微信买球astrazeneca.com/investor-relations/AIR/欧洲杯足彩冠军sustainability/ethics-and-transparency/philanthropy.html 2021 - 02 - 09 - t08:06:15.958z https://www.欧洲杯微信买球astrazeneca.com/investor-relations/AIR/欧洲杯足彩冠军sustainability/ethics-and-transparency/product-safety.html 2021 - 02 - 09 - t08:06:45.367z https://www.欧洲杯微信买球astrazeneca.com/investor-relations/AIR/欧洲杯足彩冠军sustainability/ethics-and-transparency/quality-manufacturing.html 2021 - 02 - 09 - t08:06:56.793z https://www.欧洲杯微信买球astrazeneca.com/investor-relations/AIR/欧洲杯足彩冠军sustainability/ethics-and-transparency/ethical-business-culture.html 2021 - 02 - 09 - t08:04:26.152z https://www.欧洲杯微信买球astrazeneca.com/investor relations/meet -有-管理-肿瘤- 2021 asco meeting.html——年度 2021 - 06 - 08 - t12:37:30.672z https://www.欧洲杯微信买球astrazeneca.com/partnering.html 2021 - 06 - 07 - t16:20:24.609z https://www.欧洲杯微信买球astrazeneca.com/partnering/partnering-case-studies/health-innovation-hubs-in-emerging-markets.html 2020 - 09 - 30 - t06:52:05.956z https://www.欧洲杯微信买球astrazeneca.com/partnering/our-partnering-teams.html 2021 - 05 - 25 - t12:44:26.109z https://www.欧洲杯微信买球astrazeneca.com/partnering/our-areas-of-partnering-interest.html 2021 - 05 - 28 - t15:48:07.606z https://www.欧洲杯微信买球astrazeneca.com/partnering/why-partner-with-astrazeneca.html 2021 - 05 - 25 - t12:44:08.301z https://www.欧洲杯微信买球astrazeneca.com/partnering/secrets-to-successful-partnering.html 2021 - 05 - 25 - t12:45:13.617z https://www.欧洲杯微信买球astrazeneca.com/partnering/externally-sponsored-scientific-research.html 2021 - 06 - 16 - t15:39:36.694z https://www.欧洲杯微信买球astrazeneca.com/partnering/Externally-sponsored-scientific-research-training-centre.html 2020 - 06 - 17 t11:11:56.971z https://www.欧洲杯微信买球astrazeneca.com/partnering/external-funding.html 2021 - 03 - 03 - t21:04:39.853z https://www.欧洲杯微信买球astrazeneca.com/terms-and-conditions.html 2021 - 05 - 25 - t14:34:38.806z https://www.欧洲杯微信买球astrazeneca.com/what-science-can-do.html 2021 - 06 - 15 - t16:31:36.724z https://www.欧洲杯微信买球astrazeneca.com/what-science-can-do/topics/disease-understanding.html 2021 - 05 - 13 - t08:43:51.747z https://www.欧洲杯微信买球astrazeneca.com/what-science-can-do/topics/disease-understanding/refining-cardiovascular-regenerative-medicine.html 2020 - 09 - 16 - t10:38:18.995z https://www.欧洲杯微信买球astrazeneca.com/what-science-can-do/topics/disease-understanding/opening-the-black-box-between-our-genotype-and-phenotype.html 2020 - 09 - 16 - t10:39:04.747z https://www.欧洲杯微信买球astrazeneca.com/what-science-can-do/topics/disease-understanding/improving-our-understanding-of-how-cells-work.html 2020 - 09 - 16 - t10:39:38.142z https://www.欧洲杯微信买球astrazeneca.com/what-science-can-do/topics/disease-understanding/digging-deeper-into-the-secrets-of-the-secretome.html 2020 - 09 - 16 - t10:40:11.654z https://www.欧洲杯微信买球astrazeneca.com/what-science-can-do/topics/disease-understanding/at-the-cutting-edge-of-regenerative-medicine.html 2020 - 09 - 16 - t11:32:51.521z https://www.欧洲杯微信买球astrazeneca.com/what-science-can-do/topics/disease-understanding/towards-our-genomics-ambition-new-whole-genome-sequencing-collaboration.html 2020 - 09 - 16 - t11:37:07.650z https://www.欧洲杯微信买球astrazeneca.com/what-science-can-do/topics/disease-understanding/repairing-old-lungs-to-address-unmet-patient-needs.html 2020 - 09 - 16 - t11:36:29.657z https://www.欧洲杯微信买球astrazeneca.com/what-science-can-do/topics/disease-understanding/transforming-astrazenecas-rd-productivity.html 2020 - 09 - 18 - t14:15:31.384z https://www.欧洲杯微信买球astrazeneca.com/what -科学-能- do/topics/disease understanding/transforming -阿斯利康rd -效率- 2. - html 2020 - 09 - 15 - t17:20:15.125z https://www.欧洲杯微信买球astrazeneca.com/what-science-can-do/topics/disease-understanding/making-the-connection-targeting-multiple-mechanisms-in-heart-failure.html 2020 - 11 - 16 - t15:59:24.906z https://www.欧洲杯微信买球astrazeneca.com/what -科学-可以do/topics/disease understanding/making - -连接-针对多个机制- -心-失败- 2. html 2020 - 09 - 29 - t09:15:17.174z https://www.欧洲杯微信买球astrazeneca.com/what-science-can-do/topics/disease-understanding/uncovering-the-role-of-interferons-in-immune-driven-inflammatory.html 2021 - 02 - 09 - t12:39:16.877z https://www.欧洲杯微信买球astrazeneca.com/what-science-can-do/topics/disease-understanding/can-improved-understanding-of-the-airway-epithelium-provide-new-insight-into-asthma.html 2021 - 02 - 09 - t12:33:06.882z https://www.欧洲杯微信买球astrazeneca.com/what-science-can-do/topics/disease-understanding/what-does-immunogenicity-mean-in-the-context-of-covid-19-vaccines.html 2021 - 05 - 26 - t10:14:11.882z https://www.欧洲杯微信买球astrazeneca.com/what-science-can-do/topics/disease-understanding/a-vaccination-program-to-meet-the-needs-of-a-global-pandemic.html 2021 - 05 - 14 - t08:19:05.983z https://www.欧洲杯微信买球astrazeneca.com/what -科学-能- do/topics/disease understanding/the -自然进化- - sars - x - 2.的html 2021 - 05 - 14 - t08:27:38.774z https://www.欧洲杯微信买球astrazeneca.com/what-science-can-do/topics/disease-understanding/pioneers-in-asthma-where-is-the-science-leading-us.html 2021 - 03 - 02 - t14:43:07.312z https://www.欧洲杯微信买球astrazeneca.com/what-science-can-do/topics/disease-understanding/achieving-diversity-in-vaccine-clinical-trials.html 2021 - 05 - 14 - t08:24:27.663z https://www.欧洲杯微信买球astrazeneca.com/what-science-can-do/topics/disease-understanding/Hitting-the-bullseye-finding-better-targets-for-drug-development.html 2021 - 04 - 22 - t10:36:19.027z https://www.欧洲杯微信买球astrazeneca.com/what-science-can-do/topics/disease-understanding/nash-a-new-approach-brings-new-hope.html 2021 - 06 - 10 - t12:56:08.347z https://www.欧洲杯微信买球astrazeneca.com/what-science-can-do/topics/next-generation-therapeutics.html 2021 - 05 - 13 - t08:44:47.916z https://www.欧洲杯微信买球astrazeneca.com/what-science-can-do/topics/next-generation-therapeutics/designing-the-first-ever-trial-for-an-mrna-based-therapeutic.html 2020 - 09 - 16 - t11:31:54.657z https://www.欧洲杯微信买球astrazeneca.com/what-science-can-do/topics/next-generation-therapeutics/aiming-for-disease-modification-in-respiratory-disease.html 2020 - 09 - 16 - t10:48:19.183z https://www.欧洲杯微信买球astrazeneca.com/what-science-can-do/topics/next-generation-therapeutics/transforming-the-future-of-care-for-COPD-patients.html 2020 - 10 - 19 - t06:43:21.167z https://www.欧洲杯微信买球astrazeneca.com/what-science-can-do/topics/next-generation-therapeutics/lighting-the-path-to-simplified-chemical-reactions.html 2020 - 09 - 16 - t10:46:46.079z https://www.欧洲杯微信买球astrazeneca.com/what-science-can-do/topics/next-generation-therapeutics/astrazeneca-shows-potential-of-gene-silencing-in-pancreatic-cells.html 2020 - 09 - 16 - t10:46:06.947z https://www.欧洲杯微信买球astrazeneca.com/what-science-can-do/topics/next-generation-therapeutics/the-dawn-of-a-new-era-in-chronic-kidney-disease.html 2020 - 09 - 16 - t09:05:24.369z https://www.欧洲杯微信买球astrazeneca.com/what -科学-能- do/topics/next -代therapeutics/the - - - -新时代的黎明-慢性肾脏疾病- 2. - html 2020 - 09 - 14 - t16:24:12.247z https://www.欧洲杯微信买球astrazeneca.com/what-science-can-do/topics/next-generation-therapeutics/entering-a-new-era-in-vascular-and-cardiac-regeneration-research.html 2020 - 10 - 01 - t13:27:07.774z https://www.欧洲杯微信买球astrazeneca.com/what -科学-能- do/topics/next -代therapeutics/entering - -新时代- -血管和心脏-再生-研究- 2. - html 2020 - 09 - 14 - t16:24:12.232z https://www.欧洲杯微信买球astrazeneca.com/what-science-can-do/topics/next-generation-therapeutics/developing-the-next-generation-of-drug-delivery-technologies.html 2020 - 09 - 16 - t09:07:03.809z https://www.欧洲杯微信买球astrazeneca.com/what -科学-能- do/topics/next -代therapeutics/developing - -下一代的药物-交货-技术- 2. - html 2020 - 09 - 14 - t16:24:12.245z https://www.欧洲杯微信买球astrazeneca.com/what-science-can-do/topics/next-generation-therapeutics/targeting-progression-of-liver-damage-in-nash.html 2020 - 09 - 16 - t09:07:39.511z https://www.欧洲杯微信买球astrazeneca.com/what -科学-能- do/topics/next -代therapeutics/targeting - - -肝损害的进展纳什- 2. - html 2020 - 09 - 14 - t16:24:12.255z https://www.欧洲杯微信买球astrazeneca.com/what-science-can-do/topics/next-generation-therapeutics/advancing-the-safety-of-crispr-as-a-potential-future-therapeutic.html 2020 - 09 - 16 - t10:49:31.987z https://www.欧洲杯微信买球astrazeneca.com/what-science-can-do/topics/next-generation-therapeutics/assessing-blood-flow-to-guide-clinical-intervention-in-heart-disease.html 2020年10月- 07 - t09:42:47.542z https://www.欧洲杯微信买球astrazeneca.com/what-science-can-do/topics/next-generation-therapeutics/xential-accelerating-the-creation-of-new-disease-models-with-crispr.html 2021 - 02 - 03 - t15:43:31.932z https://www.欧洲杯微信买球astrazeneca.com/what-science-can-do/topics/next-generation-therapeutics/transforming-treatment-paradigms-with-cell-therapy.html 2021 - 02 - 16 - t09:57:14.287z https://www.欧洲杯微信买球astrazeneca.com/what-science-can-do/topics/next-generation-therapeutics/defining-cell-proliferation-tracing-for-regeneration-research.html 2021 - 02年- 26 - t18:30:44.680z https://www.欧洲杯微信买球astrazeneca.com/what-science-can-do/topics/next-generation-therapeutics/New-insights-to-broaden-therapeutic-opportunities-of-oligonucleotides.html 2021 - 04 - 16 - t09:52:12.529z https://www.欧洲杯微信买球astrazeneca.com/what-science-can-do/topics/next-generation-therapeutics/transforming-treatment-for-billions-of-people-living-with-chronic-diseases.html 2021 - 05 - 07 - t08:25:14.774z https://www.欧洲杯微信买球astrazeneca.com/what-science-can-do/topics/predicting-clinical-success.html 2021 - 05 - 13 - t08:45:19.959z https://www.欧洲杯微信买球astrazeneca.com/what-science-can-do/topics/predicting-clinical-success/organs-on-chips-enhancing-our-ability-to-translate-science-into-medicines.html 2020 - 09 - 16 - t10:51:44.480z https://www.欧洲杯微信买球astrazeneca.com/what-science-can-do/topics/predicting-clinical-success/pushing-the-boundaries-of-science-through-kidney-organoid-research.html 2020 - 09 - 16 - t10:51:11.090z https://www.欧洲杯微信买球astrazeneca.com/what-science-can-do/topics/predicting-clinical-success/ddr-and-unravelling-the-complexities-of-hhr-and-hrd-diagnostic-testing.html 2021 - 04 - 06 - t08:00:54.698z https://www.欧洲杯微信买球astrazeneca.com/what-science-can-do/topics/clinical-innovation.html 2021 - 06 - 15 - t15:20:00.542z https://www.欧洲杯微信买球astrazeneca.com/what-science-can-do/topics/clinical-innovation/digitally-transforming-rd-to-help-improve-patient-outcomes.html 2020 - 10 - 29 - t12:11:43.298z https://www.欧洲杯微信买球astrazeneca.com/what -科学-可以do/topics/clinical innovation/harnessing -数字-和-科技- -维护- rd -交货-在- covid - 19. - html 2021 - 05 - 14 - t08:31:52.268z https://www.欧洲杯微信买球astrazeneca.com/what-science-can-do/topics/clinical-innovation/innovative-analytics-bridging-the-gap-between-science-and-patient.html 2020 - 09 - 16 - t09:08:20.719z https://www.欧洲杯微信买球astrazeneca.com/what -科学-能- do/topics/clinical innovation/innovative -分析-弥合差距- -科学与病人- 2. - html 2020 - 09 - 14 - t16:24:12.217z https://www.欧洲杯微信买球astrazeneca.com/what-science-can-do/topics/clinical-innovation/learning-from-patients-to-make-research-participation-less-of-a-trial.html 2021 - 02年- 18 - t09:39:21.325z https://www.欧洲杯微信买球astrazeneca.com/what-science-can-do/topics/clinical-innovation/digital-therapeutics-augmenting-patient-health-outcomes.html 2021 - 06 - 17 t16:13:45.025z https://www.欧洲杯微信买球astrazeneca.com/what-science-can-do/topics/clinical-innovation/scaling-digital-health-solutions-to-transform-medicine-development.html 2021 - 06 - 14 - t15:09:30.589z https://www.欧洲杯微信买球astrazeneca.com/what-science-can-do/topics/technologies.html 2021 - 05 - 13 - t08:46:55.982z https://www.欧洲杯微信买球astrazeneca.com/what -科学-能- do/topics/technologies/innovating -生产-和-生产- - -的-挑战covid见面- 19. - html 2021 - 03 - 03 - t21:27:45.416z https://www.欧洲杯微信买球astrazeneca.com/what -科学-能- do/topics/technologies/innovating -生产-和-生产- - -的-挑战covid见面- 19 - 2. - html 2021 - 01 - 29 t11:55:33.137z https://www.欧洲杯微信买球astrazeneca.com/what-science-can-do/topics/technologies/pushing-boundaries-to-deliver-covid-19-vaccine-accross-the-globe.html 2021 - 03 - 03 - t12:43:13.164z https://www.欧洲杯微信买球astrazeneca.com/what -科学- do/topics/technologies/pushing边界——-传递- covid - 19 -疫苗中平铺- -地球- 2. - html 2021 - 01 - 29 t11:56:34.227z https://www.欧洲杯微信买球astrazeneca.com/what-science-can-do/topics/technologies/a-global-approach-to-overcoming-the-covid-19-pandemic.html 2021 - 05 - 14 - t08:26:17.779z https://www.欧洲杯微信买球astrazeneca.com/what-science-can-do/topics/data-science-ai.html 2021 - 05 - 13 - t08:47:24.004z https://www.欧洲杯微信买球astrazeneca.com/what-science-can-do/topics/data-science-ai/ai-sweden-joining-forces-to-help-answer-big-questions-in-ai.html 2020 - 09 - 16 - t11:29:08.530z https://www.欧洲杯微信买球astrazeneca.com/what-science-can-do/topics/data-science-ai/how-data-and-ai-are-helping-unlock-the-secrets-of-disease.html 2020 - 09 - 16 - t10:56:31.389z https://www.欧洲杯微信买球astrazeneca.com/what-science-can-do/topics/data-science-ai/democratising-data-from-no-to-know.html 2020 - 09 - 16 - t11:26:25.969z https://www.欧洲杯微信买球astrazeneca.com/what-science-can-do/topics/data-science-ai/transforming-the-way-we-do-clinical-trials-with-data-science-and-ai.html 2020 - 09 - 16 - t10:57:57.081z https://www.欧洲杯微信买球astrazeneca.com/what-science-can-do/topics/data-science-ai/Embracing-the-ethics-of-data-and-AI.html 2020 - 11 - 06 - t10:15:31.838z https://www.欧洲杯微信买球astrazeneca.com/what-science-can-do/topics/data-science-ai/uniting-human-and-machine-intelligence-for-drug-discovery.html 2021 - 04 - 08 - t08:26:04.116z https://www.欧洲杯微信买球astrazeneca.com/what-science-can-do/topics/data-science-ai/targeting-the-drivers-of-immune-mediated-diseases.html 2021 - 06 - 10 - t15:13:23.944z https://www.欧洲杯微信买球astrazeneca.com/what-science-can-do/topics/欧洲杯足彩冠军sustainability.html 2021 - 05 - 13 - t08:47:55.854z https://www.欧洲杯微信买球astrazeneca.com/what-science-can-do/topics/欧洲杯足彩冠军sustainability/how-rd-is-helping-drive-a-greener-future.html 2020 - 12 - 07 - t14:15:37.565z https://www.欧洲杯微信买球astrazeneca.com/what-science-can-do/topics/欧洲杯足彩冠军sustainability/how-rd-is-helping-drive-a-greener-future2.html 2020 - 12 - 07 - t13:46:49.043z https://www.欧洲杯微信买球astrazeneca.com/what -科学-能- do/topics/covid - 19. - html 2021 - 06 - 15 - t09:36:35.976z https://www.欧洲杯微信买球astrazeneca.com/what-science-can-do/topics/covid-19/understanding-immunogenicity.html 2021 - 06 - 11 - t14:38:20.863z https://www.欧洲杯微信买球astrazeneca.com/what-science-can-do/topics/covid-19/understanding-viral-variants.html 2021 - 06 - 15 - t09:37:53.273z https://www.欧洲杯微信买球astrazeneca.com/what-science-can-do/artificial-intelligence.html 2020 - 08 - 12 - t12:31:44.514z https://www.欧洲杯微信买球astrazeneca.com/what-science-can-do/stories/why-health-system-resilience-is-key-to-a-sustainable-future.html 2020 - 09 - 23 - t08:36:26.067z https://www.欧洲杯微信买球astrazeneca.com/what-science-can-do/our-technology.html 2019 - 11 - 12 - t14:48:26.324z https://www.欧洲杯微信买球astrazeneca.com/what-science-can-do/labtalk-blog.html 2020 - 06 - 10 - t13:26:17.113z https://www.欧洲杯微信买球astrazeneca.com/what-science-can-do/labtalk-blog/cardiovascular.html 2015 - 12 - 21 - t09:38:04.777z https://www.欧洲杯微信买球astrazeneca.com/what-science-can-do/labtalk-blog/cardiovascular/pushing-the-boundaries-of-science-through-kidney-organoid-research16042019.html 2019 - 04 - 28 - t20:54:46.950z https://www.欧洲杯微信买球astrazeneca.com/what -科学-能- do/labtalk blog/cardiovascular/seeing - -新视角——贫血- -慢性肾脏疾病- 20052019. - html 2019 - 05 - 17 - t13:47:27.832z https://www.欧洲杯微信买球astrazeneca.com/what -科学-能- do/labtalk blog/cardiovascular/understanding旅程- -护理的患者——- cvrm - 30082019. - html 2020 - 01 - 26 t13:52:30.896z https://www.欧洲杯微信买球astrazeneca.com/what -科学-能- do/labtalk blog/cardiovascular/making -慢性肾脏疾病-政策-优先- 28 - 10 - 2019. - html 2020 - 01 - 06 - t13:21:54.901z https://www.欧洲杯微信买球astrazeneca.com/what-science-can-do/labtalk-blog/cardiovascular/hope-for-ckd-proactive-prevention-and-detection-strategies.html 2020 - 03 - 12 - t13:21:19.125z https://www.欧洲杯微信买球astrazeneca.com/what-science-can-do/labtalk-blog/cardiovascular/measuring-blood-flow-changes-in-coronary-arteries-aids-applicati.html 2020 - 08 - 28 - t11:09:35.026z https://www.欧洲杯微信买球astrazeneca.com/what-science-can-do/labtalk-blog/oncology.html 2015 - 12 - 21 - t14:34:39.493z https://www.欧洲杯微信买球astrazeneca.com/what -科学-能- do/labtalk blog/oncology/whats驾驶-中国令人印象深刻的水平- -生物技术创新- 06062019. - html 2019 - 06 - 06 - t16:27:41.696z https://www.欧洲杯微信买球astrazeneca.com/what -科学- do/labtalk blog/oncology/moving -对-可以治愈肺-阿斯利康-承诺- - -野心联盟- 08072019. - html 2019 - 07 - 08 - t17:52:53.077z https://www.欧洲杯微信买球astrazeneca.com/what -科学-能- do/labtalk blog/oncology/brca -基因突变————男人和女人——解决误解- -改善结果在癌症- 29092019. - html 2019 - 10 - 08 - t12:57:18.876z https://www.欧洲杯微信买球astrazeneca.com/what-science-can-do/labtalk-blog/oncology/tipping-the-scales-in-the-fight-against-cancer14112019.html 2020 - 03 - 11 - t15:27:54.678z https://www.欧洲杯微信买球astrazeneca.com/what-science-can-do/labtalk-blog/oncology/raising-awareness-and-lending-a-powerful-voice-to-women-with-ovarian-cancer-to-accelerate-pace-and-progress.html 2020 - 05 - 08 - t16:46:13.736z https://www.欧洲杯微信买球astrazeneca.com/what-science-can-do/labtalk-blog/oncology/collaborative-research-to-advance-innovation-in-oncology.html 2020 - 09 - 17 - t08:09:53.551z https://www.欧洲杯微信买球astrazeneca.com/what-science-can-do/labtalk-blog/gastrointestinal.html 2015 - 12 - 22 - t13:12:08.688z https://www.欧洲杯微信买球astrazeneca.com/what-science-can-do/labtalk-blog/respiratory.html 2020 - 04 - 29 - t14:39:17.254z https://www.欧洲杯微信买球astrazeneca.com/what -科学可以- do/labtalk blog/respiratory/aiming - -病-修改- -呼吸道疾病- 15052019. - html 2019 - 05 - 16 - t11:54:59.915z https://www.欧洲杯微信买球astrazeneca.com/what-science-can-do/labtalk-blog/respiratory/our-ambition-to-improve-rsv-care-for-infants-worldwide.html 2019 - 11 - 24 - t22:30:50.587z https://www.欧洲杯微信买球astrazeneca.com/what-science-can-do/labtalk-blog/respiratory/advancing-research-in-systemic-lupus-erythematosus.html 2020 - 04 - 28 - t19:46:55.896z https://www.欧洲杯微信买球astrazeneca.com/what-science-can-do/labtalk-blog/respiratory/transforming-the-future-of-care-for-copd-patients.html 2020 - 06 - 19 t11:28:15.257z https://www.欧洲杯微信买球astrazeneca.com/what-science-can-do/labtalk-blog/respiratory/delivering-sustainable-transformational-improvements-in-care-for-people-with-severe-asthma.html 2020 - 10 - 29 - t12:08:32.543z https://www.欧洲杯微信买球astrazeneca.com/what-science-can-do/labtalk-blog/respiratory/as-covid-19-continues-its-more-critical-than-ever-to-protect-vulnerable-patients-from-rsv.html 2020 - 10 - 29 - t12:07:17.745z https://www.欧洲杯微信买球astrazeneca.com/what-science-can-do/labtalk-blog/respiratory/redefining-new-standards-of-care-for-people-living-with-severe-asthma.html 2020 - 10 - 29 - t12:05:06.334z https://www.欧洲杯微信买球astrazeneca.com/what-science-can-do/labtalk-blog/respiratory/can-improved-understanding-of-the-airway-epithelium-provide-new-insight-into-asthma.html 2020 - 09 - 04 - t16:22:43.829z https://www.欧洲杯微信买球astrazeneca.com/what-science-can-do/labtalk-blog/infectious-disease.html 2016 - 01 - 15 - t09:59:41.871z https://www.欧洲杯微信买球astrazeneca.com/what-science-can-do/labtalk-blog/collaboration.html 2016 - 01 - 18 - t10:35:50.967z https://www.欧洲杯微信买球astrazeneca.com/what -科学-可以do/labtalk blog/collaboration/creating价值——通过-生产-合作-谈判- 08072019. - html 2020 - 09 - 17 - t08:10:48.284z https://www.欧洲杯微信买球astrazeneca.com/what -科学- - do/labtalk blog/collaboration/towards可以参与我们的基因组学-野心——————————最雄心勃勃的-排序-计划- - - 11092019.进行html 2019 - 09 - 11 - t07:44:46.870z https://www.欧洲杯微信买球astrazeneca.com/what-science-can-do/labtalk-blog/collaboration/organs-on-chips-enhancing-our-ability-to-translate-science-into-innovative-medicines.html 2020 - 02 - 11 - t12:25:02.806z https://www.欧洲杯微信买球astrazeneca.com/what-science-can-do/labtalk-blog/neuroscience.html 2016 - 01 - 19 t15:37:00.723z https://www.欧洲杯微信买球astrazeneca.com/what-science-can-do/labtalk-blog/hot-topics.html 2016 - 01 - 19 t16:29:09.054z https://www.欧洲杯微信买球astrazeneca.com/what-science-can-do/labtalk-blog/uncategorized.html 2016 - 11 - 23 - t14:19:40.580z https://www.欧洲杯微信买球astrazeneca.com/what-science-can-do/labtalk-blog/uncategorized/contract-considerations-for-resolving-partnership-disputes15042019.html 2020 - 09 - 17 - t08:22:47.799z https://www.欧洲杯微信买球astrazeneca.com/what -科学-能- do/labtalk - blog/uncategorized/biotech -创新- - - - - - - - 2019. - chinabio html显示 2019 - 05 - 29 - t09:18:13.548z https://www.欧洲杯微信买球astrazeneca.com/what-science-can-do/labtalk-blog/uncategorized/digging-deeper-into-the-secrets-of-the-secretome.html 2019 - 06 - 13 - t11:03:08.508z https://www.欧洲杯微信买球astrazeneca.com/what-science-can-do/labtalk-blog/uncategorized/data-science-taking-centre-stage-in-cancer-combination-predictions.html 2020 - 09 - 17 - t08:30:54.286z https://www.欧洲杯微信买球astrazeneca.com/what -科学-能- do/labtalk blog/uncategorized/pharmacology之外——-病人-预测-风险- - -环境-制药的馅饼- 01072019. - html 2019 - 07 - 05 - t11:46:21.001z https://www.欧洲杯微信买球astrazeneca.com/what -科学-能- do/labtalk blog/uncategorized/at - -切割边缘-再生医学- 15082019. - html 2019 - 08 - 16 - t16:47:28.050z https://www.欧洲杯微信买球astrazeneca.com/what-science-can-do/labtalk-blog/uncategorized/how-data-and-ai-are-helping-unlock-the-secrets-of-disease.html 2019 - 11 - 01 - t10:41:09.084z https://www.欧洲杯微信买球astrazeneca.com/what-science-can-do/labtalk-blog/uncategorized/democratising-data-from-no-to-know.html 2020 - 01 - 02 - t14:11:20.933z https://www.欧洲杯微信买球astrazeneca.com/what-science-can-do/labtalk-blog/uncategorized/transforming-the-way-we-do-clinical-trials-with-data-science-and.html 2020 - 01 - 02 - t14:13:47.237z https://www.欧洲杯微信买球astrazeneca.com/what-science-can-do/labtalk-blog/uncategorized/environmental-欧洲杯足彩冠军sustainability-for-post-covid-healthcare.html 2020 - 06 - 23 - t12:37:29.622z https://www.欧洲杯微信买球astrazeneca.com/what-science-can-do/labtalk-blog/uncategorized/digital-health-improving-patient-outcomes-through-digitally-transformed-rd.html 2020 - 06 - 19 t08:48:54.185z https://www.欧洲杯微信买球astrazeneca.com/what -科学-可以do/labtalk blog/uncategorized/pivoting——————大流行-利用-数字和技术解决方案-维护- rd -交货- - covid - 19. - html 2020 - 06 - 19 t08:48:21.340z https://www.欧洲杯微信买球astrazeneca.com/what-science-can-do/labtalk-blog/authors.html 2016 - 01 - 28 - t10:24:07.902z https://www.欧洲杯微信买球astrazeneca.com/what-science-can-do/labtalk-blog/authors/rongchang-chen-md-phd.html 2017 - 07 - 06 - t13:28:57.418z https://www.欧洲杯微信买球astrazeneca.com/what-science-can-do/labtalk-blog/authors/peter-smethurst.html 2017 - 07 - 06 - t13:28:57.402z https://www.欧洲杯微信买球astrazeneca.com/what-science-can-do/labtalk-blog/authors/stewart-owen.html 2021 - 06 - 04 - t12:52:23.851z https://www.欧洲杯微信买球astrazeneca.com/what-science-can-do/labtalk-blog/crispr/advancing-the-safety-of-crispr-as-a-potential-future-therapeutic.html 2020 - 09 - 07 - t08:32:47.321z https://www.欧洲杯微信买球astrazeneca.com/our-science.html 2020 - 09 - 16 - t08:19:27.474z https://www.欧洲杯微信买球astrazeneca.com/our-company.html 2021 - 05 - 07 - t08:04:31.273z https://www.欧洲杯微信买球astrazeneca.com/our-company/our-locations/cambridge.html 2021 - 06 - 16 - t11:27:04.480z https://www.欧洲杯微信买球astrazeneca.com/our-company/our-locations/cambridge/Community-in-Cambridge.html 2021 - 06 - 11 - t12:19:43.454z https://www.欧洲杯微信买球astrazeneca.com/our-company/our-locations/cambridge/collaborations.html 2021 - 06 - 11 - t11:16:37.121z https://www.欧洲杯微信买球astrazeneca.com/our-company/our-locations/gothenburg.html 2020 - 11 - 17 - t15:17:45.246z https://www.欧洲杯微信买球astrazeneca.com/our-company/our-locations/gaithersburg.html 2021 - 04 - 29 - t09:05:28.015z https://www.欧洲杯微信买球astrazeneca.com/our-company/our-strategy.html 2021 - 05 - 19 - t08:04:17.350z https://www.欧洲杯微信买球astrazeneca.com/our-company/our-strategy/be-a-great-place-to-work.html 2021 - 03 - 04 - t16:18:17.392z https://www.欧洲杯微信买球astrazeneca.com/our-company/our-strategy/be-a-great-place-to-work/our-values-and-behaviours.html 2021 - 03 - 04 - t16:19:09.278z https://www.欧洲杯微信买球astrazeneca.com/our-company/our-strategy/be-a-great-place-to-work/our-values-and-behaviours/pushing-the-boundaries-of-science-through-curiosity.html 2021 - 01 - 05 - t07:28:44.184z https://www.欧洲杯微信买球astrazeneca.com/our-company/our-strategy/be-a-great-place-to-work/our-values-and-behaviours/how-an-entrepreneurial-spirit-guides-ground-breaking-innovation.html 2020 - 10 - 26 - t15:18:02.299z https://www.欧洲杯微信买球astrazeneca.com/our - company/our strategy/be - -伟大的-地方- - work/our值-和- behaviours/keeping病人心脏- - - -我们的响应- covid - 19. - html 2020 - 11 - 16 - t15:46:13.500z https://www.欧洲杯微信买球astrazeneca.com/our-company/our-strategy/be-a-great-place-to-work/our-values-and-behaviours/why-an-inclusive-culture-and-leveraging-the-strength-and-diversity-of-our-teams-is-fundamental-to-our-success.html 2021 - 03 - 04 - t17:42:45.496z https://www.欧洲杯微信买球astrazeneca.com/our-company/our-people.html 2021 - 06 - 10 - t07:35:11.149z https://www.欧洲杯微信买球astrazeneca.com/our-company/our-people/cristina-duran.html 2020 - 10 - 16 - t16:37:24.757z https://www.欧洲杯微信买球astrazeneca.com/our-company/our-people/mark-cobbold.html 2021 - 04 - 06 - t11:44:13.339z https://www.欧洲杯微信买球astrazeneca.com/our-company/our-people/magnus-johansson.html 2020 - 11 - 17 - t18:17:47.515z https://www.欧洲杯微信买球astrazeneca.com/our-company/our-people/pablo-panella.html 2020 - 05 - 19 - t09:12:49.682z https://www.欧洲杯微信买球astrazeneca.com/our-company/our-people/teresa-klinowska.html 2020 - 05 - 29 - t09:51:43.431z https://www.欧洲杯微信买球astrazeneca.com/our-company/our-people/cristian-massacesi.html 2021 - 05 - 25 - t10:10:10.936z https://www.欧洲杯微信买球astrazeneca.com/our-company/our-people/malin-lemurell.html 2020 - 08 - 26 - t09:46:37.356z https://www.欧洲杯微信买球astrazeneca.com/our-company/our-people/serban-ghiorghiu.html 2020 - 05 - 30 - t22:31:21.991z https://www.欧洲杯微信买球astrazeneca.com/our-company/our-people/caroline-germa.html 2020 - 06 - 08 - t17:08:11.829z https://www.欧洲杯微信买球astrazeneca.com/our-company/our-people/ezogelin-oflazoglu-gruyters.html 2020 - 06 - 10 - t08:58:17.744z https://www.欧洲杯微信买球astrazeneca.com/our-company/our-people/ashling-mulvaney.html 2020 - 10 - 15 - t09:27:04.831z https://www.欧洲杯微信买球astrazeneca.com/our-company/our-people/carlos-doti.html 2020 - 08 - 10 - t16:24:53.417z https://www.欧洲杯微信买球astrazeneca.com/our-company/our-people/barry-davies.html 2020 - 08 - 25 - t12:52:41.124z https://www.欧洲杯微信买球astrazeneca.com/our-company/our-people/christopher-j-rhodes.html 2020 - 06 - 12 - t15:36:30.255z https://www.欧洲杯微信买球astrazeneca.com/our-company/our-people/nicolas-jose-guzman.html 2020 - 02 - 28 - t16:23:55.537z https://www.欧洲杯微信买球astrazeneca.com/our-company/our-people/helen-angell.html 2018 - 05 - 17 - t11:22:44.683z https://www.欧洲杯微信买球astrazeneca.com/our-company/our-people/ruth-march.html 2020 - 09 - 18 - t14:17:11.416z https://www.欧洲杯微信买球astrazeneca.com/our-company/our-people/mark-o-connor.html 2021 - 04 - 06 - t11:29:27.152z https://www.欧洲杯微信买球astrazeneca.com/our-company/our-people/regina-fritsche-danielson.html 2021 - 02年- 26 - t12:04:00.627z https://www.欧洲杯微信买球astrazeneca.com/our-company/our-people/stephen-delaney.html 2019 - 08 - 22 - t09:14:45.580z https://www.欧洲杯微信买球astrazeneca.com/our-company/our-people/david-keeling.html 2019 - 08 - 22 - t07:23:45.530z https://www.欧洲杯微信买球astrazeneca.com/our-company/our-people/maria-groves.html 2020 - 08 - 05 - t17:16:23.131z https://www.欧洲杯微信买球astrazeneca.com/our-company/our-people/william-dall-acqua.html 2019 - 08 - 19 - t14:55:17.189z https://www.欧洲杯微信买球astrazeneca.com/our-company/our-people/herren-wu.html 2019 - 08 - 22 - t07:31:36.457z https://www.欧洲杯微信买球astrazeneca.com/our-company/our-people/kumar-srinivasan.html 2019 - 09 - 26 - t17:40:25.041z https://www.欧洲杯微信买球astrazeneca.com/our-company/our-people/shaun-grady.html 2017 - 05 - 25 - t14:49:46.141z https://www.欧洲杯微信买球astrazeneca.com/our-company/our-people/menelas-pangalos.html 2021 - 01 - 05 - t13:17:49.260z https://www.欧洲杯微信买球astrazeneca.com/our-company/our-people/mark-fielding.html 2018 - 05 - 15 - t07:00:07.503z https://www.欧洲杯微信买球astrazeneca.com/our-company/our-people/li-ming-gan.html 2020 - 02 - 28 - t16:22:40.333z https://www.欧洲杯微信买球astrazeneca.com/our-company/our-people/paul-harper.html 2019 - 08 - 21 - t09:48:48.399z https://www.欧洲杯微信买球astrazeneca.com/our-company/our-people/katerina-pardali.html 2018 - 03 - 26 - t12:56:40.394z https://www.欧洲杯微信买球astrazeneca.com/our-company/our-people/emma-dean.html 2019 - 03 - 08 - t18:46:08.177z https://www.欧洲杯微信买球astrazeneca.com/our-company/our-people/amy-taylor.html 2020 - 01 - 21 t10:59:05.622z https://www.欧洲杯微信买球astrazeneca.com/our-company/our-people/slave-petrovski.html 2021 - 06 - 09 - t05:18:07.967z https://www.欧洲杯微信买球astrazeneca.com/our-company/our-people/maria-belvisi.html 2020 - 05 - 18 - t15:42:55.454z https://www.欧洲杯微信买球astrazeneca.com/our-company/our-people/ella-ekholm.html 2019 - 08 - 21 - t13:31:26.653z https://www.欧洲杯微信买球astrazeneca.com/our-company/our-people/ramon-nogueras.html 2018 - 05 - 10 - t12:13:57.152z https://www.欧洲杯微信买球astrazeneca.com/our-company/our-people/per-lindblom.html 2019 - 10 - 03 - t11:51:08.264z https://www.欧洲杯微信买球astrazeneca.com/our-company/our-people/elisa-lazaro-ibanez.html 2019 - 08 - 22 - t12:44:52.532z https://www.欧洲杯微信买球astrazeneca.com/our-company/our-people/tom-keith-roach.html 2020 - 06 - 22 - t18:28:08.333z https://www.欧洲杯微信买球astrazeneca.com/our-company/our-people/ralph-knoll.html 2019 - 08 - 19 - t16:08:34.343z https://www.欧洲杯微信买球astrazeneca.com/our-company/our-people/susan-galbraith.html 2019 - 08 - 05 - t13:11:34.692z https://www.欧洲杯微信买球astrazeneca.com/our-company/our-people/clive-green.html 2020 - 11 - 18 - t12:44:10.034z https://www.欧洲杯微信买球astrazeneca.com/our-company/our-people/ola-engkvist.html 2019 - 08 - 27 - t07:40:08.590z https://www.欧洲杯微信买球astrazeneca.com/our-company/our-people/qing-dong-wang.html 2019 - 07 - 09 - t14:41:44.679z https://www.欧洲杯微信买球astrazeneca.com/our-company/our-people/anna-sundgren.html 2020 - 02 - 28 - t16:18:45.751z https://www.欧洲杯微信买球astrazeneca.com/our-company/our-people/Lutz-Jermutus.html 2019 - 06 - 13 - t17:55:42.580z https://www.欧洲杯微信买球astrazeneca.com/our-company/our-people/Elisabeth-Bjork.html 2020 - 03 - 31 - t16:46:24.761z https://www.欧洲杯微信买球astrazeneca.com/our-company/our-people/John-Houghton.html 2020 - 04 - 08 - t16:42:43.012z https://www.欧洲杯微信买球astrazeneca.com/our-company/our-people/jason-snape.html 2020 - 06 - 01 - t14:55:47.130z https://www.欧洲杯微信买球astrazeneca.com/our-company/our-people/miriam-guest.html 2019 - 05 - 02 - t10:38:51.245z https://www.欧洲杯微信买球astrazeneca.com/our-company/our-people/fredrik-rook.html 2019 - 04 - 15 - t14:08:32.120z https://www.欧洲杯微信买球astrazeneca.com/our-company/our-people/andrea-burgos-prieto.html 2019 - 04 - 25 - t15:42:50.736z https://www.欧洲杯微信买球astrazeneca.com/our-company/our-people/kirsha-naicker.html 2019 - 05 - 02 - t13:56:55.524z https://www.欧洲杯微信买球astrazeneca.com/our-company/our-people/anders-broo.html 2019 - 08 - 27 - t07:38:58.176z https://www.欧洲杯微信买球astrazeneca.com/our-company/our-people/joris-silon.html 2020 - 02 - 28 - t16:11:45.894z https://www.欧洲杯微信买球astrazeneca.com/our-company/our-people/umaima-ahmad.html 2019 - 06 - 12 - t15:59:55.465z https://www.欧洲杯微信买球astrazeneca.com/our-company/our-people/asa-sjoholm-timen.html 2019 - 06 - 27 - t13:29:18.507z https://www.欧洲杯微信买球astrazeneca.com/our-company/our-people/chris-kenny.html 2019 - 06 - 28 - t15:26:12.063z https://www.欧洲杯微信买球astrazeneca.com/our-company/our-people/ashiq-ariff.html 2019 - 06 - 28 - t15:27:09.188z https://www.欧洲杯微信买球astrazeneca.com/our-company/our-people/jim-weatherall.html 2021 - 02年- 02 - t13:45:22.950z https://www.欧洲杯微信买球astrazeneca.com/our-company/our-people/simon-bradford.html 2019 - 07 - 04 - t11:10:43.377z https://www.欧洲杯微信买球astrazeneca.com/our-company/our-people/esben-jannik-bjerrum.html 2019 - 08 - 27 - t07:37:45.212z https://www.欧洲杯微信买球astrazeneca.com/our-company/our-people/david-geleta.html 2019 - 06 - 28 - t16:50:25.861z https://www.欧洲杯微信买球astrazeneca.com/our-company/our-people/annette-bak.html 2020 - 09 - 04 - t08:52:17.926z https://www.欧洲杯微信买球astrazeneca.com/our-company/our-people/marianne-ashford.html 2020 - 11 - 17 - t18:18:53.835z https://www.欧洲杯微信买球astrazeneca.com/our-company/our-people/alan-sabirsh.html 2019 - 08 - 29 - t22:47:47.191z https://www.欧洲杯微信买球astrazeneca.com/our-company/our-people/sanyu-puri.html 2019 - 08 - 29 - t22:50:22.715z https://www.欧洲杯微信买球astrazeneca.com/our-company/our-people/arpan-desai.html 2019 - 08 - 29 - t22:52:22.036z https://www.欧洲杯微信买球astrazeneca.com/our-company/our-people/sara-richardson.html 2019 - 08 - 30 - t06:36:31.263z https://www.欧洲杯微信买球astrazeneca.com/our-company/our-people/Lennart-lindfors.html 2020 - 02 - 03 - t17:52:02.194z https://www.欧洲杯微信买球astrazeneca.com/our-company/our-people/richard-marshall.html 2020 - 04 - 27 - t17:30:47.199z https://www.欧洲杯微信买球astrazeneca.com/our-company/our-people/anand-subramony.html 2020 - 02 - 03 - t16:12:07.231z https://www.欧洲杯微信买球astrazeneca.com/our-company/our-people/shawn-davis.html 2020 - 02 - 03 - t16:15:16.729z https://www.欧洲杯微信买球astrazeneca.com/our-company/our-people/kiran-nistala.html 2021 - 06 - 10 - t07:27:13.482z https://www.欧洲杯微信买球astrazeneca.com/our-company/our-people/renee-bailey-iacona.html 2020 - 09 - 14 - t14:41:44.363z https://www.欧洲杯微信买球astrazeneca.com/our-company/our-people/daniel-freeman.html 2020 - 10 - 22 - t15:23:00.689z https://www.欧洲杯微信买球astrazeneca.com/our-company/our-people/puja-sapra.html 2020 - 10 - 22 - t15:22:12.212z https://www.欧洲杯微信买球astrazeneca.com/our-company/our-people/saras-rosin.html 2020 - 09 - 23 - t09:52:37.203z https://www.欧洲杯微信买球astrazeneca.com/our-company/our-people/allan-mackenzie.html 2020 - 09 - 23 - t10:03:29.741z https://www.欧洲杯微信买球astrazeneca.com/our-company/our-people/alicyn-campbell.html 2020 - 10 - 22 - t15:21:36.703z https://www.欧洲杯微信买球astrazeneca.com/our-company/our-people/sunil-verma.html 2020 - 10 - 22 - t15:20:34.674z https://www.欧洲杯微信买球astrazeneca.com/our-company/our-people/andrew-foxley.html 2020 - 10 - 19 - t07:17:13.334z https://www.欧洲杯微信买球astrazeneca.com/our-company/our-people/ann-e-taylor.html 2020 - 10 - 19 - t07:20:43.856z https://www.欧洲杯微信买球astrazeneca.com/our-company/our-people/anas-younes.html 2020 - 10 - 19 - t07:19:32.662z https://www.欧洲杯微信买球astrazeneca.com/our-company/our-people/per-alfredsson.html 2020 - 11 - 11 - t16:15:29.265z https://www.欧洲杯微信买球astrazeneca.com/our-company/our-people/priti-patel.html 2020 - 12 - 05 - t09:48:23.396z https://www.欧洲杯微信买球astrazeneca.com/our-company/our-people/mika-sovak.html 2020 - 12 - 09 - t13:38:07.833z https://www.欧洲杯微信买球astrazeneca.com/our-company/our-people/ti-hwei-how.html 2020 - 12 - 17 - t14:41:03.875z https://www.欧洲杯微信买球astrazeneca.com/our-company/our-people/shin-morita.html 2020 - 12 - 17 - t14:42:32.983z https://www.欧洲杯微信买球astrazeneca.com/our-company/our-people/leora-horn.html 2021 - 01 - 27 t18:35:23.963z https://www.欧洲杯微信买球astrazeneca.com/our-company/our-people/andrea-nance.html 2021 - 02 - 01 - t11:18:31.044z https://www.欧洲杯微信买球astrazeneca.com/our-company/our-people/tonya-villafana.html 2021 - 03 - 21 - t13:35:36.692z https://www.欧洲杯微信买球astrazeneca.com/our-company/our-people/eva-yin.html 2021 - 04 - 20 - t08:16:14.381z https://www.欧洲杯微信买球astrazeneca.com/our-company/our-people/johan-hyllner.html 2021 - 03 - 31 - t15:55:39.961z https://www.欧洲杯微信买球astrazeneca.com/our-company/our-people/Slave_Petrovski.html 2021 - 03 - 31 - t15:59:55.394z https://www.欧洲杯微信买球astrazeneca.com/our-company/our-people/Phillippa-Brown.html 2021 - 04 - 01 - t15:14:09.774z https://www.欧洲杯微信买球astrazeneca.com/our-company/our-people/Steve-rees.html 2021 - 04 - 21 - t10:40:44.298z https://www.欧洲杯微信买球astrazeneca.com/our-company/our-people/stewart-owen.html 2021 - 06 - 16 - t13:51:42.509z https://www.欧洲杯微信买球astrazeneca.com/our-company/our-commitment-to-patients.html 2021 - 05 - 11 - t11:01:34.688z https://www.欧洲杯微信买球astrazeneca.com/our-company/leadership.html 2021 - 05 - 11 - t20:16:36.875z https://www.欧洲杯微信买球astrazeneca.com/our-company/leadership/pascal-soriot.html 2021 - 02 - 01 - t10:51:37.638z https://www.欧洲杯微信买球astrazeneca.com/our-company/leadership/marc-dunoyer.html 2019 - 08 - 05 - t12:45:45.650z https://www.欧洲杯微信买球astrazeneca.com/our-company/leadership/marcus-wallenberg.html 2019 - 03 - 29 - t13:48:33.637z https://www.欧洲杯微信买球astrazeneca.com/our-company/leadership/genevieve-berger.html 2019 - 05 - 09 - t15:26:01.976z https://www.欧洲杯微信买球astrazeneca.com/our-company/leadership/graham-chipchase.html 2019 - 03 - 29 - t12:47:16.690z https://www.欧洲杯微信买球astrazeneca.com/our-company/leadership/jeff-pott.html 2019 - 03 - 29 - t13:03:58.159z https://www.欧洲杯微信买球astrazeneca.com/our-company/leadership/menelas-pengalos.html 2019 - 12 - 02 - t14:56:52.146z https://www.欧洲杯微信买球astrazeneca.com/our-company/leadership/katarina-ageborg.html 2020 - 01 - 20 - t17:42:57.036z https://www.欧洲杯微信买球astrazeneca.com/our-company/leadership/pam-cheng.html 2019 - 08 - 05 - t12:53:49.618z https://www.欧洲杯微信买球astrazeneca.com/our-company/leadership/fiona-cicconi.html 2019 - 03 - 29 - t13:01:56.799z https://www.欧洲杯微信买球astrazeneca.com/our-company/leadership/ruud-dobber.html 2019 - 11 - 05 - t10:30:23.837z https://www.欧洲杯微信买球astrazeneca.com/our-company/leadership/Leon-Wang.html 2019 - 08 - 05 - t12:55:06.914z https://www.欧洲杯微信买球astrazeneca.com/our-company/leadership/Leif-Johansson.html 2019 - 08 - 05 - t12:56:36.821z https://www.欧洲杯微信买球astrazeneca.com/our-company/leadership/philip-broadley.html 2019 - 08 - 05 - t12:57:24.654z https://www.欧洲杯微信买球astrazeneca.com/our-company/leadership/iskra-reic.html 2019 - 08 - 05 - t12:58:08.662z https://www.欧洲杯微信买球astrazeneca.com/our-company/leadership/nazneen-rahman.html 2019 - 08 - 05 - t13:00:23.492z https://www.欧洲杯微信买球astrazeneca.com/our-company/leadership/sheri-mccoy.html 2019 - 08 - 05 - t12:59:57.261z https://www.欧洲杯微信买球astrazeneca.com/our-company/leadership/david-fredrickson.html 2019 - 12 - 02 - t15:01:06.117z https://www.欧洲杯微信买球astrazeneca.com/our-company/leadership/deborah-disanzo.html 2019 - 08 - 05 - t13:01:52.014z https://www.欧洲杯微信买球astrazeneca.com/our-company/leadership/tony-mok.html 2019 - 10 - 03 - t11:44:22.700z https://www.欧洲杯微信买球astrazeneca.com/our-company/leadership/michel-demare.html 2021 - 04 - 16 - t16:29:55.908z https://www.欧洲杯微信买球astrazeneca.com/our-company/leadership/euan-ashley.html 2021 - 04 - 16 - t16:29:36.243z https://www.欧洲杯微信买球astrazeneca.com/our-company/leadership/diana-layfield.html 2021 - 04 - 16 - t16:28:32.312z https://www.欧洲杯微信买球astrazeneca.com/our-company/contact-us.html 2020 - 09 - 28 - t08:52:20.927z https://www.欧洲杯微信买球astrazeneca.com/our-company/uk-hr-policies.html 2020 - 12 - 02 - t12:43:54.550z https://www.欧洲杯微信买球astrazeneca.com/country-sites.html 2015 - 09 - 16 - t10:32:46.644z https://www.欧洲杯微信买球astrazeneca.com/country-sites/african-cluster.html 2020 - 12 - 10 - t08:14:05.494z https://www.欧洲杯微信买球astrazeneca.com/country-sites/slovenia.html 2020 - 11 - 30 - t15:51:23.577z https://www.欧洲杯微信买球astrazeneca.com/country-sites/uruguay.html 2019 - 08 - 29 - t13:37:58.007z https://www.欧洲杯微信买球astrazeneca.com/country-sites/israel.html 2021 - 02年- 02 - t14:13:15.332z https://www.欧洲杯微信买球astrazeneca.com/country-sites/indonesia.html 2020 - 08 - 04 - t09:02:30.126z https://www.欧洲杯微信买球astrazeneca.com/country-sites/slovakia.html 2021 - 01 - 28 - t13:46:15.705z https://www.欧洲杯微信买球astrazeneca.com/country-sites/slovakia/dakujeme.html 2021 - 03 - 25 - t10:32:31.653z https://www.欧洲杯微信买球astrazeneca.com/country-sites/thailand.html 2021 - 06 - 10 - t08:53:47.289z https://www.欧洲杯微信买球astrazeneca.com/country-sites/thailand/press-release.html 2021 - 06 - 10 - t08:51:36.015z https://www.欧洲杯微信买球astrazeneca.com/country-sites/thailand/press-release/thai20210428.html 2021 - 04 - 28 - t04:54:29.842z https://www.欧洲杯微信买球astrazeneca.com/country-sites/thailand/press-release/astrazenecas-covid-19-vaccines-made-by-siam-bioscience-pass-quality-testing-in-europe-and-us-first-batch-delivery-is-near.html 2021 - 06 - 10 - t08:41:04.350z https://www.欧洲杯微信买球astrazeneca.com/country-sites/thailand/press-release/astrazeneca-commences-new-covid-19-vaccine-supply-chain-in-thailand.html 2021 - 06 - 10 - t08:44:45.465z https://www.欧洲杯微信买球astrazeneca.com/country-sites/georgia.html 2021 - 06 - 01 - t08:58:41.149z https://www.欧洲杯微信买球astrazeneca.com/country-sites/croatia.html 2021 - 05 - 06 - t13:10:18.924z https://www.欧洲杯微信买球astrazeneca.com/country-sites/south-africa.html 2020 - 12 - 10 - t08:03:50.974z https://www.欧洲杯微信买球astrazeneca.com/country-sites/sub-saharan-africa.html 2020 - 12 - 10 - t08:12:01.190z https://www.欧洲杯微信买球astrazeneca.com/country-sites/near-east.html 2017 - 10 - 18 - t08:52:00.541z https://www.欧洲杯微信买球astrazeneca.com/country-sites/venezuela_.html 2018 - 09 - 26 - t21:49:42.924z https://www.欧洲杯微信买球astrazeneca.com/country-sites/argentina.html 2020 - 08 - 13 - t16:25:40.664z https://www.欧洲杯微信买球astrazeneca.com/country-sites/belgium.html 2020 - 02 - 04 - t14:05:17.199z https://www.欧洲杯微信买球astrazeneca.com/country-sites/chile.html 2020 - 07 - 01 - t15:56:46.330z https://www.欧洲杯微信买球astrazeneca.com/country-sites/egypt.html 2020 - 11 - 30 - t11:42:46.986z https://www.欧洲杯微信买球astrazeneca.com/country sites/egypt/az -埃及-声明- 30052018. - html 2018 - 05 - 30 - t15:34:31.530z https://www.欧洲杯微信买球astrazeneca.com/country-sites/estonia.html 2021 - 05 - 31 - t13:05:54.289z https://www.欧洲杯微信买球astrazeneca.com/country-sites/greece.html 2021 - 06 - 08 - t06:43:31.056z https://www.欧洲杯微信买球astrazeneca.com/country-sites/gulf.html 2019 - 08 - 23 - t08:49:00.276z https://www.欧洲杯微信买球astrazeneca.com/country-sites/hungary.html 2021 - 02 - 09 - t14:50:36.945z https://www.欧洲杯微信买球astrazeneca.com/country-sites/ireland.html 2020 - 11 - 27 - t19:21:24.421z https://www.欧洲杯微信买球astrazeneca.com/country-sites/latvia.html 2021 - 02 - 16 - t07:58:35.278z https://www.欧洲杯微信买球astrazeneca.com/country-sites/levant.html 2015年10月- 07 - t12:29:28.222z https://www.欧洲杯微信买球astrazeneca.com/country-sites/lithuania.html 2021 - 02年- 02 - t11:53:06.524z https://www.欧洲杯微信买球astrazeneca.com/country-sites/luxembourg.html 2020 - 03 - 30 - t10:25:39.363z https://www.欧洲杯微信买球astrazeneca.com/country-sites/malaysia.html 2021 - 05 - 21 - t05:25:28.369z https://www.欧洲杯微信买球astrazeneca.com/country-sites/malaysia/press-relaeses/astrazeneca-continues-to-drive-healthcare-innovation-with-ai-x-r.html 2021 - 05 - 21 - t05:21:11.604z https://www.欧洲杯微信买球astrazeneca.com/country-sites/mexico.html 2020 - 10 - 15 - t04:49:20.211z https://www.欧洲杯微信买球astrazeneca.com/country-sites/mexico/mas-informacion.html 2015 - 10 - 13 - t08:23:40.227z https://www.欧洲杯微信买球astrazeneca.com/country-sites/taiwan.html 2021 - 04 - 22 - t15:46:39.465z https://www.欧洲杯微信买球astrazeneca.com/country-sites/taiwan/25092018.html 2018 - 10 - 03 - t07:31:34.444z https://www.欧洲杯微信买球astrazeneca.com/country-sites/taiwan/23032020.html 2020 - 03 - 25 - t08:34:01.728z https://www.欧洲杯微信买球astrazeneca.com/country-sites/the-philippines.html 2017 - 09 - 27 - t12:15:57.261z https://www.欧洲杯微信买球astrazeneca.com/country-sites/saudi-arabia.html 2021 - 01 - 18 - t14:38:23.928z https://www.欧洲杯微信买球astrazeneca.com/country-sites/singapore.html 2017 - 03 - 31 - t08:18:25.055z https://www.欧洲杯微信买球astrazeneca.com/country-sites/kazakhstan.html 2019 - 06 - 11 - t11:29:43.219z https://www.欧洲杯微信买球astrazeneca.com/country-sites/vietnam.html 2020 - 12 - 22 - t18:04:48.838z https://www.欧洲杯微信买球astrazeneca.com/country-sites/vietnam/legal-notice-and-terms-of-use.html 2021 - 05 - 12 - t08:18:05.243z https://www.欧洲杯微信买球astrazeneca.com/legal-notice-and-terms-of-use.html 2021 - 03 - 16 - t11:10:42.256z https://www.欧洲杯微信买球astrazeneca.com/privacy-notice.html 2017 - 07 - 07 - t13:07:53.864z https://www.欧洲杯微信买球astrazeneca.com/cookies.html 2019 - 08 - 27 - t12:34:20.025z https://www.欧洲杯微信买球astrazeneca.com/global.html 2015 - 08 - 18 - t10:07:53.662z https://www.欧洲杯微信买球astrazeneca.com/global/en.html 2015 - 09 - 03 - t11:33:45.833z https://www.欧洲杯微信买球astrazeneca.com/global/en/500.html 2015 - 09 - 21 - t16:42:07.149z https://www.欧洲杯微信买球astrazeneca.com/global/en/503.html 2015 - 09 - 21 - t16:42:07.150z https://www.欧洲杯微信买球astrazeneca.com/global/en/Resources.html 2020 - 09 - 29 - t14:39:29.220z https://www.欧洲杯微信买球astrazeneca.com/global/en/global.html 2019 - 05 - 08 - t15:31:17.198z https://www.欧洲杯微信买球astrazeneca.com/global/en/sitemap.html 2020 - 09 - 29 - t14:39:14.791z https://www.欧洲杯微信买球astrazeneca.com/global/en/404.html 2017 - 07 - 07 - t13:04:09.067z https://www.欧洲杯微信买球astrazeneca.com/global/en/AstraZeneca-Websites.html 2021 - 04 - 22 - t11:57:05.682z https://www.欧洲杯微信买球astrazeneca.com/search-results.html 2020 - 06 - 24 t17:53:40.259z